BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Klein CA. Parallel progression of primary tumours and metastases. Nat Rev Cancer. 2009;9:302-312. [PMID: 19308069 DOI: 10.1038/nrc2627] [Cited by in Crossref: 712] [Cited by in F6Publishing: 607] [Article Influence: 59.3] [Reference Citation Analysis]
Number Citing Articles
1 Markiewicz A, Ahrends T, Wełnicka-Jaśkiewicz M, Seroczyńska B, Skokowski J, Jaśkiewicz J, Szade J, Biernat W, Zaczek AJ. Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer. J Transl Med 2012;10:226. [PMID: 23157797 DOI: 10.1186/1479-5876-10-226] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
2 Han M, Watts JA, Jamshidi-Parsian A, Nadeem U, Sarimollaoglu M, Siegel ER, Zharov VP, Galanzha EI. In Vivo Lymphatic Circulating Tumor Cells and Progression of Metastatic Disease. Cancers (Basel) 2020;12:E2866. [PMID: 33028044 DOI: 10.3390/cancers12102866] [Reference Citation Analysis]
3 Tang XH, Urvalek AM, Osei-Sarfo K, Zhang T, Scognamiglio T, Gudas LJ. Gene expression profiling signatures for the diagnosis and prevention of oral cavity carcinogenesis-genome-wide analysis using RNA-seq technology. Oncotarget 2015;6:24424-35. [PMID: 26110572 DOI: 10.18632/oncotarget.4420] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
4 Ansari D, Urey C, Gundewar C, Bauden MP, Andersson R. Comparison of MUC4 expression in primary pancreatic cancer and paired lymph node metastases. Scand J Gastroenterol 2013;48:1183-7. [PMID: 24047396 DOI: 10.3109/00365521.2013.832368] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
5 Pereira L, Mariadason JM, Hannan RD, Dhillon AS. Implications of epithelial-mesenchymal plasticity for heterogeneity in colorectal cancer. Front Oncol 2015;5:13. [PMID: 25699236 DOI: 10.3389/fonc.2015.00013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
6 Ignatiadis M, Dawson SJ. Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality? Ann Oncol 2014;25:2304-13. [PMID: 25336116 DOI: 10.1093/annonc/mdu480] [Cited by in Crossref: 103] [Cited by in F6Publishing: 87] [Article Influence: 14.7] [Reference Citation Analysis]
7 Disanza A, Bisi S, Frittoli E, Malinverno C, Marchesi S, Palamidessi A, Rizvi A, Scita G. Is cell migration a selectable trait in the natural evolution of cancer development? Philos Trans R Soc Lond B Biol Sci 2019;374:20180224. [PMID: 31431177 DOI: 10.1098/rstb.2018.0224] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
8 Lu X, Mu E, Wei Y, Riethdorf S, Yang Q, Yuan M, Yan J, Hua Y, Tiede BJ, Lu X. VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors. Cancer Cell. 2011;20:701-714. [PMID: 22137794 DOI: 10.1016/j.ccr.2011.11.002s1535-6108(11)00408-9] [Reference Citation Analysis]
9 Saxena M, Christofori G. Rebuilding cancer metastasis in the mouse. Mol Oncol. 2013;7:283-296. [PMID: 23474222 DOI: 10.1016/j.molonc.2013.02.009] [Cited by in Crossref: 88] [Cited by in F6Publishing: 78] [Article Influence: 11.0] [Reference Citation Analysis]
10 Huang S. Tumor progression: Chance and necessity in Darwinian and Lamarckian somatic (mutationless) evolution. Progress in Biophysics and Molecular Biology 2012;110:69-86. [DOI: 10.1016/j.pbiomolbio.2012.05.001] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 4.8] [Reference Citation Analysis]
11 Narod SA, Sopik V. Is invasion a necessary step for metastases in breast cancer? Breast Cancer Res Treat 2018;169:9-23. [PMID: 29353366 DOI: 10.1007/s10549-017-4644-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
12 Osako T, Iwase T, Kimura K, Horii R, Akiyama F. Sentinel node tumour burden quantified based on cytokeratin 19 mRNA copy number predicts non-sentinel node metastases in breast cancer: Molecular whole-node analysis of all removed nodes. European Journal of Cancer 2013;49:1187-95. [DOI: 10.1016/j.ejca.2012.11.022] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
13 Jallow F, O'Leary KA, Rugowski DE, Guerrero JF, Ponik SM, Schuler LA. Dynamic interactions between the extracellular matrix and estrogen activity in progression of ER+ breast cancer. Oncogene 2019;38:6913-25. [PMID: 31406251 DOI: 10.1038/s41388-019-0941-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
14 Hühns M, Krohn S, Murua Escobar H, Prall F. Genomic heterogeneity in primary colorectal carcinomas and their metastases: born bad or brought up a villain? Hum Pathol 2018;74:54-63. [PMID: 29307628 DOI: 10.1016/j.humpath.2017.12.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
15 Hirata Y, Akakura K, Higano CS, Bruchovsky N, Aihara K. Quantitative mathematical modeling of PSA dynamics of prostate cancer patients treated with intermittent androgen suppression. J Mol Cell Biol 2012;4:127-32. [PMID: 22561841 DOI: 10.1093/jmcb/mjs020] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
16 Amaro A, Angelini G, Mirisola V, Esposito AI, Reverberi D, Matis S, Maffei M, Giaretti W, Viale M, Gangemi R, Emionite L, Astigiano S, Cilli M, Bachmeier BE, Killian PH, Albini A, Pfeffer U. A highly invasive subpopulation of MDA-MB-231 breast cancer cells shows accelerated growth, differential chemoresistance, features of apocrine tumors and reduced tumorigenicity in vivo. Oncotarget 2016;7:68803-20. [PMID: 27626697 DOI: 10.18632/oncotarget.11931] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
17 Custódio-Santos T, Videira M, Brito MA. Brain metastasization of breast cancer. Biochim Biophys Acta Rev Cancer 2017;1868:132-47. [PMID: 28341420 DOI: 10.1016/j.bbcan.2017.03.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
18 Sosa MS, Bragado P, Aguirre-Ghiso JA. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer. 2014;14:611-622. [PMID: 25118602 DOI: 10.1038/nrc3793] [Cited by in Crossref: 565] [Cited by in F6Publishing: 498] [Article Influence: 80.7] [Reference Citation Analysis]
19 Smith HA, Kang Y. The metastasis-promoting roles of tumor-associated immune cells. J Mol Med (Berl). 2013;91:411-429. [PMID: 23515621 DOI: 10.1007/s00109-013-1021-5] [Cited by in Crossref: 221] [Cited by in F6Publishing: 188] [Article Influence: 27.6] [Reference Citation Analysis]
20 Kassam Z, Burgers K, Walsh JC, Lee T, Leong HS, Fisher B. A prospective feasibility study evaluating the role of multimodality imaging and liquid biopsy for response assessment in locally advanced rectal carcinoma. Abdom Radiol 2019;44:3641-51. [DOI: 10.1007/s00261-019-02135-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
21 Chen W, Allen SG, Reka AK, Qian W, Han S, Zhao J, Bao L, Keshamouni VG, Merajver SD, Fu J. Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics. BMC Cancer 2016;16:614. [PMID: 27501846 DOI: 10.1186/s12885-016-2638-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
22 Alix-Panabières C, Pantel K. Challenges in circulating tumour cell research. Nat Rev Cancer. 2014;14:623-631. [PMID: 25154812 DOI: 10.1038/nrc3820] [Cited by in Crossref: 774] [Cited by in F6Publishing: 702] [Article Influence: 110.6] [Reference Citation Analysis]
23 Riihimäki M, Thomsen H, Sundquist K, Sundquist J, Hemminki K. Clinical landscape of cancer metastases. Cancer Med 2018;7:5534-42. [PMID: 30328287 DOI: 10.1002/cam4.1697] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
24 Huang S. On the intrinsic inevitability of cancer: from foetal to fatal attraction. Semin Cancer Biol 2011;21:183-99. [PMID: 21640825 DOI: 10.1016/j.semcancer.2011.05.003] [Cited by in Crossref: 54] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
25 Wen J, Luo KJ, Liu QW, Wang G, Zhang MF, Xie XY, Yang H, Fu JH, Hu Y. The epithelial-mesenchymal transition phenotype of metastatic lymph nodes impacts the prognosis of esophageal squamous cell carcinoma patients. Oncotarget 2016;7:37581-8. [PMID: 27147562 DOI: 10.18632/oncotarget.9036] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
26 Fokas E, Liersch T, Fietkau R, Hohenberger W, Beissbarth T, Hess C, Becker H, Ghadimi M, Mrak K, Merkel S, Raab H, Sauer R, Wittekind C, Rödel C. Tumor Regression Grading After Preoperative Chemoradiotherapy for Locally Advanced Rectal Carcinoma Revisited: Updated Results of the CAO/ARO/AIO-94 Trial. JCO 2014;32:1554-62. [DOI: 10.1200/jco.2013.54.3769] [Cited by in Crossref: 214] [Cited by in F6Publishing: 113] [Article Influence: 30.6] [Reference Citation Analysis]
27 Liao D, Estévez-Salmerón L, Tlsty TD. Conceptualizing a tool to optimize therapy based on dynamic heterogeneity. Phys Biol 2012;9:065005. [PMID: 23197078 DOI: 10.1088/1478-3975/9/6/065005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
28 Chimonidou M, Strati A, Tzitzira A, Sotiropoulou G, Malamos N, Georgoulias V, Lianidou ES. DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells. Clin Chem. 2011;57:1169-1177. [PMID: 21700955 DOI: 10.1373/clinchem.2011.165902] [Cited by in Crossref: 98] [Cited by in F6Publishing: 79] [Article Influence: 9.8] [Reference Citation Analysis]
29 Kim R, Schell MJ, Teer JK, Greenawalt DM, Yang M, Yeatman TJ. Co-evolution of somatic variation in primary and metastatic colorectal cancer may expand biopsy indications in the molecular era. PLoS One 2015;10:e0126670. [PMID: 25974029 DOI: 10.1371/journal.pone.0126670] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
30 Losa F, Iglesias L, Pané M, Sanz J, Nieto B, Fusté V, de la Cruz-Merino L, Concha Á, Balañá C, Matías-Guiu X. 2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary. Clin Transl Oncol 2018;20:1361-72. [PMID: 29808414 DOI: 10.1007/s12094-018-1899-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
31 Mohamed Suhaimi NA, Foong YM, Lee DY, Phyo WM, Cima I, Lee EX, Goh WL, Lim WY, Chia KS, Kong SL, Gong M, Lim B, Hillmer AM, Koh PK, Ying JY, Tan MH. Non-invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patients. Mol Oncol 2015;9:850-60. [PMID: 25605225 DOI: 10.1016/j.molonc.2014.12.011] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
32 Engel J, Weichert W, Jung A, Emeny R, Hölzel D. Lymph node infiltration, parallel metastasis and treatment success in breast cancer. The Breast 2019;48:1-6. [DOI: 10.1016/j.breast.2019.07.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
33 Conteduca V, Zamarchi R, Rossi E, Condelli V, Troiani L, Aieta M. Circulating tumor cells: utopia or reality? Future Oncology 2013;9:1337-52. [DOI: 10.2217/fon.13.101] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
34 Wedemann G, Bethge A, Haustein V, Schumacher U. Computer simulation of the metastatic progression. Methods Mol Biol 2014;1070:107-16. [PMID: 24092435 DOI: 10.1007/978-1-4614-8244-4_8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
35 Xie T, Cho YB, Wang K, Huang D, Hong HK, Choi YL, Ko YH, Nam DH, Jin J, Yang H. Patterns of somatic alterations between matched primary and metastatic colorectal tumors characterized by whole-genome sequencing. Genomics. 2014;104:234-241. [PMID: 25066378 DOI: 10.1016/j.ygeno.2014.07.012] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.7] [Reference Citation Analysis]
36 Anwar DM, El-Sayed M, Reda A, Fang JY, Khattab SN, Elzoghby AO. Recent advances in herbal combination nanomedicine for cancer: delivery technology and therapeutic outcomes. Expert Opin Drug Deliv 2021;:1-17. [PMID: 34254868 DOI: 10.1080/17425247.2021.1955853] [Reference Citation Analysis]
37 Kim MY, Na I, Kim JS, Son SH, Choi S, Lee SE, Kim JH, Jang K, Alterovitz G, Chen Y, van der Vaart A, Won HS, Uversky VN, Kim CG. Rational discovery of antimetastatic agents targeting the intrinsically disordered region of MBD2. Sci Adv 2019;5:eaav9810. [PMID: 31799386 DOI: 10.1126/sciadv.aav9810] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
38 Hosseini H, Obradović MMS, Hoffmann M, Harper KL, Sosa MS, Werner-Klein M, Nanduri LK, Werno C, Ehrl C, Maneck M, Patwary N, Haunschild G, Gužvić M, Reimelt C, Grauvogl M, Eichner N, Weber F, Hartkopf AD, Taran FA, Brucker SY, Fehm T, Rack B, Buchholz S, Spang R, Meister G, Aguirre-Ghiso JA, Klein CA. Early dissemination seeds metastasis in breast cancer. Nature 2016;540:552-8. [PMID: 27974799 DOI: 10.1038/nature20785] [Cited by in Crossref: 310] [Cited by in F6Publishing: 266] [Article Influence: 62.0] [Reference Citation Analysis]
39 Banys M, Krawczyk N, Becker S, Jakubowska J, Staebler A, Wallwiener D, Fehm T, Rothmund R. The influence of removal of primary tumor on incidence and phenotype of circulating tumor cells in primary breast cancer. Breast Cancer Res Treat. 2012;132:121-129. [PMID: 21562707 DOI: 10.1007/s10549-011-1569-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
40 Retz M, Rotering J, Nawroth R, Buchner A, Stöckle M, Gschwend JE, Lehmann J. Long-term follow-up of bladder cancer patients with disseminated tumour cells in bone marrow. Eur Urol 2011;60:231-8. [PMID: 21190793 DOI: 10.1016/j.eururo.2010.12.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
41 Han X, Wang J, Sun Y. Circulating Tumor DNA as Biomarkers for Cancer Detection. Genomics Proteomics Bioinformatics 2017;15:59-72. [PMID: 28392479 DOI: 10.1016/j.gpb.2016.12.004] [Cited by in Crossref: 113] [Cited by in F6Publishing: 94] [Article Influence: 28.3] [Reference Citation Analysis]
42 Edwards CM, Johnson RW. Targeting Histone Modifications in Bone and Lung Metastatic Cancers. Curr Osteoporos Rep 2021;19:230-46. [PMID: 33721181 DOI: 10.1007/s11914-021-00670-2] [Reference Citation Analysis]
43 Khella HWZ, White NMA, Faragalla H, Gabril M, Boazak M, Dorian D, Khalil B, Antonios H, Bao TT, Pasic MD, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Jewett MAS, Yousef GM. Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses. Tumor Biol 2012;33:131-40. [DOI: 10.1007/s13277-011-0255-5] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 4.7] [Reference Citation Analysis]
44 Massagué J, Obenauf AC. Metastatic colonization by circulating tumour cells. Nature 2016;529:298-306. [PMID: 26791720 DOI: 10.1038/nature17038] [Cited by in Crossref: 818] [Cited by in F6Publishing: 712] [Article Influence: 163.6] [Reference Citation Analysis]
45 Edwards CM, Johnson RW. From Good to Bad: The Opposing Effects of PTHrP on Tumor Growth, Dormancy, and Metastasis Throughout Cancer Progression. Front Oncol 2021;11:644303. [PMID: 33828987 DOI: 10.3389/fonc.2021.644303] [Reference Citation Analysis]
46 Hsieh JJ, Manley BJ, Khan N, Gao J, Carlo MI, Cheng EH. Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: A braided cancer river model of kidney cancer. Semin Cell Dev Biol 2017;64:98-106. [PMID: 27615548 DOI: 10.1016/j.semcdb.2016.09.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
47 Fontebasso Y, Dubinett SM. Drug Development for Metastasis Prevention. Crit Rev Oncog 2015;20:449-73. [PMID: 27279241 DOI: 10.1615/CritRevOncog.v20.i5-6.150] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 5.7] [Reference Citation Analysis]
48 Kuo YB, Chen JS, Fan CW, Li YS, Chan EC. Comparison of KRAS mutation analysis of primary tumors and matched circulating cell-free DNA in plasmas of patients with colorectal cancer. Clin Chim Acta 2014;433:284-9. [PMID: 24685572 DOI: 10.1016/j.cca.2014.03.024] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 6.6] [Reference Citation Analysis]
49 Renner P, Torzewski M, Zeman F, Babilas P, Kroemer A, Schlitt HJ, Dahlke MH. Increasing Morbidity with Extent of Lymphadenectomy for Primary Malignant Melanoma. Lymphatic Research and Biology 2017;15:146-52. [DOI: 10.1089/lrb.2016.0018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
50 Tinhofer I, Saki M, Niehr F, Keilholz U, Budach V. Cancer stem cell characteristics of circulating tumor cells. Int J Radiat Biol. 2014;90:622-627. [PMID: 24460132 DOI: 10.3109/09553002.2014.886798] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
51 Gadiya M, Chakraborty G. Signaling by discoidin domain receptor 1 in cancer metastasis. Cell Adh Migr 2018;12:315-23. [PMID: 30187813 DOI: 10.1080/19336918.2018.1520556] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
52 Kawauchi T. Cell adhesion and its endocytic regulation in cell migration during neural development and cancer metastasis. Int J Mol Sci 2012;13:4564-90. [PMID: 22605996 DOI: 10.3390/ijms13044564] [Cited by in Crossref: 87] [Cited by in F6Publishing: 76] [Article Influence: 9.7] [Reference Citation Analysis]
53 Tosca EM, Rocchetti M, Magni P. A Dynamic Energy Budget (DEB) based modeling framework to describe tumor-in-host growth inhibition and cachexia onset during anticancer treatment in in vivo xenograft studies. Oncotarget 2021;12:1434-41. [PMID: 34262653 DOI: 10.18632/oncotarget.27960] [Reference Citation Analysis]
54 Nicolini A, Rossi G, Ferrari P, Carpi A. Minimal residual disease in advanced or metastatic solid cancers: The G0-G1 state and immunotherapy are key to unwinding cancer complexity. Semin Cancer Biol 2020:S1044-579X(20)30075-4. [PMID: 32201368 DOI: 10.1016/j.semcancer.2020.03.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
55 Valkenburg KC, Amend SR, Verdone JE, van der Toom EE, Hernandez JR, Gorin MA, Pienta KJ. A simple selection-free method for detecting disseminated tumor cells (DTCs) in murine bone marrow. Oncotarget 2016;7:69794-803. [PMID: 27634877 DOI: 10.18632/oncotarget.12000] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
56 Rakaee M, Busund LR, Jamaly S, Paulsen EE, Richardsen E, Andersen S, Al-Saad S, Bremnes RM, Donnem T, Kilvaer TK. Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry. Neoplasia 2019;21:282-93. [PMID: 30743162 DOI: 10.1016/j.neo.2019.01.005] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 23.0] [Reference Citation Analysis]
57 Voutsina A, Tzardi M, Kalikaki A, Zafeiriou Z, Papadimitraki E, Papadakis M, Mavroudis D, Georgoulias V. Combined analysis of KRAS and PIK3CA mutations, MET and PTEN expression in primary tumors and corresponding metastases in colorectal cancer. Mod Pathol. 2013;26:302-313. [PMID: 22936063 DOI: 10.1038/modpathol.2012.150] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 4.2] [Reference Citation Analysis]
58 Goodman CR, Seagle BL, Friedl TWP, Rack B, Lato K, Fink V, Cristofanilli M, Donnelly ED, Janni W, Shahabi S, Strauss JB. Association of Circulating Tumor Cell Status With Benefit of Radiotherapy and Survival in Early-Stage Breast Cancer. JAMA Oncol 2018;4:e180163. [PMID: 29800954 DOI: 10.1001/jamaoncol.2018.0163] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 17.3] [Reference Citation Analysis]
59 Rajput A, Agarwal E, Leiphrakpam P, Brattain MG, Chowdhury S. Establishment and Validation of an Orthotopic Metastatic Mouse Model of Colorectal Cancer. ISRN Hepatol. 2013;2013:206875. [PMID: 27340651 DOI: 10.1155/2013/206875] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
60 Abdallah EA, Braun AC, Flores BCTCP, Senda L, Urvanegia AC, Calsavara V, Fonseca de Jesus VH, Almeida MFA, Begnami MD, Coimbra FJF, da Costa WL Jr, Nunes DN, Dias-Neto E, Chinen LTD. The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer. Oncologist 2019;24:e854-63. [PMID: 30846515 DOI: 10.1634/theoncologist.2018-0741] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
61 Gaianigo N, Melisi D, Carbone C. EMT and Treatment Resistance in Pancreatic Cancer. Cancers (Basel). 2017;9:pii: E122. [PMID: 28895920 DOI: 10.3390/cancers9090122] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 14.3] [Reference Citation Analysis]
62 Greaves M, Maley CC. Clonal evolution in cancer. Nature. 2012;481:306-313. [PMID: 22258609 DOI: 10.1038/nature10762] [Cited by in Crossref: 1813] [Cited by in F6Publishing: 1398] [Article Influence: 201.4] [Reference Citation Analysis]
63 Suh YG, Cho J. Local ablative radiotherapy for oligometastatic non-small cell lung cancer. Radiat Oncol J 2019;37:149-55. [PMID: 31591862 DOI: 10.3857/roj.2019.00514] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
64 García-Jiménez C, Goding CR. Starvation and Pseudo-Starvation as Drivers of Cancer Metastasis through Translation Reprogramming. Cell Metab 2019;29:254-67. [PMID: 30581118 DOI: 10.1016/j.cmet.2018.11.018] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 12.7] [Reference Citation Analysis]
65 Friberg S, Nyström A. Cancer Metastases: Early Dissemination and Late Recurrences. Cancer Growth Metastasis 2015;8:43-9. [PMID: 26640389 DOI: 10.4137/CGM.S31244] [Cited by in Crossref: 62] [Cited by in F6Publishing: 36] [Article Influence: 10.3] [Reference Citation Analysis]
66 Yoon HJ, Kozminsky M, Nagrath S. Emerging role of nanomaterials in circulating tumor cell isolation and analysis. ACS Nano 2014;8:1995-2017. [PMID: 24601556 DOI: 10.1021/nn5004277] [Cited by in Crossref: 178] [Cited by in F6Publishing: 147] [Article Influence: 25.4] [Reference Citation Analysis]
67 Schmid-Alliana A, Schmid-Antomarchi H, Al-Sahlanee R, Lagadec P, Scimeca JC, Verron E. Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets. Int J Mol Sci 2018;19:E148. [PMID: 29300334 DOI: 10.3390/ijms19010148] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
68 Xie J, Zhang XB, Wen J, Zhang YS, Li HZ. Comparison of clinicopathological features in metastatic upper tract urothelial carcinoma and urothelial bladder cancer. Int Urol Nephrol 2016;48:481-7. [PMID: 26797856 DOI: 10.1007/s11255-016-1214-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
69 Cross WCh, Graham TA, Wright NA. New paradigms in clonal evolution: punctuated equilibrium in cancer. J Pathol 2016;240:126-36. [PMID: 27282810 DOI: 10.1002/path.4757] [Cited by in Crossref: 57] [Cited by in F6Publishing: 42] [Article Influence: 11.4] [Reference Citation Analysis]
70 Pukazhendhi G, Glück S. Circulating tumor cells in breast cancer. J Carcinog 2014;13:8. [PMID: 25191136 DOI: 10.4103/1477-3163.135578] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
71 Deryugina EI, Kiosses WB. Intratumoral Cancer Cell Intravasation Can Occur Independent of Invasion into the Adjacent Stroma. Cell Rep. 2017;19:601-616. [PMID: 28423322 DOI: 10.1016/j.celrep.2017.03.064] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 10.5] [Reference Citation Analysis]
72 Park M, Lee D, Shim MK, Jang EH, Lee JK, Jeong SY, Kim J. Piperlongumine inhibits TGF-β-induced epithelial-to-mesenchymal transition by modulating the expression of E-cadherin, Snail1, and Twist1. European Journal of Pharmacology 2017;812:243-9. [DOI: 10.1016/j.ejphar.2017.07.036] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
73 Peitzsch C, Tyutyunnykova A, Pantel K, Dubrovska A. Cancer stem cells: The root of tumor recurrence and metastases. Seminars in Cancer Biology 2017;44:10-24. [DOI: 10.1016/j.semcancer.2017.02.011] [Cited by in Crossref: 157] [Cited by in F6Publishing: 146] [Article Influence: 39.3] [Reference Citation Analysis]
74 Moussa RA, Khalil EZI, Ali AI. Prognostic Role of Epithelial-Mesenchymal Transition Markers "E-Cadherin, β-Catenin, ZEB1, ZEB2 and p63" in Bladder Carcinoma. World J Oncol 2019;10:199-217. [PMID: 31921376 DOI: 10.14740/wjon1234] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
75 Hölzel D, Emeny RT, Engel J. True local recurrences do not metastasize. Cancer Metastasis Rev 2011;30:161-76. [PMID: 21267770 DOI: 10.1007/s10555-011-9275-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
76 Castaño Z, San Juan BP, Spiegel A, Pant A, DeCristo MJ, Laszewski T, Ubellacker JM, Janssen SR, Dongre A, Reinhardt F, Henderson A, Del Rio AG, Gifford AM, Herbert ZT, Hutchinson JN, Weinberg RA, Chaffer CL, McAllister SS. IL-1β inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization. Nat Cell Biol 2018;20:1084-97. [PMID: 30154549 DOI: 10.1038/s41556-018-0173-5] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 18.7] [Reference Citation Analysis]
77 Riihimäki M, Thomsen H, Hemminki A, Sundquist K, Hemminki K. Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer. BMC Cancer 2013;13:36. [PMID: 23356713 DOI: 10.1186/1471-2407-13-36] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]
78 Yu L, Shi Z, Gao L, Li C. Mitigated reactive oxygen species generation leads to an improvement of cell proliferation on poly[glycidyl methacrylate- co -poly(ethylene glycol) methacrylate] functionalized polydimethylsiloxane surfaces: ROS GENERATION ON POLY(GMA- CO -PEGMA). J Biomed Mater Res 2015;103:2987-97. [DOI: 10.1002/jbm.a.35432] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
79 Hu Z, Li Z, Ma Z, Curtis C. Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases. Nat Genet 2020;52:701-8. [PMID: 32424352 DOI: 10.1038/s41588-020-0628-z] [Cited by in Crossref: 60] [Cited by in F6Publishing: 43] [Article Influence: 60.0] [Reference Citation Analysis]
80 Renner P, Rovira J, Klein C, Schlitt HJ, Geissler EK, Kroemer A. KLRG1+ natural killer cells protect against pulmonary metastatic disease by immunosurveillance. Oncoimmunology 2014;3:e28328. [PMID: 25050205 DOI: 10.4161/onci.28328] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
81 Gabriel MT, Calleja LR, Chalopin A, Ory B, Heymann D. Circulating Tumor Cells: A Review of Non–EpCAM-Based Approaches for Cell Enrichment and Isolation. Clinical Chemistry 2016;62:571-81. [DOI: 10.1373/clinchem.2015.249706] [Cited by in Crossref: 121] [Cited by in F6Publishing: 110] [Article Influence: 24.2] [Reference Citation Analysis]
82 Malik UU, Zarina S, Pennington SR. Oral squamous cell carcinoma: Key clinical questions, biomarker discovery, and the role of proteomics. Archives of Oral Biology 2016;63:53-65. [DOI: 10.1016/j.archoralbio.2015.11.017] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 9.2] [Reference Citation Analysis]
83 Guerrini L, Garcia-Rico E, O'Loghlen A, Giannini V, Alvarez-Puebla RA. Surface-Enhanced Raman Scattering (SERS) Spectroscopy for Sensing and Characterization of Exosomes in Cancer Diagnosis. Cancers (Basel) 2021;13:2179. [PMID: 33946619 DOI: 10.3390/cancers13092179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
84 Willaert W, Ceelen W. Extent of surgery in cancer of the colon: is more better? World J Gastroenterol. 2015;21:132-138. [PMID: 25574086 DOI: 10.3748/wjg.v21.i1.132] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
85 Khoo BL, Lee SC, Kumar P, Tan TZ, Warkiani ME, Ow SG, Nandi S, Lim CT, Thiery JP. Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy. Oncotarget 2015;6:15578-93. [PMID: 26008969 DOI: 10.18632/oncotarget.3903] [Cited by in Crossref: 86] [Cited by in F6Publishing: 82] [Article Influence: 17.2] [Reference Citation Analysis]
86 Wick MR. Metastases of malignant neoplasms: Historical, biological, & clinical considerations. Semin Diagn Pathol 2018;35:112-22. [PMID: 29198586 DOI: 10.1053/j.semdp.2017.11.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
87 Shen J, Lu J, Sui L, Wang D, Yin M, Hoffmann I, Legler A, Pflugfelder GO. The orthologous Tbx transcription factors Omb and TBX2 induce epithelial cell migration and extrusion in vivo without involvement of matrix metalloproteinases. Oncotarget 2014;5:11998-2015. [PMID: 25344916 DOI: 10.18632/oncotarget.2426] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
88 Juratli MA, Sarimollaoglu M, Nedosekin DA, Melerzanov AV, Zharov VP, Galanzha EI. Dynamic Fluctuation of Circulating Tumor Cells during Cancer Progression. Cancers (Basel) 2014;6:128-42. [PMID: 24434542 DOI: 10.3390/cancers6010128] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
89 Zhong WZ, Wu YL, Yang XN, Guo AL, Su J, Zhang XC, Luo DL, Wang Z, Chen HJ, Zhou Q, Xu CR, Qiao GB, Liao RQ, Yang JJ, Mok TS. Genetic evolution of epidermal growth factor receptor in adenocarcinoma with a bronchioloalveolar carcinoma component. Clin Lung Cancer 2010;11:160-8. [PMID: 20439191 DOI: 10.3816/CLC.2010.n.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
90 Hartkopf AD, Brucker SY, Taran FA, Harbeck N, von Au A, Naume B, Pierga JY, Hoffmann O, Beckmann MW, Rydén L, Fehm T, Aft R, Solà M, Walter V, Rack B, Schuetz F, Borgen E, Ta MH, Bittner AK, Fasching PA, Fernö M, Krawczyk N, Weilbaecher K, Margelí M, Hahn M, Jueckstock J, Domschke C, Bidard FC, Kasimir-Bauer S, Schoenfisch B, Kurt AG, Wallwiener M, Gebauer G, Klein CA, Wallwiener D, Janni W, Pantel K. Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis. Eur J Cancer 2021;154:128-37. [PMID: 34265505 DOI: 10.1016/j.ejca.2021.06.028] [Reference Citation Analysis]
91 Bidard FC, Ferrand FR, Huguet F, Hammel P, Louvet C, Malka D, Boige V, Ducreux M, Andre T, de Gramont A, Mariani P, Pierga JY. Disseminated and circulating tumor cells in gastrointestinal oncology. Crit Rev Oncol Hematol 2012;82:103-15. [PMID: 21680197 DOI: 10.1016/j.critrevonc.2011.05.008] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
92 Schuler LA, Murdoch FE. Endogenous and Therapeutic Estrogens: Maestro Conductors of the Microenvironment of ER+ Breast Cancers. Cancers (Basel) 2021;13:3725. [PMID: 34359625 DOI: 10.3390/cancers13153725] [Reference Citation Analysis]
93 Faltas B. Cornering metastases: therapeutic targeting of circulating tumor cells and stem cells. Front Oncol 2012;2:68. [PMID: 22783544 DOI: 10.3389/fonc.2012.00068] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
94 Wimmer K, Strobl S, Bolliger M, Devyatko Y, Korkmaz B, Exner R, Fitzal F, Gnant M. Optimal duration of adjuvant endocrine therapy: how to apply the newest data. Ther Adv Med Oncol. 2017;9:679-692. [PMID: 29344105 DOI: 10.1177/1758834017732966] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
95 Pani G, Galeotti T, Chiarugi P. Metastasis: cancer cell's escape from oxidative stress. Cancer Metastasis Rev 2010;29:351-78. [PMID: 20386957 DOI: 10.1007/s10555-010-9225-4] [Cited by in Crossref: 200] [Cited by in F6Publishing: 166] [Article Influence: 18.2] [Reference Citation Analysis]
96 Mathiesen RR, Fjelldal R, Liestøl K, Due EU, Geigl JB, Riethdorf S, Borgen E, Rye IH, Schneider IJ, Obenauf AC, Mauermann O, Nilsen G, Christian Lingjaerde O, Børresen-Dale AL, Pantel K, Speicher MR, Naume B, Baumbusch LO. High-resolution analyses of copy number changes in disseminated tumor cells of patients with breast cancer. Int J Cancer 2012;131:E405-15. [PMID: 21935921 DOI: 10.1002/ijc.26444] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
97 Hardingham JE, Grover P, Winter M, Hewett PJ, Price TJ, Thierry B. Detection and Clinical Significance of Circulating Tumor Cells in Colorectal Cancer--20 Years of Progress. Mol Med. 2015;21 Suppl 1:S25-S31. [PMID: 26605644 DOI: 10.2119/molmed.2015.00149] [Cited by in Crossref: 75] [Cited by in F6Publishing: 68] [Article Influence: 12.5] [Reference Citation Analysis]
98 Kimbung S, Loman N, Hedenfalk I. Clinical and molecular complexity of breast cancer metastases. Semin Cancer Biol. 2015;35:85-95. [PMID: 26319607 DOI: 10.1016/j.semcancer.2015.08.009] [Cited by in Crossref: 69] [Cited by in F6Publishing: 61] [Article Influence: 11.5] [Reference Citation Analysis]
99 Bleckmann A, Conradi LC, Menck K, Schmick NA, Schubert A, Rietkötter E, Arackal J, Middel P, Schambony A, Liersch T, Homayounfar K, Beißbarth T, Klemm F, Binder C, Pukrop T. β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases. Clin Exp Metastasis 2016;33:309-23. [PMID: 26862065 DOI: 10.1007/s10585-016-9780-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
100 Gomis RR, Gawrzak S. Tumor cell dormancy. Mol Oncol 2017;11:62-78. [PMID: 28017284 DOI: 10.1016/j.molonc.2016.09.009] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 13.4] [Reference Citation Analysis]
101 Rifatbegovic F, Frech C, Abbasi MR, Taschner-Mandl S, Weiss T, Schmidt WM, Schmidt I, Ladenstein R, Ambros IM, Ambros PF. Neuroblastoma cells undergo transcriptomic alterations upon dissemination into the bone marrow and subsequent tumor progression. Int J Cancer 2018;142:297-307. [PMID: 28921546 DOI: 10.1002/ijc.31053] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
102 She X, Gao Y, Zhao Y, Yin Y, Dong Z. A high-throughput screen identifies inhibitors of lung cancer stem cells. Biomed Pharmacother 2021;140:111748. [PMID: 34044271 DOI: 10.1016/j.biopha.2021.111748] [Reference Citation Analysis]
103 Kalinowski L, Saunus JM, Mccart Reed AE, Lakhani SR. Breast Cancer Heterogeneity in Primary and Metastatic Disease. In: Ahmad A, editor. Breast Cancer Metastasis and Drug Resistance. Cham: Springer International Publishing; 2019. pp. 75-104. [DOI: 10.1007/978-3-030-20301-6_6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
104 Gao H, Liu W, Yang S, Zhang W, Li X, Qin H, Wang W, Zhao C. Detection of circulating tumor cells using oHSV1-hTERT-GFP in lung cancer. Thorac Cancer 2018;9:44-50. [PMID: 29068150 DOI: 10.1111/1759-7714.12526] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
105 Naxerova K, Jain RK. Using tumour phylogenetics to identify the roots of metastasis in humans. Nat Rev Clin Oncol 2015;12:258-72. [DOI: 10.1038/nrclinonc.2014.238] [Cited by in Crossref: 90] [Cited by in F6Publishing: 77] [Article Influence: 15.0] [Reference Citation Analysis]
106 Loeb LA. Human cancers express mutator phenotypes: origin, consequences and targeting. Nat Rev Cancer 2011;11:450-7. [PMID: 21593786 DOI: 10.1038/nrc3063] [Cited by in Crossref: 263] [Cited by in F6Publishing: 206] [Article Influence: 26.3] [Reference Citation Analysis]
107 Chitty JL, Filipe EC, Lucas MC, Herrmann D, Cox TR, Timpson P. Recent advances in understanding the complexities of metastasis. F1000Res 2018;7:F1000 Faculty Rev-1169. [PMID: 30135716 DOI: 10.12688/f1000research.15064.2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 12.0] [Reference Citation Analysis]
108 Yang L, Lin PC. Mechanisms that drive inflammatory tumor microenvironment, tumor heterogeneity, and metastatic progression. Semin Cancer Biol 2017;47:185-95. [PMID: 28782608 DOI: 10.1016/j.semcancer.2017.08.001] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 14.3] [Reference Citation Analysis]
109 Hiller JG, Perry NJ, Poulogiannis G, Riedel B, Sloan EK. Perioperative events influence cancer recurrence risk after surgery. Nat Rev Clin Oncol. 2018;15:205-218. [PMID: 29283170 DOI: 10.1038/nrclinonc.2017.194] [Cited by in Crossref: 154] [Cited by in F6Publishing: 128] [Article Influence: 38.5] [Reference Citation Analysis]
110 Rida PC, Cantuaria G, Reid MD, Kucuk O, Aneja R. How to be good at being bad: centrosome amplification and mitotic propensity drive intratumoral heterogeneity. Cancer Metastasis Rev 2015;34:703-13. [PMID: 26358854 DOI: 10.1007/s10555-015-9590-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
111 Guldvik IJ, Ekseth L, Kishan AU, Stensvold A, Inderberg EM, Lilleby W. Circulating Tumor Cell Persistence Associates with Long-Term Clinical Outcome to a Therapeutic Cancer Vaccine in Prostate Cancer. J Pers Med 2021;11:605. [PMID: 34206815 DOI: 10.3390/jpm11070605] [Reference Citation Analysis]
112 Li J, Chen F, Peng Y, Lv Z, Lin X, Chen Z, Wang H. N6-Methyladenosine Regulates the Expression and Secretion of TGFβ1 to Affect the Epithelial-Mesenchymal Transition of Cancer Cells. Cells 2020;9:E296. [PMID: 31991845 DOI: 10.3390/cells9020296] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 18.0] [Reference Citation Analysis]
113 Casalino L, Verde P. Multifaceted Roles of DNA Methylation in Neoplastic Transformation, from Tumor Suppressors to EMT and Metastasis. Genes (Basel) 2020;11:E922. [PMID: 32806509 DOI: 10.3390/genes11080922] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
114 Lee KH, Kim JS, Kim JY. Necessity of Genetic Evaluation of Metachronous Metastases of Colorectal Cancer: Quantitative Analysis of Genetic Discordance Between Metachronous Metastases and Radically Resected Primary Colorectal Cancers Using Next-Generation Sequencing. Dis Colon Rectum 2019;62:832-9. [PMID: 31188184 DOI: 10.1097/DCR.0000000000001386] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
115 Pavlidis N, Briasoulis E, Pentheroudakis G; ESMO Guidelines Working Group. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21 Suppl 5:v228-31. [PMID: 20555087 DOI: 10.1093/annonc/mdq193] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
116 Falck AK, Fernö M, Bendahl PO, Rydén L. Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer? World J Surg 2010;34:1434-41. [PMID: 20213203 DOI: 10.1007/s00268-010-0499-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
117 Kataoka K, Ysebaert H, Shiozawa M, Reynders D, Ikeda M, Tomita N, Goetghebeur E, Ceelen W. Prognostic significance of number versus location of positive mesenteric nodes in stage iii colon cancer. Eur J Surg Oncol 2019;45:1862-9. [PMID: 31153766 DOI: 10.1016/j.ejso.2019.05.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
118 Hu Y, Yu X, Xu G, Liu S. Metastasis: an early event in cancer progression. J Cancer Res Clin Oncol 2017;143:745-57. [DOI: 10.1007/s00432-016-2279-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
119 Dasgupta A, Lim AR, Ghajar CM. Circulating and disseminated tumor cells: harbingers or initiators of metastasis? Mol Oncol. 2017;11:40-61. [PMID: 28085223 DOI: 10.1002/1878-0261.12022] [Cited by in Crossref: 97] [Cited by in F6Publishing: 80] [Article Influence: 32.3] [Reference Citation Analysis]
120 Bergström SH, Rudolfsson SH, Bergh A. Rat Prostate Tumor Cells Progress in the Bone Microenvironment to a Highly Aggressive Phenotype. Neoplasia 2016;18:152-61. [PMID: 26992916 DOI: 10.1016/j.neo.2016.01.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
121 Abbasi MR, Rifatbegovic F, Brunner C, Mann G, Ziegler A, Pötschger U, Crazzolara R, Ussowicz M, Benesch M, Ebetsberger-Dachs G, Chan GCF, Jones N, Ladenstein R, Ambros IM, Ambros PF. Impact of Disseminated Neuroblastoma Cells on the Identification of the Relapse-Seeding Clone. Clin Cancer Res 2017;23:4224-32. [PMID: 28228384 DOI: 10.1158/1078-0432.CCR-16-2082] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 4.8] [Reference Citation Analysis]
122 Nanduri LK, Hissa B, Weitz J, Schölch S, Bork U. The prognostic role of circulating tumor cells in colorectal cancer.Expert Rev Anticancer Ther. 2019;19:1077-1088. [PMID: 31778322 DOI: 10.1080/14737140.2019.1699065] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
123 Hartkopf AD, Wallwiener M, Hahn M, Fehm TN, Brucker SY, Taran FA. Simultaneous Detection of Disseminated and Circulating Tumor Cells in Primary Breast Cancer Patients. Cancer Res Treat 2016;48:115-24. [PMID: 25687853 DOI: 10.4143/crt.2014.287] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
124 Driessens G, Beck B, Caauwe A, Simons BD, Blanpain C. Defining the mode of tumour growth by clonal analysis. Nature. 2012;488:527-530. [PMID: 22854777 DOI: 10.1038/nature11344] [Cited by in Crossref: 514] [Cited by in F6Publishing: 459] [Article Influence: 57.1] [Reference Citation Analysis]
125 Beca F, Schmitt F. Growing indication for FNA to study and analyze tumor heterogeneity at metastatic sites: FNA and Metastatic Cancer. Cancer Cytopathology 2014;122:504-11. [DOI: 10.1002/cncy.21395] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
126 Huang S, Ernberg I, Kauffman S. Cancer attractors: a systems view of tumors from a gene network dynamics and developmental perspective. Semin Cell Dev Biol 2009;20:869-76. [PMID: 19595782 DOI: 10.1016/j.semcdb.2009.07.003] [Cited by in Crossref: 312] [Cited by in F6Publishing: 208] [Article Influence: 26.0] [Reference Citation Analysis]
127 Bartkowiak K, Riethdorf S, Pantel K. The interrelating dynamics of hypoxic tumor microenvironments and cancer cell phenotypes in cancer metastasis. Cancer Microenviron 2012;5:59-72. [PMID: 21626313 DOI: 10.1007/s12307-011-0067-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
128 Pluim D, Devriese LA, Beijnen JH, Schellens JH. Validation of a multiparameter flow cytometry method for the determination of phosphorylated extracellular-signal-regulated kinase and DNA in circulating tumor cells. Cytometry A 2012;81:664-71. [PMID: 22499242 DOI: 10.1002/cyto.a.22049] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
129 Zappalà G, McDonald PG, Cole SW. Tumor dormancy and the neuroendocrine system: an undisclosed connection? Cancer Metastasis Rev 2013;32:189-200. [PMID: 23090259 DOI: 10.1007/s10555-012-9400-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
130 Yu Y, Chen Z, Dong J, Wei P, Hu R, Zhou C, Sun N, Luo M, Yang W, Yao R, Gao Y, Li J, Yang G, He W, He J. Folate receptor-positive circulating tumor cells as a novel diagnostic biomarker in non-small cell lung cancer. Transl Oncol. 2013;6:697-702. [PMID: 24466372 DOI: 10.1593/tlo.13535] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 5.3] [Reference Citation Analysis]
131 Yang WH, Chang JT, Hsu SF, Li TM, Cho DY, Huang CY, Fong YC, Tang CH. Bradykinin enhances cell migration in human chondrosarcoma cells through BK receptor signaling pathways. J Cell Biochem 2010;109:82-92. [PMID: 19885862 DOI: 10.1002/jcb.22383] [Cited by in Crossref: 4] [Cited by in F6Publishing: 14] [Article Influence: 0.4] [Reference Citation Analysis]
132 Ho KC, Fang YD, Chung HW, Liu YC, Chang JW, Hou MM, Yang CT, Cheng NM, Su TP, Yen TC. TLG-S criteria are superior to both EORTC and PERCIST for predicting outcomes in patients with metastatic lung adenocarcinoma treated with erlotinib. Eur J Nucl Med Mol Imaging 2016;43:2155-65. [PMID: 27260520 DOI: 10.1007/s00259-016-3433-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
133 Beerling E, Ritsma L, Vrisekoop N, Derksen PW, van Rheenen J. Intravital microscopy: new insights into metastasis of tumors. J Cell Sci. 2011;124:299-310. [PMID: 21242309 DOI: 10.1242/jcs.072728] [Cited by in Crossref: 105] [Cited by in F6Publishing: 90] [Article Influence: 10.5] [Reference Citation Analysis]
134 Michaels AD, Newhook TE, Adair SJ, Morioka S, Goudreau BJ, Nagdas S, Mullen MG, Persily JB, Bullock TNJ, Slingluff CL Jr, Ravichandran KS, Parsons JT, Bauer TW. CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer. Clin Cancer Res. 2018;24:1415-1425. [PMID: 29288236 DOI: 10.1158/1078-0432.ccr-17-2283] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 9.8] [Reference Citation Analysis]
135 Deasy S, Szczepanek K, Hunter KW. Targeting metastatic breast cancer: problems and potential. F1000 Fac Rev 2015;4:141. [PMID: 33842931 DOI: 10.12688/f1000research.6151.1] [Reference Citation Analysis]
136 Amelot A, Terrier L, Mazeron J, Valery C, Cornu P, Carpentier A, Leveque M. Timeline metastatic progression: in the wake of the « seed and soil » theory. Med Oncol 2017;34. [DOI: 10.1007/s12032-017-1045-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
137 Glia A, Deliorman M, Sukumar P, Janahi FK, Samara B, Brimmo AT, Qasaimeh MA. Herringbone Microfluidic Probe for Multiplexed Affinity‐Capture of Prostate Circulating Tumor Cells. Adv Mater Technol 2021;6:2100053. [DOI: 10.1002/admt.202100053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
138 Vikeså J, Møller AK, Kaczkowski B, Borup R, Winther O, Henao R, Krogh A, Perell K, Jensen F, Daugaard G, Nielsen FC. Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin. BMC Cancer 2015;15:151. [PMID: 25885340 DOI: 10.1186/s12885-015-1128-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
139 DeGraff DJ, Clark PE, Cates JM, Yamashita H, Robinson VL, Yu X, Smolkin ME, Chang SS, Cookson MS, Herrick MK, Shariat SF, Steinberg GD, Frierson HF, Wu XR, Theodorescu D, Matusik RJ. Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation. PLoS One 2012;7:e36669. [PMID: 22590586 DOI: 10.1371/journal.pone.0036669] [Cited by in Crossref: 64] [Cited by in F6Publishing: 47] [Article Influence: 7.1] [Reference Citation Analysis]
140 Abdollahi A, Folkman J. Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy. Drug Resist Updat. 2010;13:16-28. [PMID: 20061178 DOI: 10.1016/j.drup.2009.12.001] [Cited by in Crossref: 167] [Cited by in F6Publishing: 142] [Article Influence: 15.2] [Reference Citation Analysis]
141 Han H, Eom D, Kim JH, Kim K, Shin H, An JY, Lee KM, Choe KH, Lee KH, Kim ST, Koo JH, Lee H, Lee O. EGFR Mutation Status in Primary Lung Adenocarcinomas and Corresponding Metastatic Lesions: Discordance in Pleural Metastases. Clinical Lung Cancer 2011;12:380-6. [DOI: 10.1016/j.cllc.2011.02.006] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 7.2] [Reference Citation Analysis]
142 Reda A, Hosseiny S, El-Sherbiny IM. Next-generation nanotheranostics targeting cancer stem cells. Nanomedicine (Lond) 2019;14:2487-514. [PMID: 31490100 DOI: 10.2217/nnm-2018-0443] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
143 Caputo S, Grioni M, Brambillasca CS, Monno A, Brevi A, Freschi M, Piras IS, Elia AR, Pieri V, Baccega T, Lombardo A, Galli R, Briganti A, Doglioni C, Jachetti E, Bellone M. Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis. Front Immunol 2020;11:1820. [PMID: 33013832 DOI: 10.3389/fimmu.2020.01820] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
144 Lee DE, Jang EH, Bang C, Kim GL, Yoon SY, Lee DH, Koo J, Na JH, Lee S, Kim JH. Bakuchiol, main component of root bark of Ulmus davidiana var. japonica, inhibits TGF-β-induced in vitro EMT and in vivo metastasis. Arch Biochem Biophys 2021;709:108969. [PMID: 34153297 DOI: 10.1016/j.abb.2021.108969] [Reference Citation Analysis]
145 Cisneros LH, Newman TJ. Quantifying metastatic inefficiency: rare genotypes versus rare dynamics. Phys Biol 2014;11:046003. [PMID: 25033031 DOI: 10.1088/1478-3975/11/4/046003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
146 Czyż ZT, Hoffmann M, Schlimok G, Polzer B, Klein CA. Reliable single cell array CGH for clinical samples. PLoS One 2014;9:e85907. [PMID: 24465780 DOI: 10.1371/journal.pone.0085907] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 6.1] [Reference Citation Analysis]
147 Hwang IK, Kim H, Lee YS, Kim J, Cho JY, Yoon YS, Han HS, Hwang JH. Presence of pancreatic intraepithelial neoplasia-3 in a background of chronic pancreatitis in pancreatic cancer patients. Cancer Sci 2015;106:1408-13. [PMID: 26183380 DOI: 10.1111/cas.12744] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
148 Shen YJ, Mishima Y, Shi J, Sklavenitis-Pistofidis R, Redd RA, Moschetta M, Manier S, Roccaro AM, Sacco A, Tai YT, Mercier F, Kawano Y, Su NK, Berrios B, Doench JG, Root DE, Michor F, Scadden DT, Ghobrial IM. Progression signature underlies clonal evolution and dissemination of multiple myeloma. Blood 2021;137:2360-72. [PMID: 33150374 DOI: 10.1182/blood.2020005885] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
149 Demicheli R, Biganzoli E. Late Recurrence in Breast Cancer: To Run after the Oxen or to Try to Close the Barn? Cancers (Basel) 2021;13:2026. [PMID: 33922205 DOI: 10.3390/cancers13092026] [Reference Citation Analysis]
150 Aprile G, Casagrande M, De Maglio G, Fontanella C, Rihawi K, Bonotto M, Pisa FE, Tuniz F, Pizzolitto S, Fasola G. Comparison of the molecular profile of brain metastases from colorectal cancer and corresponding primary tumors. Future Oncol 2017;13:135-44. [PMID: 27578453 DOI: 10.2217/fon-2016-0196] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
151 Khan I, Steeg PS. Metastasis suppressors: functional pathways. Lab Invest 2018;98:198-210. [PMID: 28967874 DOI: 10.1038/labinvest.2017.104] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 8.0] [Reference Citation Analysis]
152 Linde N, Fluegen G, Aguirre-Ghiso JA. The Relationship Between Dormant Cancer Cells and Their Microenvironment. Adv Cancer Res 2016;132:45-71. [PMID: 27613129 DOI: 10.1016/bs.acr.2016.07.002] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 15.2] [Reference Citation Analysis]
153 Chakraborty G, Kumar S, Mishra R, Patil TV, Kundu GC. Semaphorin 3A suppresses tumor growth and metastasis in mice melanoma model. PLoS One 2012;7:e33633. [PMID: 22448259 DOI: 10.1371/journal.pone.0033633] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 6.8] [Reference Citation Analysis]
154 Guo H, Li M, Chen P, Blake DJ, Kong X, Hao X, Niu R, Zhang N. 4-Methyl-3-nitro-benzoic acid, a migration inhibitor, prevents breast cancer metastasis in SCID mice. Cancer Lett 2011;305:69-75. [PMID: 21429660 DOI: 10.1016/j.canlet.2011.02.028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
155 Sosa MS, Avivar-Valderas A, Bragado P, Wen HC, Aguirre-Ghiso JA. ERK1/2 and p38α/β signaling in tumor cell quiescence: opportunities to control dormant residual disease. Clin Cancer Res. 2011;17:5850-5857. [PMID: 21673068 DOI: 10.1158/1078-0432.CCR-10-2574] [Cited by in Crossref: 131] [Cited by in F6Publishing: 85] [Article Influence: 13.1] [Reference Citation Analysis]
156 Banys-Paluchowski M, Fehm T, Janni W, Solomayer EF, Hartkopf A. Circulating and Disseminated Tumor Cells in Breast Carcinoma: Report from the Consensus Conference on Tumor Cell Dissemination during the 39th Annual Meeting of the German Society of Senology, Berlin, 27 June 2019. Geburtshilfe Frauenheilkd 2019;79:1320-7. [PMID: 31875861 DOI: 10.1055/a-1031-1120] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
157 Strzelecka PM, Ranzoni AM, Cvejic A. Dissecting human disease with single-cell omics: application in model systems and in the clinic. Dis Model Mech 2018;11:dmm036525. [PMID: 30401698 DOI: 10.1242/dmm.036525] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 9.7] [Reference Citation Analysis]
158 Miyano S, Hanazawa K, Kitabatake T, Fujisawa M, Kojima K. Detecting KRAS mutations in peripheral blood of colorectal cancer patients by peptide nucleic acid clamp PCR. Exp Ther Med 2012;4:790-4. [PMID: 23226727 DOI: 10.3892/etm.2012.694] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
159 Hartkopf AD, Taran F, Wallwiener M, Hahn M, Becker S, Solomayer E, Brucker SY, Fehm TN, Wallwiener D. Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients – Results from a large single-centre analysis. European Journal of Cancer 2014;50:2550-9. [DOI: 10.1016/j.ejca.2014.06.025] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 5.9] [Reference Citation Analysis]
160 Torresan C, Oliveira MM, Pereira SR, Ribeiro EM, Marian C, Gusev Y, Lima RS, Urban CA, Berg PE, Haddad BR, Cavalli IJ, Cavalli LR. Increased copy number of the DLX4 homeobox gene in breast axillary lymph node metastasis. Cancer Genet 2014;207:177-87. [PMID: 24947980 DOI: 10.1016/j.cancergen.2014.04.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
161 Almendro V, Kim HJ, Cheng YK, Gönen M, Itzkovitz S, Argani P, van Oudenaarden A, Sukumar S, Michor F, Polyak K. Genetic and phenotypic diversity in breast tumor metastases. Cancer Res 2014;74:1338-48. [PMID: 24448237 DOI: 10.1158/0008-5472.CAN-13-2357-T] [Cited by in Crossref: 127] [Cited by in F6Publishing: 75] [Article Influence: 18.1] [Reference Citation Analysis]
162 Castro-vega LJ, Jouravleva K, Ortiz-montero P, Liu W, Galeano JL, Romero M, Popova T, Bacchetti S, Vernot JP, Londoño-vallejo A. The senescent microenvironment promotes the emergence of heterogeneous cancer stem-like cells. CARCIN 2015;36:1180-92. [DOI: 10.1093/carcin/bgv101] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
163 Knijn N, Mekenkamp LJ, Klomp M, Vink-Börger ME, Tol J, Teerenstra S, Meijer JW, Tebar M, Riemersma S, van Krieken JH. KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients. Br J Cancer. 2011;104:1020-1026. [PMID: 21364579 DOI: 10.1038/bjc.2011.26] [Cited by in Crossref: 203] [Cited by in F6Publishing: 177] [Article Influence: 20.3] [Reference Citation Analysis]
164 Hill L, Browne G, Tulchinsky E. ZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancer. Int J Cancer. 2013;132:745-754. [PMID: 22753312 DOI: 10.1002/ijc.27708] [Cited by in Crossref: 154] [Cited by in F6Publishing: 149] [Article Influence: 17.1] [Reference Citation Analysis]
165 Pillai SG, Li S, Siddappa CM, Ellis MJ, Watson MA, Aft R. Identifying biomarkers of breast cancer micrometastatic disease in bone marrow using a patient-derived xenograft mouse model. Breast Cancer Res 2018;20:2. [PMID: 29291741 DOI: 10.1186/s13058-017-0927-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
166 Möhlendick B, Bartenhagen C, Behrens B, Honisch E, Raba K, Knoefel WT, Stoecklein NH. A robust method to analyze copy number alterations of less than 100 kb in single cells using oligonucleotide array CGH. PLoS One 2013;8:e67031. [PMID: 23825608 DOI: 10.1371/journal.pone.0067031] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
167 Lazebnik Y. What are the hallmarks of cancer? Nat Rev Cancer. 2010;10:232-233. [PMID: 20355252 DOI: 10.1038/nrc2827] [Cited by in Crossref: 113] [Cited by in F6Publishing: 84] [Article Influence: 10.3] [Reference Citation Analysis]
168 Grover PK, Cummins AG, Price TJ, Roberts-Thomson IC, Hardingham JE. Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research. Ann Oncol. 2014;25:1506-1516. [PMID: 24651410 DOI: 10.1093/annonc/mdu018] [Cited by in Crossref: 120] [Cited by in F6Publishing: 113] [Article Influence: 17.1] [Reference Citation Analysis]
169 [DOI: 10.1101/454306] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
170 Cole K, Pravoverov K, Talmadge JE. Role of myeloid-derived suppressor cells in metastasis. Cancer Metastasis Rev 2021;40:391-411. [PMID: 33411082 DOI: 10.1007/s10555-020-09947-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
171 Goldman E, Zinger A, da Silva D, Yaari Z, Kajal A, Vardi-oknin D, Goldfeder M, Schroeder JE, Shainsky-roitman J, Hershkovitz D, Schroeder A. Nanoparticles target early-stage breast cancer metastasis in vivo. Nanotechnology 2017;28:43LT01. [DOI: 10.1088/1361-6528/aa8a3d] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 5.8] [Reference Citation Analysis]
172 Sorenson EC, Khanin R, Bamboat ZM, Cavnar MJ, Kim TS, Sadot E, Zeng S, Greer JB, Seifert AM, Cohen NA, Crawley MH, Green BL, Klimstra DS, DeMatteo RP. Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation. PLoS One 2017;12:e0176562. [PMID: 28486549 DOI: 10.1371/journal.pone.0176562] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
173 Hansell CAH, Fraser AR, Hayes AJ, Pingen M, Burt CL, Lee KM, Medina-Ruiz L, Brownlie D, Macleod MKL, Burgoyne P, Wilson GJ, Nibbs RJB, Graham GJ. The Atypical Chemokine Receptor Ackr2 Constrains NK Cell Migratory Activity and Promotes Metastasis. J Immunol 2018;201:2510-9. [PMID: 30158126 DOI: 10.4049/jimmunol.1800131] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
174 Kang Y, Pantel K. Tumor cell dissemination: emerging biological insights from animal models and cancer patients. Cancer Cell. 2013;23:573-581. [PMID: 23680145 DOI: 10.1016/j.ccr.2013.04.017] [Cited by in Crossref: 268] [Cited by in F6Publishing: 236] [Article Influence: 33.5] [Reference Citation Analysis]
175 Armbrecht L, Rutschmann O, Szczerba BM, Nikoloff J, Aceto N, Dittrich PS. Quantification of Protein Secretion from Circulating Tumor Cells in Microfluidic Chambers. Adv Sci (Weinh) 2020;7:1903237. [PMID: 32537399 DOI: 10.1002/advs.201903237] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
176 Moriarity BS, Otto GM, Rahrmann EP, Rathe SK, Wolf NK, Weg MT, Manlove LA, LaRue RS, Temiz NA, Molyneux SD, Choi K, Holly KJ, Sarver AL, Scott MC, Forster CL, Modiano JF, Khanna C, Hewitt SM, Khokha R, Yang Y, Gorlick R, Dyer MA, Largaespada DA. A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis. Nat Genet 2015;47:615-24. [PMID: 25961939 DOI: 10.1038/ng.3293] [Cited by in Crossref: 147] [Cited by in F6Publishing: 133] [Article Influence: 24.5] [Reference Citation Analysis]
177 Lee KH, Kim JS, Lee CS, Kim JY. KRAS discordance between primary and recurrent tumors after radical resection of colorectal cancers. J Surg Oncol 2015;111:1059-64. [PMID: 26031776 DOI: 10.1002/jso.23936] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
178 Amelio I, Melino G. The "Sharp" blade against HIF-mediated metastasis. Cell Cycle 2012;11:4530-5. [PMID: 23187809 DOI: 10.4161/cc.22820] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
179 Vanharanta S, Massagué J. Origins of metastatic traits. Cancer Cell. 2013;24:410-421. [PMID: 24135279 DOI: 10.1016/j.ccr.2013.09.007] [Cited by in Crossref: 321] [Cited by in F6Publishing: 288] [Article Influence: 40.1] [Reference Citation Analysis]
180 Eyles J, Puaux AL, Wang X, Toh B, Prakash C, Hong M, Tan TG, Zheng L, Ong LC, Jin Y, Kato M, Prévost-Blondel A, Chow P, Yang H, Abastado JP. Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. J Clin Invest 2010;120:2030-9. [PMID: 20501944 DOI: 10.1172/JCI42002] [Cited by in Crossref: 314] [Cited by in F6Publishing: 206] [Article Influence: 28.5] [Reference Citation Analysis]
181 Bingham C, Fernandez SV, Fittipaldi P, Dempsey PW, Ruth KJ, Cristofanilli M, Katherine Alpaugh R. Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients. Breast Cancer Res Treat 2017;163:219-30. [PMID: 28271309 DOI: 10.1007/s10549-017-4176-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
182 Piranlioglu R, Lee E, Ouzounova M, Bollag RJ, Vinyard AH, Arbab AS, Marasco D, Guzel M, Cowell JK, Thangaraju M, Chadli A, Hassan KA, Wicha MS, Celis E, Korkaya H. Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model. Nat Commun 2019;10:1430. [PMID: 30926774 DOI: 10.1038/s41467-019-09015-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 14.5] [Reference Citation Analysis]
183 Watkins TBK, Schwarz RF. Phylogenetic Quantification of Intratumor Heterogeneity. Cold Spring Harb Perspect Med 2018;8:a028316. [PMID: 28710259 DOI: 10.1101/cshperspect.a028316] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
184 Gerges N, Jabado N. Biomarkers in cancer micrometastasis: where are we at? Bioanalysis 2010;2:881-99. [PMID: 21083219 DOI: 10.4155/bio.10.49] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
185 De Angelis ML, Francescangeli F, Zeuner A. Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities. Cancers (Basel). 2019;11. [PMID: 31619007 DOI: 10.3390/cancers11101569] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 23.0] [Reference Citation Analysis]
186 Quentmeier H, Amini RM, Berglund M, Dirks WG, Ehrentraut S, Geffers R, Macleod RA, Nagel S, Romani J, Scherr M, Zaborski M, Drexler HG. U-2932: two clones in one cell line, a tool for the study of clonal evolution. Leukemia 2013;27:1155-64. [PMID: 23295736 DOI: 10.1038/leu.2012.358] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
187 Banys M, Gruber I, Krawczyk N, Becker S, Kurth R, Wallwiener D, Jakubowska J, Hoffmann J, Rothmund R, Staebler A, Fehm T. Hematogenous and lymphatic tumor cell dissemination may be detected in patients diagnosed with ductal carcinoma in situ of the breast. Breast Cancer Res Treat 2012;131:801-8. [DOI: 10.1007/s10549-011-1478-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
188 Banys M, Solomayer EF, Gebauer G, Janni W, Krawczyk N, Lueck HJ, Becker S, Huober J, Kraemer B, Wackwitz B, Hirnle P, Wallwiener D, Fehm T. Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial. BMC Cancer 2013;13:480. [PMID: 24128322 DOI: 10.1186/1471-2407-13-480] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 5.5] [Reference Citation Analysis]
189 Shigdar S, Lin J, Li Y, Yang CJ, Wei M, Zhus Y, Liu H, Duan W. Cancer stem cell targeting: the next generation of cancer therapy and molecular imaging. Ther Deliv 2012;3:227-44. [PMID: 22834199 DOI: 10.4155/tde.11.148] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
190 Castaño Z, Marsh T, Tadipatri R, Kuznetsov HS, Al-Shahrour F, Paktinat M, Greene-Colozzi A, Nilsson B, Richardson AL, McAllister SS. Stromal EGF and igf-I together modulate plasticity of disseminated triple-negative breast tumors. Cancer Discov 2013;3:922-35. [PMID: 23689072 DOI: 10.1158/2159-8290.CD-13-0041] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 3.9] [Reference Citation Analysis]
191 Schlicke P, Kuttler C, Schumann C. How mathematical modeling could contribute to the quantification of metastatic tumor burden under therapy: insights in immunotherapeutic treatment of non-small cell lung cancer. Theor Biol Med Model 2021;18:11. [PMID: 34078405 DOI: 10.1186/s12976-021-00142-1] [Reference Citation Analysis]
192 Yin L, Li J, Ma D, Li D, Sun Y. Angiogenesis in primary colorectal cancer and matched metastatic tissues: Biological and clinical implications for anti-angiogenic therapies. Oncol Lett 2020;19:3558-66. [PMID: 32269630 DOI: 10.3892/ol.2020.11450] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
193 Bos PD, Nguyen DX, Massagué J. Modeling metastasis in the mouse. Curr Opin Pharmacol 2010;10:571-7. [PMID: 20598638 DOI: 10.1016/j.coph.2010.06.003] [Cited by in Crossref: 81] [Cited by in F6Publishing: 65] [Article Influence: 7.4] [Reference Citation Analysis]
194 Budczies J, von Winterfeld M, Klauschen F, Bockmayr M, Lennerz JK, Denkert C, Wolf T, Warth A, Dietel M, Anagnostopoulos I, Weichert W, Wittschieber D, Stenzinger A. The landscape of metastatic progression patterns across major human cancers. Oncotarget. 2015;6:570-583. [PMID: 25402435 DOI: 10.18632/oncotarget.2677] [Cited by in Crossref: 114] [Cited by in F6Publishing: 93] [Article Influence: 22.8] [Reference Citation Analysis]
195 Timme-Bronsert S, Bronsert P, Werner M, Kulemann B, Höppner J. [Circulating tumor cells in pancreatic cancer : Results of morphological and molecular analyses and comparisons with the primary tumor]. Pathologe 2018;39:311-4. [PMID: 30483865 DOI: 10.1007/s00292-018-0550-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
196 Te Boekhorst V, Friedl P. Plasticity of Cancer Cell Invasion-Mechanisms and Implications for Therapy. Adv Cancer Res 2016;132:209-64. [PMID: 27613134 DOI: 10.1016/bs.acr.2016.07.005] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 8.4] [Reference Citation Analysis]
197 Dubrovska A. Report on the International Workshop 'Cancer stem cells: the mechanisms of radioresistance and biomarker discovery'. Int J Radiat Biol 2014;90:607-14. [PMID: 24844377 DOI: 10.3109/09553002.2014.920968] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
198 Magbanua MJ, Park JW. Advances in genomic characterization of circulating tumor cells. Cancer Metastasis Rev 2014;33:757-69. [PMID: 24867683 DOI: 10.1007/s10555-014-9503-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
199 Carlson P, Dasgupta A, Grzelak CA, Kim J, Barrett A, Coleman IM, Shor RE, Goddard ET, Dai J, Schweitzer EM, Lim AR, Crist SB, Cheresh DA, Nelson PS, Hansen KC, Ghajar CM. Targeting the perivascular niche sensitizes disseminated tumour cells to chemotherapy. Nat Cell Biol 2019;21:238-50. [PMID: 30664790 DOI: 10.1038/s41556-018-0267-0] [Cited by in Crossref: 100] [Cited by in F6Publishing: 78] [Article Influence: 50.0] [Reference Citation Analysis]
200 Pantel K, Speicher MR. The biology of circulating tumor cells. Oncogene. 2016;35:1216-1224. [PMID: 26050619 DOI: 10.1038/onc.2015.192] [Cited by in Crossref: 230] [Cited by in F6Publishing: 188] [Article Influence: 38.3] [Reference Citation Analysis]
201 Abdul-wahid A, Cydzik M, Prodeus A, Alwash M, Stanojcic M, Thompson M, Huang EH, Shively JE, Gray-owen SD, Gariépy J. Induction of antigen-specific T H 9 immunity accompanied by mast cell activation blocks tumor cell engraftment: T H 9 immunity blocks tumor implantation. Int J Cancer 2016;139:841-53. [DOI: 10.1002/ijc.30121] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
202 Bhatia S, Monkman J, Toh AKL, Nagaraj SH, Thompson EW. Targeting epithelial-mesenchymal plasticity in cancer: clinical and preclinical advances in therapy and monitoring. Biochem J 2017;474:3269-306. [PMID: 28931648 DOI: 10.1042/BCJ20160782] [Cited by in Crossref: 39] [Cited by in F6Publishing: 26] [Article Influence: 9.8] [Reference Citation Analysis]
203 Tsung K, Norton JA. In situ vaccine, immunological memory and cancer cure. Hum Vaccin Immunother 2016;12:117-9. [PMID: 26360526 DOI: 10.1080/21645515.2015.1073427] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
204 Carpenter EL, Rader J, Ruden J, Rappaport EF, Hunter KN, Hallberg PL, Krytska K, O'Dwyer PJ, Mosse YP. Dielectrophoretic capture and genetic analysis of single neuroblastoma tumor cells. Front Oncol 2014;4:201. [PMID: 25133137 DOI: 10.3389/fonc.2014.00201] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
205 Benzekry S, Tracz A, Mastri M, Corbelli R, Barbolosi D, Ebos JM. Modeling Spontaneous Metastasis following Surgery: An In Vivo-In Silico Approach. Cancer Res 2016;76:535-47. [PMID: 26511632 DOI: 10.1158/0008-5472.CAN-15-1389] [Cited by in Crossref: 47] [Cited by in F6Publishing: 18] [Article Influence: 7.8] [Reference Citation Analysis]
206 Liu W, Xing F, Iiizumi-Gairani M, Okuda H, Watabe M, Pai SK, Pandey PR, Hirota S, Kobayashi A, Mo YY, Fukuda K, Li Y, Watabe K. N-myc downstream regulated gene 1 modulates Wnt-β-catenin signalling and pleiotropically suppresses metastasis. EMBO Mol Med 2012;4:93-108. [PMID: 22246988 DOI: 10.1002/emmm.201100190] [Cited by in Crossref: 130] [Cited by in F6Publishing: 121] [Article Influence: 14.4] [Reference Citation Analysis]
207 Müller V, Alix-panabières C, Pantel K. Insights into minimal residual disease in cancer patients: Implications for anti-cancer therapies. European Journal of Cancer 2010;46:1189-97. [DOI: 10.1016/j.ejca.2010.02.038] [Cited by in Crossref: 51] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
208 Baratchart E, Benzekry S, Bikfalvi A, Colin T, Cooley LS, Pineau R, Ribot EJ, Saut O, Souleyreau W. Computational Modelling of Metastasis Development in Renal Cell Carcinoma. PLoS Comput Biol 2015;11:e1004626. [PMID: 26599078 DOI: 10.1371/journal.pcbi.1004626] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
209 Park HJ, Kim JK, Jeon HM, Oh SY, Kim SH, Nam DH, Kim H. The neural stem cell fate determinant TLX promotes tumorigenesis and genesis of cells resembling glioma stem cells. Mol Cells 2010;30:403-8. [PMID: 20814749 DOI: 10.1007/s10059-010-0122-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
210 de Oliveira Gamba C, Scaratti D, de Andrade VP, Estrela-Lima A, Ferreira E, Cassali GD. Invasive micropapillary carcinoma of the mammary gland in humans and canines: Clinicopathological, immunophenotypical and survival approaches. Res Vet Sci 2017;115:189-94. [PMID: 28475997 DOI: 10.1016/j.rvsc.2017.04.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
211 Yang G, Li X, He Y, Xiong X, Wang P, Zhou S. Capturing Circulating Tumor Cells through a Combination of Hierarchical Nanotopography and Surface Chemistry. ACS Biomater Sci Eng 2018;4:2081-8. [PMID: 33434965 DOI: 10.1021/acsbiomaterials.7b00683] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
212 Halama N, Zoernig I, Berthel A, Kahlert C, Klupp F, Suarez-Carmona M, Suetterlin T, Brand K, Krauss J, Lasitschka F, Lerchl T, Luckner-Minden C, Ulrich A, Koch M, Weitz J, Schneider M, Buechler MW, Zitvogel L, Herrmann T, Benner A, Kunz C, Luecke S, Springfeld C, Grabe N, Falk CS, Jaeger D. Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients. Cancer Cell. 2016;29:587-601. [PMID: 27070705 DOI: 10.1016/j.ccell.2016.03.005] [Cited by in Crossref: 213] [Cited by in F6Publishing: 188] [Article Influence: 42.6] [Reference Citation Analysis]
213 Kulasinghe A, Perry C, Jovanovic L, Nelson C, Punyadeera C. Circulating tumour cells in metastatic head and neck cancers: Circulating tumour cells in metastatic HNC. Int J Cancer 2015;136:2515-23. [DOI: 10.1002/ijc.29108] [Cited by in Crossref: 69] [Cited by in F6Publishing: 61] [Article Influence: 9.9] [Reference Citation Analysis]
214 Damsky WE, Theodosakis N, Bosenberg M. Melanoma metastasis: new concepts and evolving paradigms. Oncogene 2014;33:2413-22. [PMID: 23728340 DOI: 10.1038/onc.2013.194] [Cited by in Crossref: 76] [Cited by in F6Publishing: 57] [Article Influence: 9.5] [Reference Citation Analysis]
215 Shor RE, Dai J, Lee SY, Pisarsky L, Matei I, Lucotti S, Lyden D, Bissell MJ, Ghajar CM. The PI3K/mTOR inhibitor Gedatolisib eliminates dormant breast cancer cells in organotypic culture, but fails to prevent metastasis in preclinical settings. Mol Oncol 2021. [PMID: 34058066 DOI: 10.1002/1878-0261.13031] [Reference Citation Analysis]
216 Stueber TN, Weiss CR, Woeckel A, Haeusler S. Influences of adjuvant treatments in hormone receptor positive breast cancer on receptor conversion in recurrent breast cancer. Arch Gynecol Obstet 2019;299:533-41. [PMID: 30411159 DOI: 10.1007/s00404-018-4954-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
217 Popeda M, Stokowy T, Bednarz-Knoll N, Jurek A, Niemira M, Bielska A, Kretowski A, Kalinowski L, Szade J, Markiewicz A, Zaczek AJ. NF-kappa B Signaling-Related Signatures Are Connected with the Mesenchymal Phenotype of Circulating Tumor Cells in Non-Metastatic Breast Cancer. Cancers (Basel) 2019;11:E1961. [PMID: 31817685 DOI: 10.3390/cancers11121961] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
218 Steinert G, Schölch S, Koch M, Weitz J. Biology and significance of circulating and disseminated tumour cells in colorectal cancer. Langenbecks Arch Surg. 2012;397:535-542. [PMID: 22350614 DOI: 10.1007/s00423-012-0917-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
219 Widschwendter M, Evans I, Jones A, Ghazali S, Reisel D, Ryan A, Gentry-Maharaj A, Zikan M, Cibula D, Eichner J, Alunni-Fabbroni M, Koch J, Janni WJ, Paprotka T, Wittenberger T, Menon U, Wahl B, Rack B, Lempiäinen H. Methylation patterns in serum DNA for early identification of disseminated breast cancer. Genome Med 2017;9:115. [PMID: 29268762 DOI: 10.1186/s13073-017-0499-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
220 Turajlic S, Swanton C. Metastasis as an evolutionary process. Science. 2016;352:169-175. [PMID: 27124450 DOI: 10.1126/science.aaf2784] [Cited by in Crossref: 280] [Cited by in F6Publishing: 241] [Article Influence: 56.0] [Reference Citation Analysis]
221 Pavlidis N, Khaled H, Gaafar R. A mini review on cancer of unknown primary site: A clinical puzzle for the oncologists. J Adv Res 2015;6:375-82. [PMID: 26257935 DOI: 10.1016/j.jare.2014.11.007] [Cited by in Crossref: 49] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
222 Kamiyama H, Noda H, Konishi F, Rikiyama T. Molecular biomarkers for the detection of metastatic colorectal cancer cells. World J Gastroenterol 2014;20:8928-38. [PMID: 25083065 DOI: 10.3748/wjg.v20.i27.8928] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
223 Sprouse ML, Welte T, Boral D, Liu HN, Yin W, Vishnoi M, Goswami-Sewell D, Li L, Pei G, Jia P, Glitza-Oliva IC, Marchetti D. PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling. Int J Mol Sci 2019;20:E1916. [PMID: 31003475 DOI: 10.3390/ijms20081916] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 15.5] [Reference Citation Analysis]
224 Ren Y, Huang S, Dai C, Xie D, Zheng L, Xie H, Zheng H, She Y, Zhou F, Wang Y, Li P, Fei K, Jiang G, Zhang Y, Su B, Sweet-Cordero EA, Tran NL, Yang Y, Patel JN, Rolfo C, Rocco G, Cardona AF, Tuzi A, Suter MB, Yang P, Xu W, Chen C. Germline Predisposition and Copy Number Alteration in Pre-stage Lung Adenocarcinomas Presenting as Ground-Glass Nodules. Front Oncol 2019;9:288. [PMID: 31058088 DOI: 10.3389/fonc.2019.00288] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
225 Denes V, Lakk M, Makarovskiy A, Jakso P, Szappanos S, Graf L, Mandel L, Karadi I, Geck P. Metastasis blood test by flow cytometry: In vivo cancer spheroids and the role of hypoxia: Flow Cytometry Blood Test of Metastasis. Int J Cancer 2015;136:1528-36. [DOI: 10.1002/ijc.29155] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
226 Palmer TD, Ashby WJ, Lewis JD, Zijlstra A. Targeting tumor cell motility to prevent metastasis. Adv Drug Deliv Rev 2011;63:568-81. [PMID: 21664937 DOI: 10.1016/j.addr.2011.04.008] [Cited by in Crossref: 100] [Cited by in F6Publishing: 92] [Article Influence: 10.0] [Reference Citation Analysis]
227 Croucher PI, McDonald MM, Martin TJ. Bone metastasis: the importance of the neighbourhood. Nat Rev Cancer. 2016;16:373-386. [PMID: 27220481 DOI: 10.1038/nrc.2016.44] [Cited by in Crossref: 225] [Cited by in F6Publishing: 186] [Article Influence: 56.3] [Reference Citation Analysis]
228 Szynglarewicz B, Kasprzak P, Donizy P, Biecek P, Halon A, Matkowski R. Ductal carcinoma in situ on stereotactic biopsy of suspicious breast microcalcifications: Expression of SPARC (Secreted Protein, Acidic and Rich in Cysteine) can predict postoperative invasion: SPARC Expression in Breast DCIS. J Surg Oncol 2016;114:548-56. [DOI: 10.1002/jso.24373] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
229 Ansari D, Friess H, Bauden M, Samnegård J, Andersson R. Pancreatic cancer: disease dynamics, tumor biology and the role of the microenvironment. Oncotarget 2018;9:6644-51. [PMID: 29464100 DOI: 10.18632/oncotarget.24019] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
230 Lilleby W, Stensvold A, Mills IG, Nesland JM. Disseminated tumor cells and their prognostic significance in nonmetastatic prostate cancer patients. Int J Cancer 2013;133:149-55. [PMID: 23280694 DOI: 10.1002/ijc.28002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
231 Xu W, Hu X. Fibroblasts induced epithelial to mesenchymal transition of tumor cells and their extra circulation traveling behavior. Med Hypotheses 2016;89:24-7. [PMID: 26968903 DOI: 10.1016/j.mehy.2016.01.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
232 Gould SE, Junttila MR, de Sauvage FJ. Translational value of mouse models in oncology drug development. Nat Med 2015;21:431-9. [PMID: 25951530 DOI: 10.1038/nm.3853] [Cited by in Crossref: 170] [Cited by in F6Publishing: 141] [Article Influence: 28.3] [Reference Citation Analysis]
233 Veine DM, Yao H, Stafford DR, Fay KS, Livant DL. A D-amino acid containing peptide as a potent, noncovalent inhibitor of α5β1 integrin in human prostate cancer invasion and lung colonization. Clin Exp Metastasis 2014;31:379-93. [PMID: 24464034 DOI: 10.1007/s10585-013-9634-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
234 Wu X, Chen S, Lu C. Amyloid precursor protein promotes the migration and invasion of breast cancer cells by regulating the MAPK signaling pathway. Int J Mol Med 2020;45:162-74. [PMID: 31746365 DOI: 10.3892/ijmm.2019.4404] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
235 Møller EK, Kumar P, Voet T, Peterson A, Van Loo P, Mathiesen RR, Fjelldal R, Grundstad J, Borgen E, Baumbusch LO, Naume B, Børresen-Dale AL, White KP, Nord S, Kristensen VN. Next-generation sequencing of disseminated tumor cells. Front Oncol 2013;3:320. [PMID: 24427740 DOI: 10.3389/fonc.2013.00320] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
236 Khadge S, Cole K, Talmadge JE. Myeloid derived suppressor cells and the release of micro-metastases from dormancy. Clin Exp Metastasis 2021;38:279-93. [PMID: 34014424 DOI: 10.1007/s10585-021-10098-8] [Reference Citation Analysis]
237 Chen Y, Nam S, Chaudhuri O, Huang HC. The evolution of spindles and their mechanical implications for cancer metastasis. Cell Cycle 2019;18:1671-5. [PMID: 31234701 DOI: 10.1080/15384101.2019.1632137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
238 Alix-panabières C, Pierga J. Cellules tumorales circulantes : biopsie liquide du cancer. Bulletin du Cancer 2014;101:17-23. [DOI: 10.1684/bdc.2014.1883] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
239 Fizazi K, Greco FA, Pavlidis N, Pentheroudakis G. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2011;22 Suppl 6:vi64-vi68. [PMID: 21908507 DOI: 10.1093/annonc/mdr389] [Cited by in Crossref: 79] [Cited by in F6Publishing: 55] [Article Influence: 7.9] [Reference Citation Analysis]
240 Franceschilli M, Di Carlo S, Vinci D, Sensi B, Siragusa L, Bellato V, Caronna R, Rossi P, Cavallaro G, Guida A, Sibio S. Complete mesocolic excision and central vascular ligation in colorectal cancer in the era of minimally invasive surgery. WJCC 2021;9:7297-305. [DOI: 10.12998/wjcc.v9.i25.7297] [Reference Citation Analysis]
241 Ueda S, Takanashi M, Sudo K, Kanekura K, Kuroda M. miR-27a ameliorates chemoresistance of breast cancer cells by disruption of reactive oxygen species homeostasis and impairment of autophagy. Lab Invest 2020;100:863-73. [PMID: 32066826 DOI: 10.1038/s41374-020-0409-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
242 Grisard E, Nicoloso MS. Following MicroRNAs Through the Cancer Metastatic Cascade. Int Rev Cell Mol Biol 2017;333:173-228. [PMID: 28729025 DOI: 10.1016/bs.ircmb.2017.04.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
243 Hemminki K, Bevier M, Sundquist J, Hemminki A. Site-specific cancer deaths in cancer of unknown primary diagnosed with lymph node metastasis may reveal hidden primaries. Int J Cancer 2013;132:944-50. [PMID: 22730111 DOI: 10.1002/ijc.27678] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
244 Kraj P. Bone Morphogenic Protein Signaling and Melanoma. Curr Treat Options Oncol 2021;22:48. [PMID: 33866453 DOI: 10.1007/s11864-021-00849-w] [Reference Citation Analysis]
245 Ghajar CM, Peinado H, Mori H, Matei IR, Evason KJ, Brazier H, Almeida D, Koller A, Hajjar KA, Stainier DY. The perivascular niche regulates breast tumour dormancy. Nat Cell Biol. 2013;15:807-817. [PMID: 23728425 DOI: 10.1038/ncb2767] [Cited by in Crossref: 652] [Cited by in F6Publishing: 547] [Article Influence: 81.5] [Reference Citation Analysis]
246 Kim KT, Lee HW, Lee HO, Song HJ, Jeong da E, Shin S, Kim H, Shin Y, Nam DH, Jeong BC, Kirsch DG, Joo KM, Park WY. Application of single-cell RNA sequencing in optimizing a combinatorial therapeutic strategy in metastatic renal cell carcinoma. Genome Biol. 2016;17:80. [PMID: 27139883 DOI: 10.1186/s13059-016-0945-9] [Cited by in Crossref: 109] [Cited by in F6Publishing: 84] [Article Influence: 21.8] [Reference Citation Analysis]
247 Kim TM, An CH, Rhee JK, Jung SH, Lee SH, Baek IP, Kim MS, Lee SH, Chung YJ. Clonal origins and parallel evolution of regionally synchronous colorectal adenoma and carcinoma. Oncotarget 2015;6:27725-35. [PMID: 26336987 DOI: 10.18632/oncotarget.4834] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
248 Kawamura Y, Sanchez Calle A, Yamamoto Y, Sato TA, Ochiya T. Extracellular vesicles mediate the horizontal transfer of an active LINE-1 retrotransposon. J Extracell Vesicles 2019;8:1643214. [PMID: 31448067 DOI: 10.1080/20013078.2019.1643214] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
249 Martin OA, Anderson RL, Narayan K, MacManus MP. Does the mobilization of circulating tumour cells during cancer therapy cause metastasis? Nat Rev Clin Oncol 2017;14:32-44. [PMID: 27550857 DOI: 10.1038/nrclinonc.2016.128] [Cited by in Crossref: 85] [Cited by in F6Publishing: 71] [Article Influence: 17.0] [Reference Citation Analysis]
250 Stübke K, Wicklein D, Herich L, Schumacher U, Nehmann N. Selectin-deficiency reduces the number of spontaneous metastases in a xenograft model of human breast cancer. Cancer Lett 2012;321:89-99. [PMID: 22366582 DOI: 10.1016/j.canlet.2012.02.019] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
251 Stoecklein NH, Klein CA. Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis. Int J Cancer. 2010;126:589-598. [PMID: 19795462 DOI: 10.1002/ijc.24916] [Cited by in Crossref: 137] [Cited by in F6Publishing: 111] [Article Influence: 12.5] [Reference Citation Analysis]
252 Yu L, Ng SR, Xu Y, Dong H, Wang YJ, Li CM. Advances of lab-on-a-chip in isolation, detection and post-processing of circulating tumour cells. Lab Chip 2013;13:3163. [DOI: 10.1039/c3lc00052d] [Cited by in Crossref: 84] [Cited by in F6Publishing: 70] [Article Influence: 10.5] [Reference Citation Analysis]
253 Leung ML, Davis A, Gao R, Casasent A, Wang Y, Sei E, Vilar E, Maru D, Kopetz S, Navin NE. Single-cell DNA sequencing reveals a late-dissemination model in metastatic colorectal cancer. Genome Res 2017;27:1287-99. [PMID: 28546418 DOI: 10.1101/gr.209973.116] [Cited by in Crossref: 111] [Cited by in F6Publishing: 77] [Article Influence: 27.8] [Reference Citation Analysis]
254 Zhao ZM, Zhao B, Bai Y, Iamarino A, Gaffney SG, Schlessinger J, Lifton RP, Rimm DL, Townsend JP. Early and multiple origins of metastatic lineages within primary tumors. Proc Natl Acad Sci U S A 2016;113:2140-5. [PMID: 26858460 DOI: 10.1073/pnas.1525677113] [Cited by in Crossref: 95] [Cited by in F6Publishing: 67] [Article Influence: 19.0] [Reference Citation Analysis]
255 Kim ST, Chang WJ, Jin L, Sung JS, Choi YJ, Kim YH. Can Serum be Used for Analyzing the KRAS Mutation Status in Patients with Advanced Colorectal Cancer? Cancer Res Treat 2015;47:796-803. [PMID: 25687873 DOI: 10.4143/crt.2014.106] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
256 Ejaeidi AA, Craft BS, Puneky LV, Lewis RE, Cruse JM. Hormone receptor-independent CXCL10 production is associated with the regulation of cellular factors linked to breast cancer progression and metastasis. Exp Mol Pathol 2015;99:163-72. [PMID: 26079660 DOI: 10.1016/j.yexmp.2015.06.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
257 Choe SC, Zhao G, Zhao Z, Rosenblatt JD, Cho HM, Shin SU, Johnson NF. Model for in vivo progression of tumors based on co-evolving cell population and vasculature. Sci Rep. 2011;1:31. [PMID: 22355550 DOI: 10.1038/srep00031] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
258 Lewis SM, Asselin-Labat ML, Nguyen Q, Berthelet J, Tan X, Wimmer VC, Merino D, Rogers KL, Naik SH. Spatial omics and multiplexed imaging to explore cancer biology. Nat Methods 2021. [PMID: 34341583 DOI: 10.1038/s41592-021-01203-6] [Reference Citation Analysis]
259 Ruan M, Liu L, Wang L, Lei B, Sun X, Chang C, Shen Y, Xie W. Correlation between combining 18F–FDG PET/CT metabolic parameters and other clinical features and ALK or ROS1 fusion in patients with non-small-cell lung cancer. Eur J Nucl Med Mol Imaging 2020;47:1183-97. [DOI: 10.1007/s00259-019-04652-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
260 Riggio AI, Varley KE, Welm AL. The lingering mysteries of metastatic recurrence in breast cancer. Br J Cancer 2021;124:13-26. [PMID: 33239679 DOI: 10.1038/s41416-020-01161-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 14.0] [Reference Citation Analysis]
261 Lianidou ES. Circulating Tumor Cells—New Challenges Ahead. Clinical Chemistry 2012;58:805-7. [DOI: 10.1373/clinchem.2011.180646] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
262 Rietkötter E, Bleckmann A, Bayerlová M, Menck K, Chuang HN, Wenske B, Schwartz H, Erez N, Binder C, Hanisch UK, Pukrop T. Anti-CSF-1 treatment is effective to prevent carcinoma invasion induced by monocyte-derived cells but scarcely by microglia. Oncotarget 2015;6:15482-93. [PMID: 26098772 DOI: 10.18632/oncotarget.3855] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
263 Britton KM, Kirby JA, Lennard TW, Meeson AP. Cancer stem cells and side population cells in breast cancer and metastasis. Cancers (Basel) 2011;3:2106-30. [PMID: 24212798 DOI: 10.3390/cancers3022106] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
264 Nel I, Morawetz EW, Tschodu D, Käs JA, Aktas B. The Mechanical Fingerprint of Circulating Tumor Cells (CTCs) in Breast Cancer Patients. Cancers (Basel) 2021;13:1119. [PMID: 33807790 DOI: 10.3390/cancers13051119] [Reference Citation Analysis]
265 Papadaki MA, Koutsopoulos AV, Tsoulfas PG, Lagoudaki E, Aggouraki D, Monastirioti A, Koutoulaki C, Apostolopoulou CA, Merodoulaki AC, Papadaki C, Mavroudis D, Agelaki S. Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast Cancer. Cancers (Basel) 2020;12:E376. [PMID: 32041353 DOI: 10.3390/cancers12020376] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
266 Noorani A, Li X, Goddard M, Crawte J, Alexandrov LB, Secrier M, Eldridge MD, Bower L, Weaver J, Lao-Sirieix P, Martincorena I, Debiram-Beecham I, Grehan N, MacRae S, Malhotra S, Miremadi A, Thomas T, Galbraith S, Petersen L, Preston SD, Gilligan D, Hindmarsh A, Hardwick RH, Stratton MR, Wedge DC, Fitzgerald RC. Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma. Nat Genet 2020;52:74-83. [PMID: 31907488 DOI: 10.1038/s41588-019-0551-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 21.0] [Reference Citation Analysis]
267 Marconato L, Zorzan E, Giantin M, Di Palma S, Cancedda S, Dacasto M. Concordance of c-kit mutational status in matched primary and metastatic cutaneous canine mast cell tumors at baseline. J Vet Intern Med 2014;28:547-53. [PMID: 24372836 DOI: 10.1111/jvim.12266] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
268 Sarkar S, Bustard BL, Welter JF, Baskaran H. Combined experimental and mathematical approach for development of microfabrication-based cancer migration assay. Ann Biomed Eng 2011;39:2346-59. [PMID: 21701934 DOI: 10.1007/s10439-011-0337-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
269 Uhlig J, Case MD, Blasberg JD, Boffa DJ, Chiang A, Gettinger SN, Kim HS. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer. JAMA Netw Open 2019;2:e199702. [PMID: 31433481 DOI: 10.1001/jamanetworkopen.2019.9702] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
270 Klein CA. Cancer progression and the invisible phase of metastatic colonization. Nat Rev Cancer 2020;20:681-94. [DOI: 10.1038/s41568-020-00300-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 28.0] [Reference Citation Analysis]
271 Lianidou ES, Markou A. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges. Clin Chem. 2011;57:1242-1255. [PMID: 21784769 DOI: 10.1373/clinchem.2011.165068] [Cited by in Crossref: 183] [Cited by in F6Publishing: 162] [Article Influence: 18.3] [Reference Citation Analysis]
272 Hartkopf AD, Stefanescu D, Wallwiener M, Hahn M, Becker S, Solomayer E, Fehm TN, Brucker SY, Taran F. Tumor cell dissemination to the bone marrow and blood is associated with poor outcome in patients with metastatic breast cancer. Breast Cancer Res Treat 2014;147:345-51. [DOI: 10.1007/s10549-014-3113-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
273 Charpentier MS, Whipple RA, Vitolo MI, Boggs AE, Slovic J, Thompson KN, Bhandary L, Martin SS. Curcumin targets breast cancer stem-like cells with microtentacles that persist in mammospheres and promote reattachment. Cancer Res 2014;74:1250-60. [PMID: 24371229 DOI: 10.1158/0008-5472.CAN-13-1778] [Cited by in Crossref: 59] [Cited by in F6Publishing: 34] [Article Influence: 7.4] [Reference Citation Analysis]
274 Zhou X, Tian L, Fan J, Lai Y, Li S, Che G, Huang J. Method for discriminating synchronous multiple lung cancers of the same histological type: miRNA expression analysis. Medicine (Baltimore) 2016;95:e4478. [PMID: 27495091 DOI: 10.1097/MD.0000000000004478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
275 Pons-Tostivint E, Alouani E, Kirova Y, Dalenc F, Vaysse C. Is there a role for locoregional treatment of the primary tumor in de novo metastatic breast cancer in the era of tailored therapies?: Evidences, unresolved questions and a practical algorithm. Crit Rev Oncol Hematol 2021;157:103146. [PMID: 33227574 DOI: 10.1016/j.critrevonc.2020.103146] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
276 Fu T, Pappou EP, Guzzetta AA, Calmon Mde F, Sun L, Herrera A, Li F, Wolfgang CL, Baylin SB, Iacobuzio-Donahue CA. IGFBP-3 Gene Methylation in Primary Tumor Predicts Recurrence of Stage II Colorectal Cancers. Ann Surg. 2016;263:337-344. [PMID: 25822686 DOI: 10.1097/sla.0000000000001204] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
277 Knudsen BS, Vasioukhin V. Mechanisms of prostate cancer initiation and progression. Adv Cancer Res 2010;109:1-50. [PMID: 21070913 DOI: 10.1016/B978-0-12-380890-5.00001-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
278 Fabisiewicz A, Szostakowska-Rodzos M, Zaczek AJ, Grzybowska EA. Circulating Tumor Cells in Early and Advanced Breast Cancer; Biology and Prognostic Value. Int J Mol Sci 2020;21:E1671. [PMID: 32121386 DOI: 10.3390/ijms21051671] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
279 Riaz S, Nawaz MK, Faruqui ZS, Saeed Kazmi SA, Loya A, Bashir H. Diagnostic Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in the Evaluation of Carcinoma of Unknown Primary. Mol Imaging Radionucl Ther 2016;25:11-8. [PMID: 27299283 DOI: 10.4274/mirt.05706] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
280 Abdul-Wahid A, Huang EH, Cydzik M, Bolewska-Pedyczak E, Gariépy J. The carcinoembryonic antigen IgV-like N domain plays a critical role in the implantation of metastatic tumor cells. Mol Oncol 2014;8:337-50. [PMID: 24388361 DOI: 10.1016/j.molonc.2013.12.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
281 Bilous M, Serdjebi C, Boyer A, Tomasini P, Pouypoudat C, Barbolosi D, Barlesi F, Chomy F, Benzekry S. Quantitative mathematical modeling of clinical brain metastasis dynamics in non-small cell lung cancer. Sci Rep 2019;9:13018. [PMID: 31506498 DOI: 10.1038/s41598-019-49407-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
282 Hoogstraat M, de Pagter MS, Cirkel GA, van Roosmalen MJ, Harkins TT, Duran K, Kreeftmeijer J, Renkens I, Witteveen PO, Lee CC, Nijman IJ, Guy T, van 't Slot R, Jonges TN, Lolkema MP, Koudijs MJ, Zweemer RP, Voest EE, Cuppen E, Kloosterman WP. Genomic and transcriptomic plasticity in treatment-naive ovarian cancer. Genome Res 2014;24:200-11. [PMID: 24221193 DOI: 10.1101/gr.161026.113] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 6.4] [Reference Citation Analysis]
283 Chen D, Gassenmaier M, Maruschke M, Riesenberg R, Pohla H, Stief CG, Zimmermann W, Buchner A. Expression and Prognostic Significance of a Comprehensive Epithelial-Mesenchymal Transition Gene Set in Renal Cell Carcinoma. Journal of Urology 2014;191:479-86. [DOI: 10.1016/j.juro.2013.08.052] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
284 Ren C, Chen H, Han C, Jin G, Wang D, Wang D, Tang D. Detection and molecular analysis of circulating tumor cells for early diagnosis of pancreatic cancer. Med Hypotheses. 2013;80:833-836. [PMID: 23587480 DOI: 10.1016/j.mehy.2013.03.027] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
285 Liu Q, Luo D, Li Q, Zhu J, Li X. Evaluating the Effect of Lymph Node Status on Survival in Large Colon Cancer. Front Oncol 2018;8:602. [PMID: 30619744 DOI: 10.3389/fonc.2018.00602] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
286 Herheliuk T, Perepelytsina O, Ugnivenko A, Ostapchenko L, Sydorenko M. Investigation of multicellular tumor spheroids enriched for a cancer stem cell phenotype. Stem Cell Investig 2019;6:21. [PMID: 31559308 DOI: 10.21037/sci.2019.06.07] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
287 Bonnomet A, Brysse A, Tachsidis A, Waltham M, Thompson EW, Polette M, Gilles C. Epithelial-to-mesenchymal transitions and circulating tumor cells. J Mammary Gland Biol Neoplasia. 2010;15:261-273. [PMID: 20449641 DOI: 10.1007/s10911-010-9174-0] [Cited by in Crossref: 151] [Cited by in F6Publishing: 134] [Article Influence: 13.7] [Reference Citation Analysis]
288 Curtin J, Choi SW, Thomson PJ, Lam AK. Characterization and clinicopathological significance of circulating tumour cells in patients with oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2021:S0901-5027(21)00205-8. [PMID: 34154876 DOI: 10.1016/j.ijom.2021.05.020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
289 Ogle LF, Orr JG, Willoughby CE, Hutton C, McPherson S, Plummer R, Boddy AV, Curtin NJ, Jamieson D, Reeves HL. Imagestream detection and characterisation of circulating tumour cells - A liquid biopsy for hepatocellular carcinoma? J Hepatol. 2016;65:305-313. [PMID: 27132171 DOI: 10.1016/j.jhep.2016.04.014] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 11.2] [Reference Citation Analysis]
290 Liao D, Estévez-Salmerón L, Tlsty TD. Generalized principles of stochasticity can be used to control dynamic heterogeneity. Phys Biol 2012;9:065006. [PMID: 23197162 DOI: 10.1088/1478-3975/9/6/065006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
291 Wang H, Stoecklein NH, Lin PP, Gires O. Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion. Oncotarget 2017;8:1884-912. [PMID: 27683128 DOI: 10.18632/oncotarget.12242] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 13.7] [Reference Citation Analysis]
292 Lian H, Ding Z, Yuan D, Ma J, Qin J. [Diagnostic Value of Folate Receptor-positive Circulating Tumor Cell in Lung Cancer: A Pilot Study]. Zhongguo Fei Ai Za Zhi 2016;19:813-20. [PMID: 27978866 DOI: 10.3779/j.issn.1009-3419.2016.12.03] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
293 Balic M. Disseminated tumor cells as biomarkers for breast cancer. Biomark Med 2009;3:215-7. [PMID: 20477471 DOI: 10.2217/bmm.09.17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
294 Lorusso G, Rüegg C. New insights into the mechanisms of organ-specific breast cancer metastasis. Semin Cancer Biol 2012;22:226-33. [PMID: 22504658 DOI: 10.1016/j.semcancer.2012.03.007] [Cited by in Crossref: 103] [Cited by in F6Publishing: 94] [Article Influence: 11.4] [Reference Citation Analysis]
295 Kanwar N, Done SJ. Molecular Profiling and Significance of Circulating Tumor Cell Based Genetic Signatures. Adv Exp Med Biol 2017;994:143-67. [PMID: 28560673 DOI: 10.1007/978-3-319-55947-6_8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
296 Lavilla-Alonso S, Abo-Ramadan U, Halavaara J, Escutenaire S, Tatlisumak T, Saksela K, Kanerva A, Hemminki A, Pesonen S. Optimized mouse model for the imaging of tumor metastasis upon experimental therapy. PLoS One 2011;6:e26810. [PMID: 22073198 DOI: 10.1371/journal.pone.0026810] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
297 Hölzel D, Eckel R, Emeny RT, Engel J. Distant metastases do not metastasize. Cancer Metastasis Rev 2010;29:737-50. [PMID: 20878451 DOI: 10.1007/s10555-010-9260-1] [Cited by in Crossref: 52] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
298 Xie F, Zhang Y, Mao X, Zheng X, Han-Zhang H, Ye J, Zhao R, Zhang X, Sun J. Comparison of genetic profiles among primary lung tumor, metastatic lymph nodes and circulating tumor DNA in treatment-naïve advanced non-squamous non-small cell lung cancer patients. Lung Cancer 2018;121:54-60. [PMID: 29858028 DOI: 10.1016/j.lungcan.2018.05.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
299 Hu Z, Curtis C. Looking backward in time to define the chronology of metastasis. Nat Commun 2020;11:3213. [PMID: 32587245 DOI: 10.1038/s41467-020-16995-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
300 Keup C, Kimmig R, Kasimir-Bauer S. Liquid Biopsies to Evaluate Immunogenicity of Gynecological/Breast Tumors: On the Way to Blood-Based Biomarkers for Immunotherapies. Breast Care (Basel) 2020;15:470-80. [PMID: 33223990 DOI: 10.1159/000510509] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
301 Campbell PJ, Yachida S, Mudie LJ, Stephens PJ, Pleasance ED, Stebbings LA, Morsberger LA, Latimer C, McLaren S, Lin ML, McBride DJ, Varela I, Nik-Zainal SA, Leroy C, Jia M, Menzies A, Butler AP, Teague JW, Griffin CA, Burton J, Swerdlow H, Quail MA, Stratton MR, Iacobuzio-Donahue C, Futreal PA. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 2010;467:1109-13. [PMID: 20981101 DOI: 10.1038/nature09460] [Cited by in Crossref: 937] [Cited by in F6Publishing: 808] [Article Influence: 85.2] [Reference Citation Analysis]
302 Podolskiy DI, Lobanov AV, Kryukov GV, Gladyshev VN. Analysis of cancer genomes reveals basic features of human aging and its role in cancer development. Nat Commun 2016;7:12157. [PMID: 27515585 DOI: 10.1038/ncomms12157] [Cited by in Crossref: 54] [Cited by in F6Publishing: 37] [Article Influence: 10.8] [Reference Citation Analysis]
303 Krawczyk N, Meier-Stiegen F, Banys M, Neubauer H, Ruckhaeberle E, Fehm T. Expression of stem cell and epithelial-mesenchymal transition markers in circulating tumor cells of breast cancer patients. Biomed Res Int 2014;2014:415721. [PMID: 24895575 DOI: 10.1155/2014/415721] [Cited by in Crossref: 59] [Cited by in F6Publishing: 49] [Article Influence: 8.4] [Reference Citation Analysis]
304 Ciriello G, Magnani L. The many faces of cancer evolution. iScience 2021;24:102403. [PMID: 34027317 DOI: 10.1016/j.isci.2021.102403] [Reference Citation Analysis]
305 Sethi N, Kang Y. Unravelling the complexity of metastasis - molecular understanding and targeted therapies. Nat Rev Cancer 2011;11:735-48. [PMID: 21941285 DOI: 10.1038/nrc3125] [Cited by in Crossref: 253] [Cited by in F6Publishing: 231] [Article Influence: 25.3] [Reference Citation Analysis]
306 Reeh M, Effenberger KE, Koenig AM, Riethdorf S, Eichstädt D, Vettorazzi E, Uzunoglu FG, Vashist YK, Izbicki JR, Pantel K. Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer. Ann Surg. 2015;261:1124-1130. [PMID: 25607767 DOI: 10.1097/sla.0000000000001130] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 9.8] [Reference Citation Analysis]
307 Jin L, Fan WH, Luan Y, Wu M, Zhao W. Evaluation of circulating tumor cells as a prognostic biomarker for early recurrence in stage II-III breast cancer patients using CytoSorter® system: a retrospective study. PeerJ 2021;9:e11366. [PMID: 33987029 DOI: 10.7717/peerj.11366] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
308 Yang CY, Tseng JY, Chen CF, Chou TY, Gao HW, Hua CL, Lin CH, Lin JK, Jiang JK. Genome-wide copy number changes and CD133 expression characterized distinct subset of colon polyps: differentiation between incidental polyps and cancer-associated polyps. Int J Colorectal Dis 2015;30:1617-26. [PMID: 26206347 DOI: 10.1007/s00384-015-2319-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
309 Klein CA. Tumour cell dissemination and growth of metastasis. Nat Rev Cancer 2010;10:156-156. [DOI: 10.1038/nrc2627-c2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
310 Zhou Y, Kopeček J. Biological rationale for the design of polymeric anti-cancer nanomedicines. J Drug Target 2013;21:1-26. [PMID: 23009337 DOI: 10.3109/1061186X.2012.723213] [Cited by in Crossref: 47] [Cited by in F6Publishing: 19] [Article Influence: 5.2] [Reference Citation Analysis]
311 Massihnia D, Perez A, Bazan V, Bronte G, Castiglia M, Fanale D, Barraco N, Cangemi A, Di Piazza F, Calò V, Rizzo S, Cicero G, Pantuso G, Russo A. A headlight on liquid biopsies: a challenging tool for breast cancer management. Tumor Biol 2016;37:4263-73. [DOI: 10.1007/s13277-016-4856-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
312 Navin NE. Cancer genomics: one cell at a time. Genome Biol 2014;15:452. [PMID: 25222669 DOI: 10.1186/s13059-014-0452-9] [Cited by in Crossref: 191] [Cited by in F6Publishing: 144] [Article Influence: 27.3] [Reference Citation Analysis]
313 Goddard ET, Bozic I, Riddell SR, Ghajar CM. Dormant tumour cells, their niches and the influence of immunity. Nat Cell Biol 2018;20:1240-9. [PMID: 30361702 DOI: 10.1038/s41556-018-0214-0] [Cited by in Crossref: 63] [Cited by in F6Publishing: 55] [Article Influence: 21.0] [Reference Citation Analysis]
314 Rahbari NN, Bork U, Motschall E, Thorlund K, Büchler MW, Koch M, Weitz J. Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and meta-analysis. J Clin Oncol. 2012;30:60-70. [PMID: 22124103 DOI: 10.1200/jco.2011.36.9504] [Cited by in Crossref: 107] [Cited by in F6Publishing: 55] [Article Influence: 10.7] [Reference Citation Analysis]
315 Gassenmaier M, Eigentler TK, Keim U, Goebeler M, Fiedler E, Schuler G, Leiter U, Weide B, Grischke E, Martus P, Garbe C. Serial or Parallel Metastasis of Cutaneous Melanoma? A Study of the German Central Malignant Melanoma Registry. Journal of Investigative Dermatology 2017;137:2570-7. [DOI: 10.1016/j.jid.2017.07.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 4.8] [Reference Citation Analysis]
316 Laget S, Broncy L, Hormigos K, Dhingra DM, BenMohamed F, Capiod T, Osteras M, Farinelli L, Jackson S, Paterlini-Bréchot P. Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion. PLoS One 2017;12:e0169427. [PMID: 28060956 DOI: 10.1371/journal.pone.0169427] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 8.8] [Reference Citation Analysis]
317 Hartkopf AD, Wallwiener M, Fehm TN, Hahn M, Walter CB, Gruber I, Brucker SY, Taran FA. Disseminated tumor cells from the bone marrow of patients with nonmetastatic primary breast cancer are predictive of locoregional relapse. Ann Oncol 2015;26:1155-60. [PMID: 25791636 DOI: 10.1093/annonc/mdv148] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
318 Klein CA. Selection and adaptation during metastatic cancer progression. Nature. 2013;501:365-372. [PMID: 24048069 DOI: 10.1038/nature12628] [Cited by in Crossref: 179] [Cited by in F6Publishing: 150] [Article Influence: 22.4] [Reference Citation Analysis]
319 Hartung F, Wang Y, Aronow B, Weber GF. A core program of gene expression characterizes cancer metastases. Oncotarget 2017;8:102161-75. [PMID: 29254233 DOI: 10.18632/oncotarget.22240] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
320 Krøigård AB, Larsen MJ, Lænkholm AV, Knoop AS, Jensen JD, Bak M, Mollenhauer J, Kruse TA, Thomassen M. Clonal expansion and linear genome evolution through breast cancer progression from pre-invasive stages to asynchronous metastasis. Oncotarget 2015;6:5634-49. [PMID: 25730902 DOI: 10.18632/oncotarget.3111] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 6.2] [Reference Citation Analysis]
321 Han YM, Lee SK, Jeong DG, Ryu SE, Han DC, Kim DK, Kwon BM. Emodin inhibits migration and invasion of DLD-1 (PRL-3) cells via inhibition of PRL-3 phosphatase activity. Bioorg Med Chem Lett 2012;22:323-6. [PMID: 22137788 DOI: 10.1016/j.bmcl.2011.11.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
322 Aguado BA, Bushnell GG, Rao SS, Jeruss JS, Shea LD. Engineering the pre-metastatic niche. Nat Biomed Eng 2017;1:0077. [PMID: 28989814 DOI: 10.1038/s41551-017-0077] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 16.0] [Reference Citation Analysis]
323 Lee JM. The good oncogene: When bad genes identify good outcome in cancer. Med Hypotheses 2011;76:259-63. [PMID: 21050670 DOI: 10.1016/j.mehy.2010.10.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
324 Li C, Bonazzoli E, Bellone S, Choi J, Dong W, Menderes G, Altwerger G, Han C, Manzano A, Bianchi A, Pettinella F, Manara P, Lopez S, Yadav G, Riccio F, Zammataro L, Zeybek B, Yang-Hartwich Y, Buza N, Hui P, Wong S, Ravaggi A, Bignotti E, Romani C, Todeschini P, Zanotti L, Zizioli V, Odicino F, Pecorelli S, Ardighieri L, Silasi DA, Litkouhi B, Ratner E, Azodi M, Huang GS, Schwartz PE, Lifton RP, Schlessinger J, Santin AD. Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors. Proc Natl Acad Sci U S A 2019;116:619-24. [PMID: 30584090 DOI: 10.1073/pnas.1814027116] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
325 Johnson RW, Suva LJ. Hallmarks of Bone Metastasis. Calcif Tissue Int 2018;102:141-51. [PMID: 29138883 DOI: 10.1007/s00223-017-0362-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 6.8] [Reference Citation Analysis]
326 Naxerova K, Brachtel E, Salk JJ, Seese AM, Power K, Abbasi B, Snuderl M, Chiang S, Kasif S, Jain RK. Hypermutable DNA chronicles the evolution of human colon cancer. Proc Natl Acad Sci U S A 2014;111:E1889-98. [PMID: 24753616 DOI: 10.1073/pnas.1400179111] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
327 Martins D, Beca F, Schmitt F. Metastatic breast cancer: mechanisms and opportunities for cytology. Cytopathology 2014;25:225-30. [PMID: 24889678 DOI: 10.1111/cyt.12158] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
328 Jensen JD, Knoop A, Ewertz M, Laenkholm AV. ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer. Breast Cancer Res Treat 2012;132:511-21. [PMID: 21667123 DOI: 10.1007/s10549-011-1610-3] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
329 Chinen LT, Mello CA, Abdallah EA, Ocea LM, Buim ME, Breve NM, Gasparini JL Junior, Fanelli MF, Paterlini-Bréchot P. Isolation, detection, and immunomorphological characterization of circulating tumor cells (CTCs) from patients with different types of sarcoma using isolation by size of tumor cells: a window on sarcoma-cell invasion. Onco Targets Ther 2014;7:1609-17. [PMID: 25258541 DOI: 10.2147/OTT.S62349] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
330 Beca F, Polyak K. Intratumor Heterogeneity in Breast Cancer. Adv Exp Med Biol 2016;882:169-89. [PMID: 26987535 DOI: 10.1007/978-3-319-22909-6_7] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 13.2] [Reference Citation Analysis]
331 Caswell DR, Chuang CH, Yang D, Chiou SH, Cheemalavagu S, Kim-Kiselak C, Connolly A, Winslow MM. Obligate progression precedes lung adenocarcinoma dissemination. Cancer Discov 2014;4:781-9. [PMID: 24740995 DOI: 10.1158/2159-8290.CD-13-0862] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 4.9] [Reference Citation Analysis]
332 Yan N, Zhang Y, Guo X, Yuan D, Tian G, Yang J. A Review on Cancer of Unknown Primary Origin: The Role of Molecular Biomarkers in the Identification of Unknown Primary Origin. Methods Mol Biol 2020;2204:109-19. [PMID: 32710319 DOI: 10.1007/978-1-0716-0904-0_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
333 Schrijver WA, Jiwa LS, van Diest PJ, Moelans CB. Promoter hypermethylation profiling of distant breast cancer metastases. Breast Cancer Res Treat 2015;151:41-55. [PMID: 25841351 DOI: 10.1007/s10549-015-3362-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
334 Bochtler T, Krämer A. Does Cancer of Unknown Primary (CUP) Truly Exist as a Distinct Cancer Entity? Front Oncol 2019;9:402. [PMID: 31165045 DOI: 10.3389/fonc.2019.00402] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 10.5] [Reference Citation Analysis]
335 Gerber DE. Oligometastatic Non-Small-Cell Lung Cancer: How Should We Define and Manage It? J Oncol Pract 2018;14:32-4. [PMID: 29324207 DOI: 10.1200/JOP.2017.028290] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
336 Toh B, Wang X, Keeble J, Sim WJ, Khoo K, Wong WC, Kato M, Prevost-Blondel A, Thiery JP, Abastado JP. Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor. PLoS Biol 2011;9:e1001162. [PMID: 21980263 DOI: 10.1371/journal.pbio.1001162] [Cited by in Crossref: 211] [Cited by in F6Publishing: 194] [Article Influence: 21.1] [Reference Citation Analysis]
337 Zeeshan R, Mutahir Z. Cancer metastasis - tricks of the trade. Bosn J Basic Med Sci 2017;17:172-82. [PMID: 28278128 DOI: 10.17305/bjbms.2017.1908] [Cited by in Crossref: 12] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
338 Yang PS, Hsu HH, Hsu TC, Chen MJ, Wang CD, Yu SL, Hsu YC, Li KC. Genome-Wide Scan for Copy Number Alteration Association with Relapse-Free Survival in Colorectal Cancer with Liver Metastasis Patients. J Clin Med 2018;7:E446. [PMID: 30453668 DOI: 10.3390/jcm7110446] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
339 Neophytou C, Boutsikos P, Papageorgis P. Molecular Mechanisms and Emerging Therapeutic Targets of Triple-Negative Breast Cancer Metastasis. Front Oncol 2018;8:31. [PMID: 29520340 DOI: 10.3389/fonc.2018.00031] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 19.7] [Reference Citation Analysis]
340 Bednarz-Knoll N, Alix-Panabières C, Pantel K. Plasticity of disseminating cancer cells in patients with epithelial malignancies. Cancer Metastasis Rev. 2012;31:673-687. [PMID: 22733306 DOI: 10.1007/s10555-012-9370-z] [Cited by in Crossref: 139] [Cited by in F6Publishing: 134] [Article Influence: 17.4] [Reference Citation Analysis]
341 Lankelma J, Kooi B, Krab K, Dorsman JC, Joenje H, Westerhoff HV. A reason for intermittent fasting to suppress the awakening of dormant breast tumors. Biosystems 2015;127:1-6. [PMID: 25448890 DOI: 10.1016/j.biosystems.2014.11.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
342 Paulsen EE, Kilvaer TK, Rakaee M, Richardsen E, Hald SM, Andersen S, Busund LT, Bremnes RM, Donnem T. CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases. Cancer Immunol Immunother 2017;66:1449-61. [PMID: 28707078 DOI: 10.1007/s00262-017-2039-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 8.5] [Reference Citation Analysis]
343 Bethge A, Schumacher U, Wree A, Wedemann G. Are metastases from metastases clinical relevant? Computer modelling of cancer spread in a case of hepatocellular carcinoma. PLoS One. 2012;7:e35689. [PMID: 22539992 DOI: 10.1371/journal.pone.0035689] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
344 Qian JJ, Akçay E. Competition and niche construction in a model of cancer metastasis. PLoS One 2018;13:e0198163. [PMID: 29813117 DOI: 10.1371/journal.pone.0198163] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
345 Yao X, Choudhury AD, Yamanaka YJ, Adalsteinsson VA, Gierahn TM, Williamson CA, Lamb CR, Taplin ME, Nakabayashi M, Chabot MS, Li T, Lee GS, Boehm JS, Kantoff PW, Hahn WC, Wittrup KD, Love JC. Functional analysis of single cells identifies a rare subset of circulating tumor cells with malignant traits. Integr Biol (Camb) 2014;6:388-98. [PMID: 24522233 DOI: 10.1039/c3ib40264a] [Cited by in Crossref: 39] [Cited by in F6Publishing: 21] [Article Influence: 5.6] [Reference Citation Analysis]
346 Wu ZJ, Tan JC, Qin X, Liu B, Yuan ZC. Significance of circulating tumor cells in osteosarcoma patients treated by neoadjuvant chemotherapy and surgery. Cancer Manag Res 2018;10:3333-9. [PMID: 30237736 DOI: 10.2147/CMAR.S176515] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 3.7] [Reference Citation Analysis]
347 Ocaña A, Freedman O, Amir E, Seruga B, Pandiella A. Biological insights into effective and antagonistic combinations of targeted agents with chemotherapy in solid tumors. Cancer Metastasis Rev 2014;33:295-307. [PMID: 24338003 DOI: 10.1007/s10555-013-9451-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
348 Lee MH, Wu PH, Gilkes D, Aifuwa I, Wirtz D. Normal mammary epithelial cells promote carcinoma basement membrane invasion by inducing microtubule-rich protrusions. Oncotarget 2015;6:32634-45. [PMID: 26334095 DOI: 10.18632/oncotarget.4728] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
349 Swoboda A, Rasin-streden D, Schanab O, Okamoto I, Pehamberger H, Petzelbauer P, Mikula M. Identification of genetic disparity between primary and metastatic melanoma in human patients. Genes Chromosom Cancer 2011;50:680-8. [DOI: 10.1002/gcc.20890] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
350 Schumacher S, Bartenhagen C, Hoffmann M, Will D, Fischer JC, Baldus SE, Vay C, Fluegen G, Dizdar L, Vallböhmer D, Klein CA, Knoefel WT, Stoecklein NH, Möhlendick B. Disseminated tumour cells with highly aberrant genomes are linked to poor prognosis in operable oesophageal adenocarcinoma. Br J Cancer 2017;117:725-33. [PMID: 28728164 DOI: 10.1038/bjc.2017.233] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
351 Lu X, Mu E, Wei Y, Riethdorf S, Yang Q, Yuan M, Yan J, Hua Y, Tiede BJ, Lu X. VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors. Cancer Cell. 2011;20:701-714. [PMID: 22137794 DOI: 10.1016/j.ccr.2011.11.002] [Cited by in Crossref: 314] [Cited by in F6Publishing: 273] [Article Influence: 31.4] [Reference Citation Analysis]
352 Sistigu A, Musella M, Galassi C, Vitale I, De Maria R. Tuning Cancer Fate: Tumor Microenvironment's Role in Cancer Stem Cell Quiescence and Reawakening. Front Immunol 2020;11:2166. [PMID: 33193295 DOI: 10.3389/fimmu.2020.02166] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
353 Tabor S, Szostakowska-Rodzos M, Fabisiewicz A, Grzybowska EA. How to Predict Metastasis in Luminal Breast Cancer? Current Solutions and Future Prospects. Int J Mol Sci 2020;21:E8415. [PMID: 33182512 DOI: 10.3390/ijms21218415] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
354 Maiti A, Okano I, Oshi M, Okano M, Tian W, Kawaguchi T, Katsuta E, Takabe K, Yan L, Patnaik S, Hait NC. Altered Expression of Secreted Mediator Genes That Mediate Aggressive Breast Cancer Metastasis to Distant Organs. Cancers (Basel) 2021;13:2641. [PMID: 34072157 DOI: 10.3390/cancers13112641] [Reference Citation Analysis]
355 Sosa MS, Bragado P, Debnath J, Aguirre-Ghiso JA. Regulation of tumor cell dormancy by tissue microenvironments and autophagy. Adv Exp Med Biol 2013;734:73-89. [PMID: 23143976 DOI: 10.1007/978-1-4614-1445-2_5] [Cited by in Crossref: 58] [Cited by in F6Publishing: 45] [Article Influence: 7.3] [Reference Citation Analysis]
356 Lianidou ES, Mavroudis D, Georgoulias V. Clinical challenges in the molecular characterization of circulating tumour cells in breast cancer. Br J Cancer 2013;108:2426-32. [PMID: 23756869 DOI: 10.1038/bjc.2013.265] [Cited by in Crossref: 47] [Cited by in F6Publishing: 35] [Article Influence: 5.9] [Reference Citation Analysis]
357 Braun AC, de Mello CAL, Corassa M, Abdallah EA, Urvanegia AC, Alves VS, Flores BCTCP, Díaz M, Nicolau UR, Silva VSE, Calsavara V, Paterlini-Brechót P, Chinen LTD. EGFR expression in circulating tumor cells from high-grade metastatic soft tissue sarcomas. Cancer Biol Ther 2018;19:454-60. [PMID: 29394136 DOI: 10.1080/15384047.2018.1433498] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
358 Bethge A, Schumacher U, Wedemann G. Simulation of metastatic progression using a computer model including chemotherapy and radiation therapy. Journal of Biomedical Informatics 2015;57:74-87. [DOI: 10.1016/j.jbi.2015.07.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
359 Fu F, Nowak MA, Bonhoeffer S. Spatial heterogeneity in drug concentrations can facilitate the emergence of resistance to cancer therapy. PLoS Comput Biol 2015;11:e1004142. [PMID: 25789469 DOI: 10.1371/journal.pcbi.1004142] [Cited by in Crossref: 72] [Cited by in F6Publishing: 52] [Article Influence: 12.0] [Reference Citation Analysis]
360 Kraus S, Vay C, Baldus S, Knoefel WT, Stoecklein NH, Vallbohmer D. Expression of wingless-type mouse mammary tumor virus integration site family pathway effectors in lymphatic and hepatic metastases of patients with colorectal cancer: Associations with the primary tumor. Oncol Lett. 2015;10:863-868. [PMID: 26622584 DOI: 10.3892/ol.2015.3291] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
361 Buta M, Džodić R, Đurišić I, Marković I, Vujasinović T, Markićević M, Nikolić-vukosavljević D. Potential clinical relevance of uPA and PAI-1 levels in node-negative, postmenopausal breast cancer patients bearing histological grade II tumors with ER/PR expression, during an early follow-up. Tumor Biol 2015;36:8193-200. [DOI: 10.1007/s13277-015-3573-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
362 Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646-674. [PMID: 21376230 DOI: 10.1016/j.cell.2011.02.013] [Cited by in Crossref: 33789] [Cited by in F6Publishing: 28995] [Article Influence: 3378.9] [Reference Citation Analysis]
363 Gösling T, Becker-schiebe M. Chirurgische Therapie der Skelettmetastasen. Unfallchirurg 2015;118:347-63. [DOI: 10.1007/s00113-015-2742-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
364 Yu Z, Song M, Chouchane L, Ma X. Functional Genomic Analysis of Breast Cancer Metastasis: Implications for Diagnosis and Therapy. Cancers (Basel) 2021;13:3276. [PMID: 34208889 DOI: 10.3390/cancers13133276] [Reference Citation Analysis]
365 Kulemann B, Rösch S, Seifert S, Timme S, Bronsert P, Seifert G, Martini V, Kuvendjiska J, Glatz T, Hussung S, Fritsch R, Becker H, Pitman MB, Hoeppner J. Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations. Sci Rep 2017;7:4510. [PMID: 28674438 DOI: 10.1038/s41598-017-04601-z] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 10.3] [Reference Citation Analysis]
366 Lekka M, Pabijan J. Measuring Elastic Properties of Single Cancer Cells by AFM. Methods Mol Biol 2019;1886:315-24. [PMID: 30374876 DOI: 10.1007/978-1-4939-8894-5_18] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
367 Uhara H, Ashida A, Koga H, Ogawa E, Uchiyama A, Uchiyama R, Hayashi K, Kiniwa Y, Okuyama R. NRAS mutations in primary and metastatic melanomas of Japanese patients. Int J Clin Oncol 2014;19:544-8. [DOI: 10.1007/s10147-013-0573-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
368 Pachmayr E, Treese C, Stein U. Underlying Mechanisms for Distant Metastasis - Molecular Biology. Visc Med 2017;33:11-20. [PMID: 28785563 DOI: 10.1159/000454696] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 10.5] [Reference Citation Analysis]
369 Ross JB, Huh D, Noble LB, Tavazoie SF. Identification of molecular determinants of primary and metastatic tumour re-initiation in breast cancer. Nat Cell Biol 2015;17:651-64. [PMID: 25866923 DOI: 10.1038/ncb3148] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 7.3] [Reference Citation Analysis]
370 Agnoletto C, Corrà F, Minotti L, Baldassari F, Crudele F, Cook WJJ, Di Leva G, d'Adamo AP, Gasparini P, Volinia S. Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset. Cancers (Basel) 2019;11:E483. [PMID: 30959764 DOI: 10.3390/cancers11040483] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 27.0] [Reference Citation Analysis]
371 Stasinopoulos I, Penet MF, Krishnamachary B, Bhujwalla ZM. Molecular and functional imaging of invasion and metastasis: windows into the metastatic cascade. Cancer Biomark 2010;7:173-88. [PMID: 21576811 DOI: 10.3233/CBM-2010-0188] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
372 Hurst DR, Welch DR. Metastasis suppressor genes at the interface between the environment and tumor cell growth. Int Rev Cell Mol Biol 2011;286:107-80. [PMID: 21199781 DOI: 10.1016/B978-0-12-385859-7.00003-3] [Cited by in Crossref: 85] [Cited by in F6Publishing: 55] [Article Influence: 8.5] [Reference Citation Analysis]
373 Seeberg LT, Brunborg C, Waage A, Hugenschmidt H, Renolen A, Stav I, Bjørnbeth BA, Borgen E, Naume B, Brudvik KW, Wiedswang G. Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases. Ann Surg Oncol 2017;24:2113-21. [PMID: 28258416 DOI: 10.1245/s10434-017-5818-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
374 McAllister SS, Weinberg RA. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat Cell Biol. 2014;16:717-727. [PMID: 25082194 DOI: 10.1038/ncb3015] [Cited by in Crossref: 469] [Cited by in F6Publishing: 434] [Article Influence: 67.0] [Reference Citation Analysis]
375 Naidoo K, Pinder SE. Micro- and macro-metastasis in the axillary lymph node: A review. The Surgeon 2017;15:76-82. [DOI: 10.1016/j.surge.2016.07.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
376 Nandy A, Gangopadhyay S, Mukhopadhyay A. Individualizing breast cancer treatment—The dawn of personalized medicine. Experimental Cell Research 2014;320:1-11. [DOI: 10.1016/j.yexcr.2013.09.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
377 Tang Y, Shi J, Li S, Wang L, Cayre YE, Chen Y. Microfluidic device with integrated microfilter of conical-shaped holes for high efficiency and high purity capture of circulating tumor cells. Sci Rep 2014;4:6052. [PMID: 25116599 DOI: 10.1038/srep06052] [Cited by in Crossref: 84] [Cited by in F6Publishing: 66] [Article Influence: 12.0] [Reference Citation Analysis]
378 Ouzounova M, Lee E, Piranlioglu R, El Andaloussi A, Kolhe R, Demirci MF, Marasco D, Asm I, Chadli A, Hassan KA, Thangaraju M, Zhou G, Arbab AS, Cowell JK, Korkaya H. Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade. Nat Commun 2017;8:14979. [PMID: 28382931 DOI: 10.1038/ncomms14979] [Cited by in Crossref: 162] [Cited by in F6Publishing: 128] [Article Influence: 40.5] [Reference Citation Analysis]
379 Vignot S, Besse B, André F, Spano JP, Soria JC. Discrepancies between primary tumor and metastasis: a literature review on clinically established biomarkers. Crit Rev Oncol Hematol 2012;84:301-13. [PMID: 22710198 DOI: 10.1016/j.critrevonc.2012.05.002] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 6.2] [Reference Citation Analysis]
380 Sleeman JP, Cady B, Pantel K. The connectivity of lymphogenous and hematogenous tumor cell dissemination: biological insights and clinical implications. Clin Exp Metastasis 2012;29:737-46. [PMID: 22669542 DOI: 10.1007/s10585-012-9489-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
381 Chrabaszcz K, Kaminska K, Augustyniak K, Kujdowicz M, Smeda M, Jasztal A, Stojak M, Marzec KM, Malek K. Tracking Extracellular Matrix Remodeling in Lungs Induced by Breast Cancer Metastasis. Fourier Transform Infrared Spectroscopic Studies. Molecules 2020;25:E236. [PMID: 31935974 DOI: 10.3390/molecules25010236] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
382 Santullo F, Biondi A, Cananzi FCM, Fico V, Tirelli F, Ricci R, Rizzo G, Coco C, Mattana C, D'Ugo D, Persiani R. Tumor size as a prognostic factor in patients with stage IIa colon cancer. Am J Surg 2018;215:71-7. [PMID: 28410630 DOI: 10.1016/j.amjsurg.2017.03.038] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
383 Deng J, Liu Y, Lee H, Herrmann A, Zhang W, Zhang C, Shen S, Priceman SJ, Kujawski M, Pal SK, Raubitschek A, Hoon DS, Forman S, Figlin RA, Liu J, Jove R, Yu H. S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites. Cancer Cell. 2012;21:642-654. [PMID: 22624714 DOI: 10.1016/j.ccr.2012.03.039] [Cited by in Crossref: 170] [Cited by in F6Publishing: 148] [Article Influence: 18.9] [Reference Citation Analysis]
384 Heinrich EL, Walser TC, Krysan K, Liclican EL, Grant JL, Rodriguez NL, Dubinett SM. The inflammatory tumor microenvironment, epithelial mesenchymal transition and lung carcinogenesis. Cancer Microenviron 2012;5:5-18. [PMID: 21922183 DOI: 10.1007/s12307-011-0089-0] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
385 Jiménez-Zenteno AK, Cerf A. Liquid Biopsy Based on Circulating Cancer-Associated Cells: Bridging the Gap from an Emerging Concept to a Mainstream Tool in Precision Medicine. Adv Biosyst 2020;4:e1900164. [PMID: 32293131 DOI: 10.1002/adbi.201900164] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
386 Grunewald TG, Herbst SM, Heinze J, Burdach S. Understanding tumor heterogeneity as functional compartments--superorganisms revisited. J Transl Med. 2011;9:79. [PMID: 21619636 DOI: 10.1186/1479-5876-9-79] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
387 Sutton PA, Jithesh PV, Jones RP, Evans JP, Vimalachandran D, Malik HZ, Park BK, Goldring CE, Palmer DH, Kitteringham NR. Exome sequencing of synchronously resected primary colorectal tumours and colorectal liver metastases to inform oncosurgical management. Eur J Surg Oncol 2018;44:115-21. [PMID: 29174709 DOI: 10.1016/j.ejso.2017.10.211] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
388 Vismara M, Reduzzi C, Daidone MG, Cappelletti V. Circulating Tumor Cells (CTCs) Heterogeneity in Metastatic Breast Cancer: Different Approaches for Different Needs. Adv Exp Med Biol 2020;1220:81-91. [PMID: 32304081 DOI: 10.1007/978-3-030-35805-1_6] [Reference Citation Analysis]
389 Duan M, Hao J, Cui S, Worthley DL, Zhang S, Wang Z, Shi J, Liu L, Wang X, Ke A, Cao Y, Xi R, Zhang X, Zhou J, Fan J, Li C, Gao Q. Diverse modes of clonal evolution in HBV-related hepatocellular carcinoma revealed by single-cell genome sequencing. Cell Res. 2018;28:359-373. [PMID: 29327728 DOI: 10.1038/cr.2018.11] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 15.7] [Reference Citation Analysis]
390 Rassy E, Pavlidis N. The diagnostic challenges of patients with carcinoma of unknown primary. Expert Rev Anticancer Ther 2020;20:775-83. [PMID: 32779501 DOI: 10.1080/14737140.2020.1807948] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
391 van Zijl F, Krupitza G, Mikulits W. Initial steps of metastasis: cell invasion and endothelial transmigration. Mutat Res 2011;728:23-34. [PMID: 21605699 DOI: 10.1016/j.mrrev.2011.05.002] [Cited by in Crossref: 396] [Cited by in F6Publishing: 350] [Article Influence: 39.6] [Reference Citation Analysis]
392 Avanzini S, Antal T. Cancer recurrence times from a branching process model. PLoS Comput Biol 2019;15:e1007423. [PMID: 31751332 DOI: 10.1371/journal.pcbi.1007423] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
393 Wang HC, Chiang WF, Huang HH, Shen YY, Chiang HC. Src-homology 2 domain-containing tyrosine phosphatase 2 promotes oral cancer invasion and metastasis. BMC Cancer 2014;14:442. [PMID: 24931737 DOI: 10.1186/1471-2407-14-442] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
394 Lee HW, Jose CC, Cuddapah S. Epithelial-mesenchymal transition: Insights into nickel-induced lung diseases. Semin Cancer Biol 2021:S1044-579X(21)00150-4. [PMID: 34058338 DOI: 10.1016/j.semcancer.2021.05.020] [Reference Citation Analysis]
395 Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK, Vonderheide RH, Leach SD, Stanger BZ. EMT and dissemination precede pancreatic tumor formation. Cell. 2012;148:349-361. [PMID: 22265420 DOI: 10.1016/j.cell.2011.11.025] [Cited by in Crossref: 1226] [Cited by in F6Publishing: 1115] [Article Influence: 136.2] [Reference Citation Analysis]
396 Lee JY, Yoon JK, Kim B, Kim S, Kim MA, Lim H, Bang D, Song YS. Tumor evolution and intratumor heterogeneity of an epithelial ovarian cancer investigated using next-generation sequencing. BMC Cancer 2015;15:85. [PMID: 25881093 DOI: 10.1186/s12885-015-1077-4] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 8.8] [Reference Citation Analysis]
397 Strati A, Markou A, Parisi C, Politaki E, Mavroudis D, Georgoulias V, Lianidou E. Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR. BMC Cancer. 2011;11:422. [PMID: 21967632 DOI: 10.1186/1471-2407-11-422] [Cited by in Crossref: 78] [Cited by in F6Publishing: 70] [Article Influence: 7.8] [Reference Citation Analysis]
398 Huang S. Reconciling Non-Genetic Plasticity with Somatic Evolution in Cancer. Trends Cancer 2021;7:309-22. [PMID: 33536158 DOI: 10.1016/j.trecan.2020.12.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 11.0] [Reference Citation Analysis]
399 Patriarca C, Pini GM, Conti G. Invasion and metastasis: a historical perspective. Pathologica 2020;112:229-33. [PMID: 33393528 DOI: 10.32074/1591-951X-111] [Reference Citation Analysis]
400 Abdul-Wahid A, Cydzik M, Fischer NW, Prodeus A, Shively JE, Martel A, Alminawi S, Ghorab Z, Berinstein NL, Gariépy J. Serum-derived carcinoembryonic antigen (CEA) activates fibroblasts to induce a local re-modeling of the extracellular matrix that favors the engraftment of CEA-expressing tumor cells. Int J Cancer 2018;143:1963-77. [PMID: 29756328 DOI: 10.1002/ijc.31586] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
401 Xu HT, Miao J, Liu JW, Zhang LG, Zhang QG. Prognostic value of circulating tumor cells in esophageal cancer. World J Gastroenterol 2017;23:1310-8. [PMID: 28275311 DOI: 10.3748/wjg.v23.i7.1310] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
402 López-muñoz E, Méndez-montes M. Markers of Circulating Breast Cancer Cells. Elsevier; 2013. pp. 175-224. [DOI: 10.1016/b978-0-12-407680-8.00007-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
403 Doiron B, DeFronzo RA. A novel experimental model for human mixed acinar-ductal pancreatic cancer. Carcinogenesis 2018;39:180-90. [PMID: 29106450 DOI: 10.1093/carcin/bgx119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
404 Spadafora C. A LINE-1-encoded reverse transcriptase-dependent regulatory mechanism is active in embryogenesis and tumorigenesis. Ann N Y Acad Sci. 2015;1341:164-171. [PMID: 25586649 DOI: 10.1111/nyas.12637] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
405 Yang F, Sun L, Li Q, Han X, Lei L, Zhang H, Shang Y. SET8 promotes epithelial-mesenchymal transition and confers TWIST dual transcriptional activities. EMBO J. 2012;31:110-123. [PMID: 21983900 DOI: 10.1038/emboj.2011.364] [Cited by in Crossref: 152] [Cited by in F6Publishing: 141] [Article Influence: 15.2] [Reference Citation Analysis]
406 McCreery MQ, Halliwill KD, Chin D, Delrosario R, Hirst G, Vuong P, Jen KY, Hewinson J, Adams DJ, Balmain A. Evolution of metastasis revealed by mutational landscapes of chemically induced skin cancers. Nat Med 2015;21:1514-20. [PMID: 26523969 DOI: 10.1038/nm.3979] [Cited by in Crossref: 71] [Cited by in F6Publishing: 61] [Article Influence: 11.8] [Reference Citation Analysis]
407 Krishnan V, Stadick N, Clark R, Bainer R, Veneris JT, Khan S, Drew A, Rinker-Schaeffer C. Using MKK4's metastasis suppressor function to identify and dissect cancer cell-microenvironment interactions during metastatic colonization. Cancer Metastasis Rev 2012;31:605-13. [PMID: 22706843 DOI: 10.1007/s10555-012-9371-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
408 Merino D, Weber TS, Serrano A, Vaillant F, Liu K, Pal B, Di Stefano L, Schreuder J, Lin D, Chen Y, Asselin-Labat ML, Schumacher TN, Cameron D, Smyth GK, Papenfuss AT, Lindeman GJ, Visvader JE, Naik SH. Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer. Nat Commun 2019;10:766. [PMID: 30770823 DOI: 10.1038/s41467-019-08595-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 32] [Article Influence: 22.5] [Reference Citation Analysis]
409 Werner-Klein M, Grujovic A, Irlbeck C, Obradović M, Hoffmann M, Koerkel-Qu H, Lu X, Treitschke S, Köstler C, Botteron C, Weidele K, Werno C, Polzer B, Kirsch S, Gužvić M, Warfsmann J, Honarnejad K, Czyz Z, Feliciello G, Blochberger I, Grunewald S, Schneider E, Haunschild G, Patwary N, Guetter S, Huber S, Rack B, Harbeck N, Buchholz S, Rümmele P, Heine N, Rose-John S, Klein CA. Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latency. Nat Commun 2020;11:4977. [PMID: 33020483 DOI: 10.1038/s41467-020-18701-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
410 Lu X, Kang Y. Cell fusion hypothesis of the cancer stem cell. Adv Exp Med Biol. 2011;714:129-140. [PMID: 21506011 DOI: 10.1007/978-94-007-0782-5_6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
411 Karacz CM, Yan J, Zhu H, Gerber DE. Timing, Sites, and Correlates of Lung Cancer Recurrence. Clin Lung Cancer 2020;21:127-135.e3. [PMID: 31932216 DOI: 10.1016/j.cllc.2019.12.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
412 Qi M, Xie L, Duan G. Adriamycin-resistant cells are significantly less fit than adriamycin-sensitive cells in cervical cancer. Open Life Sci 2021;16:53-60. [PMID: 33817298 DOI: 10.1515/biol-2021-0004] [Reference Citation Analysis]
413 Economopoulou P, Georgoulias V, Kotsakis A. Classifying circulating tumor cells to monitor cancer progression. Expert Review of Molecular Diagnostics 2016;17:153-65. [DOI: 10.1080/14737159.2017.1275572] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
414 Tan DSW, Thomas GV, Garrett MD, Banerji U, de Bono JS, Kaye SB, Workman P. Biomarker-Driven Early Clinical Trials in Oncology: A Paradigm Shift in Drug Development. The Cancer Journal 2009;15:406-20. [DOI: 10.1097/ppo.0b013e3181bd0445] [Cited by in Crossref: 130] [Cited by in F6Publishing: 40] [Article Influence: 10.8] [Reference Citation Analysis]
415 Wen J, Luo KJ, Hu Y, Yang H, Fu JH. Metastatic lymph node CHIP expression is a potential prognostic marker for resected esophageal squamous cell carcinoma patients. Ann Surg Oncol. 2013;20:1668-1675. [PMID: 23429937 DOI: 10.1245/s10434-012-2733-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
416 Calvo J, Sánchez-Cid L, Muñoz M, Lozano JJ, Thomson TM, Fernández PL. Infrequent loss of luminal differentiation in ductal breast cancer metastasis. PLoS One 2013;8:e78097. [PMID: 24205108 DOI: 10.1371/journal.pone.0078097] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
417 Jafri MA, Al-Qahtani MH, Shay JW. Role of miRNAs in human cancer metastasis: Implications for therapeutic intervention. Semin Cancer Biol 2017;44:117-31. [PMID: 28188828 DOI: 10.1016/j.semcancer.2017.02.004] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 12.8] [Reference Citation Analysis]
418 Koscielny S, Tubiana M. Parallel progression of tumour and metastases. Nat Rev Cancer 2010;10:156-156. [DOI: 10.1038/nrc2627-c1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
419 Vegas H, André T, Bidard FC, Ferrand FR, Huguet F, Mariani P, Pierga JY. [Disseminated and circulating tumor cells in gastrointestinal oncology]. Bull Cancer. 2012;99:535-544. [PMID: 22531892 DOI: 10.1684/bdc.2012.1581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
420 Kataoka K, Beppu N, Shiozawa M, Ikeda M, Tomita N, Kobayashi H, Sugihara K, Ceelen W. Colorectal cancer treated by resection and extended lymphadenectomy: patterns of spread in left- and right-sided tumours. Br J Surg 2020;107:1070-8. [PMID: 32246469 DOI: 10.1002/bjs.11517] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
421 Newton PK, Mason J, Bethel K, Bazhenova L, Nieva J, Norton L, Kuhn P. Spreaders and sponges define metastasis in lung cancer: a Markov chain Monte Carlo mathematical model. Cancer Res 2013;73:2760-9. [PMID: 23447576 DOI: 10.1158/0008-5472.CAN-12-4488] [Cited by in Crossref: 59] [Cited by in F6Publishing: 23] [Article Influence: 7.4] [Reference Citation Analysis]
422 Cunha PO, Ornstein M, Jones JL. Progression of Ductal Carcinoma in Situ from the Pathological Perspective. Breast Care (Basel) 2010;5:233-9. [PMID: 22590443 DOI: 10.1159/000319625] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
423 Alix-panabières C, Pantel K. Circulating Tumor Cells: Liquid Biopsy of Cancer. Clinical Chemistry 2013;59:110-8. [DOI: 10.1373/clinchem.2012.194258] [Cited by in Crossref: 660] [Cited by in F6Publishing: 571] [Article Influence: 82.5] [Reference Citation Analysis]
424 Alshareeda AT, Al-Sowayan BS, Alkharji RR, Aldosari SM, Al Subayyil AM, Alghuwainem A. Cancer of Unknown Primary Site: Real Entity or Misdiagnosed Disease? J Cancer 2020;11:3919-31. [PMID: 32328196 DOI: 10.7150/jca.42880] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
425 Kilic N, Feldhaus S, Kilic E, Tennstedt P, Wicklein D, Wasielewski RV, Viebahn C, Kreipe H, Schumacher U. Brachyury expression predicts poor prognosis at early stages of colorectal cancer. European Journal of Cancer 2011;47:1080-5. [DOI: 10.1016/j.ejca.2010.11.015] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 5.8] [Reference Citation Analysis]
426 Chen W, Weng S, Zhang F, Allen S, Li X, Bao L, Lam RH, Macoska JA, Merajver SD, Fu J. Nanoroughened surfaces for efficient capture of circulating tumor cells without using capture antibodies. ACS Nano 2013;7:566-75. [PMID: 23194329 DOI: 10.1021/nn304719q] [Cited by in Crossref: 176] [Cited by in F6Publishing: 144] [Article Influence: 19.6] [Reference Citation Analysis]
427 Delpech Y, Bashour SI, Lousquy R, Rouzier R, Hess K, Coutant C, Barranger E, Esteva FJ, Ueno NT, Pusztai L, Ibrahim NK. Clinical nomogram to predict bone-only metastasis in patients with early breast carcinoma. Br J Cancer 2015;113:1003-9. [PMID: 26393887 DOI: 10.1038/bjc.2015.308] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
428 Neerincx M, Sie DL, van de Wiel MA, van Grieken NC, Burggraaf JD, Dekker H, Eijk PP, Ylstra B, Verhoef C, Meijer GA, Buffart TE, Verheul HM. MiR expression profiles of paired primary colorectal cancer and metastases by next-generation sequencing. Oncogenesis 2015;4:e170. [PMID: 26436952 DOI: 10.1038/oncsis.2015.29] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
429 Kim NK, Kim YW, Han YD, Cho MS, Hur H, Min BS, Lee KY. Complete mesocolic excision and central vascular ligation for colon cancer: Principle, anatomy, surgical technique, and outcomes. Surg Oncol. 2016;25:252-262. [PMID: 27566031 DOI: 10.1016/j.suronc.2016.05.009] [Cited by in Crossref: 52] [Cited by in F6Publishing: 35] [Article Influence: 10.4] [Reference Citation Analysis]
430 Oliveira ÉA, Lima DS, Cardozo LE, Souza GF, de Souza N, Alves-Fernandes DK, Faião-Flores F, Quincoces JAP, Barros SBM, Nakaya HI, Monteiro G, Maria-Engler SS. Toxicogenomic and bioinformatics platforms to identify key molecular mechanisms of a curcumin-analogue DM-1 toxicity in melanoma cells. Pharmacol Res 2017;125:178-87. [PMID: 28882690 DOI: 10.1016/j.phrs.2017.08.018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
431 Géraud C, Koch PS, Damm F, Schledzewski K, Goerdt S. The metastatic cycle: metastatic niches and cancer cell dissemination. J Dtsch Dermatol Ges 2014;12:1012-9. [PMID: 25307562 DOI: 10.1111/ddg.12451] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
432 Evrard S. Limits of colorectal liver metastases resectability: how and why to overcome them? For progress in cancer research. Recent Results Cancer Res 2014;203:213-29. [PMID: 25103008 DOI: 10.1007/978-3-319-08060-4_15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
433 Peinado H, Zhang H, Matei IR, Costa-Silva B, Hoshino A, Rodrigues G, Psaila B, Kaplan RN, Bromberg JF, Kang Y, Bissell MJ, Cox TR, Giaccia AJ, Erler JT, Hiratsuka S, Ghajar CM, Lyden D. Pre-metastatic niches: organ-specific homes for metastases. Nat Rev Cancer. 2017;17:302-317. [PMID: 28303905 DOI: 10.1038/nrc.2017.6] [Cited by in Crossref: 647] [Cited by in F6Publishing: 557] [Article Influence: 161.8] [Reference Citation Analysis]
434 Werner-Klein M, Scheitler S, Hoffmann M, Hodak I, Dietz K, Lehnert P, Naimer V, Polzer B, Treitschke S, Werno C, Markiewicz A, Weidele K, Czyz Z, Hohenleutner U, Hafner C, Haferkamp S, Berneburg M, Rümmele P, Ulmer A, Klein CA. Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanoma. Nat Commun 2018;9:595. [PMID: 29426936 DOI: 10.1038/s41467-017-02674-y] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 13.7] [Reference Citation Analysis]
435 Mack GS, Marshall A. Lost in migration. Nat Biotechnol 2010;28:214-29. [PMID: 20212481 DOI: 10.1038/nbt0310-214] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
436 Turtoi A, Blomme A, Castronovo V. Intratumoral heterogeneity and consequences for targeted therapies. Bull Cancer 2015;102:17-23. [PMID: 25609489 DOI: 10.1016/j.bulcan.2014.12.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
437 Morisaki T, Umebayashi M, Kiyota A, Koya N, Tanaka H, Onishi H, Katano M. Combining cetuximab with killer lymphocytes synergistically inhibits human cholangiocarcinoma cells in vitro. Anticancer Res. 2012;32:2249-2256. [PMID: 22641659 DOI: 10.1016/j.semcancer.2012.03.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
438 Reher D, Klink B, Deutsch A, Voss-Böhme A. Cell adhesion heterogeneity reinforces tumour cell dissemination: novel insights from a mathematical model. Biol Direct 2017;12:18. [PMID: 28800767 DOI: 10.1186/s13062-017-0188-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
439 Lianidou ES, Markou A. Circulating tumor cells as emerging tumor biomarkers in breast cancer. Clinical Chemistry and Laboratory Medicine 2011;49. [DOI: 10.1515/cclm.2011.628] [Cited by in Crossref: 40] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
440 Liu JC, Egan SE, Zacksenhaus E. A Tumor initiating cell-enriched prognostic signature for HER2+:ERα- breast cancer; rationale, new features, controversies and future directions. Oncotarget 2013;4:1317-28. [PMID: 23945331 DOI: 10.18632/oncotarget.1170] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
441 Kloosterman WP, Hoogstraat M, Paling O, Tavakoli-Yaraki M, Renkens I, Vermaat JS, van Roosmalen MJ, van Lieshout S, Nijman IJ, Roessingh W, van 't Slot R, van de Belt J, Guryev V, Koudijs M, Voest E, Cuppen E. Chromothripsis is a common mechanism driving genomic rearrangements in primary and metastatic colorectal cancer. Genome Biol. 2011;12:R103. [PMID: 22014273 DOI: 10.1186/gb-2011-12-10-r103] [Cited by in Crossref: 127] [Cited by in F6Publishing: 111] [Article Influence: 12.7] [Reference Citation Analysis]
442 Schweiger MR, Kerick M, Timmermann B, Isau M. The power of NGS technologies to delineate the genome organization in cancer: from mutations to structural variations and epigenetic alterations. Cancer Metastasis Rev 2011;30:199-210. [PMID: 21267768 DOI: 10.1007/s10555-011-9278-z] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 5.1] [Reference Citation Analysis]
443 Wang L, Zhang S, Wang X. The Metabolic Mechanisms of Breast Cancer Metastasis. Front Oncol 2020;10:602416. [PMID: 33489906 DOI: 10.3389/fonc.2020.602416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
444 Lim SY, Macheleidt I, Dalvi P, Schäfer SC, Kerick M, Ozretić L, Ortiz-Cuaran S, George J, Merkelbach-Bruse S, Wolf J, Timmermann B, Thomas RK, Schweiger MR, Buettner R, Odenthal M. LSD1 modulates the non-canonical integrin β3 signaling pathway in non-small cell lung carcinoma cells. Sci Rep 2017;7:10292. [PMID: 28860622 DOI: 10.1038/s41598-017-09554-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
445 Byrne NM, Summers MA, McDonald MM. Tumor Cell Dormancy and Reactivation in Bone: Skeletal Biology and Therapeutic Opportunities. JBMR Plus 2019;3:e10125. [PMID: 30918917 DOI: 10.1002/jbm4.10125] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
446 Gao D, Li S. Biological resonance for cancer metastasis, a new hypothesis based on comparisons between primary cancers and metastases. Cancer Microenviron 2013;6:213-30. [PMID: 24214411 DOI: 10.1007/s12307-013-0138-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
447 Tan IB, Malik S, Ramnarayanan K, McPherson JR, Ho DL, Suzuki Y, Ng SB, Yan S, Lim KH, Koh D, Hoe CM, Chan CY, Ten R, Goh BK, Chung AY, Tan J, Chan CX, Tay ST, Alexander L, Nagarajan N, Hillmer AM, Tang CL, Chua C, Teh BT, Rozen S, Tan P. High-depth sequencing of over 750 genes supports linear progression of primary tumors and metastases in most patients with liver-limited metastatic colorectal cancer. Genome Biol 2015;16:32. [PMID: 25808843 DOI: 10.1186/s13059-015-0589-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
448 Fehm T, Banys M. Circulating free DNA: a new surrogate marker for minimal residual disease? Breast Cancer Res Treat 2011;130:119-22. [PMID: 21327462 DOI: 10.1007/s10549-011-1392-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
449 Bracher A, Cardona AS, Tauber S, Fink AM, Steiner A, Pehamberger H, Niederleithner H, Petzelbauer P, Gröger M, Loewe R. Epidermal growth factor facilitates melanoma lymph node metastasis by influencing tumor lymphangiogenesis. J Invest Dermatol 2013;133:230-8. [PMID: 22951723 DOI: 10.1038/jid.2012.272] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
450 Zacksenhaus E, Egan SE. Progression to Metastasis of Solid Cancer. Cancers (Basel) 2021;13:717. [PMID: 33578666 DOI: 10.3390/cancers13040717] [Reference Citation Analysis]
451 Pradella D, Naro C, Sette C, Ghigna C. EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression. Mol Cancer. 2017;16:8. [PMID: 28137272 DOI: 10.1186/s12943-016-0579-2] [Cited by in Crossref: 120] [Cited by in F6Publishing: 119] [Article Influence: 30.0] [Reference Citation Analysis]
452 Grellety T, Lucchesi C, Hostein I, Auzanneau C, Khalifa E, Soubeyran I, Italiano A. High-depth sequencing of paired primary and metastatic tumours: Implications for personalised medicine. Eur J Cancer 2017;84:250-6. [PMID: 28841542 DOI: 10.1016/j.ejca.2017.07.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
453 Falck AK, Bendahl PO, Chebil G, Olsson H, Fernö M, Rydén L. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up. Breast Cancer Res Treat 2013;140:93-104. [PMID: 23807420 DOI: 10.1007/s10549-013-2617-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
454 Scatena R, Bottoni P, Giardina B. Circulating tumour cells and cancer stem cells: a role for proteomics in defining the interrelationships between function, phenotype and differentiation with potential clinical applications. Biochim Biophys Acta 2013;1835:129-43. [PMID: 23228700 DOI: 10.1016/j.bbcan.2012.12.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
455 Oh J, Seo J, Hong CM, Jeong SY, Lee S, Lee J, Min J, Song H, Bom H, Kim Y, Ahn B. Extra-thoracic tumor burden but not thoracic tumor burden on 18F-FDG PET/CT is an independent prognostic biomarker for extensive-disease small cell lung cancer. Lung Cancer 2013;81:218-25. [DOI: 10.1016/j.lungcan.2013.05.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
456 Ignatiadis M, Reinholz M. Minimal residual disease and circulating tumor cells in breast cancer. Breast Cancer Res 2011;13:222. [PMID: 22078011 DOI: 10.1186/bcr2906] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
457 Fukui K, Werner C, Pestel G. [Influence of anesthesia procedure on malignant tumor outcome]. Anaesthesist 2012;61:193-201. [PMID: 22430549 DOI: 10.1007/s00101-012-1997-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
458 Malihi PD, Morikado M, Welter L, Liu ST, Miller ET, Cadaneanu RM, Knudsen BS, Lewis MS, Carlsson A, Velasco CR, Kolatkar A, Rodriguez-Lee M, Garraway IP, Hicks J, Kuhn P. Clonal diversity revealed by morphoproteomic and copy number profiles of single prostate cancer cells at diagnosis. Converg Sci Phys Oncol 2018;4:015003. [PMID: 32670616 DOI: 10.1088/2057-1739/aaa00b] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
459 Alvarenga EC, Fonseca MC, Carvalho CC, Florentino RM, França A, Matias E, Guimarães PB, Batista C, Freire V, Carmona AK, Pesquero JB, de Paula AM, Foureaux G, Leite MF. Angiotensin Converting Enzyme Regulates Cell Proliferation and Migration. PLoS One 2016;11:e0165371. [PMID: 27992423 DOI: 10.1371/journal.pone.0165371] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
460 Brudvik KW, Bains SJ, Seeberg LT, Labori KJ, Waage A, Taskén K, Aandahl EM, Bjørnbeth BA. Aggressive treatment of patients with metastatic colorectal cancer increases survival: a scandinavian single-center experience. HPB Surg 2013;2013:727095. [PMID: 23840074 DOI: 10.1155/2013/727095] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
461 Marusyk A, Almendro V, Polyak K. Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer. 2012;12:323-334. [PMID: 22513401 DOI: 10.1038/nrc3261] [Cited by in Crossref: 1190] [Cited by in F6Publishing: 1002] [Article Influence: 132.2] [Reference Citation Analysis]
462 Yonekura R, Osako T, Iwase T, Ogiya A, Ueno T, Kitagawa M, Ohno S, Akiyama F. Prognostic impact and possible pathogenesis of lymph node metastasis in ductal carcinoma in situ of the breast. Breast Cancer Res Treat 2019;174:103-11. [PMID: 30474777 DOI: 10.1007/s10549-018-5068-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
463 Greaves M. Leukaemia 'firsts' in cancer research and treatment. Nat Rev Cancer 2016;16:163-72. [DOI: 10.1038/nrc.2016.3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
464 Horimoto Y, Polanska UM, Takahashi Y, Orimo A. Emerging roles of the tumor-associated stroma in promoting tumor metastasis. Cell Adh Migr 2012;6:193-202. [PMID: 22568980 DOI: 10.4161/cam.20631] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
465 Brabletz T. To differentiate or not--routes towards metastasis. Nat Rev Cancer. 2012;12:425-436. [PMID: 22576165 DOI: 10.1038/nrc3265] [Cited by in Crossref: 402] [Cited by in F6Publishing: 370] [Article Influence: 44.7] [Reference Citation Analysis]
466 Prado-lópez S, González-ballesteros N, Carmen Rodríguez-argüelles M. Nanometals in Cancer Diagnosis and Therapy. In: Zivic F, Affatato S, Trajanovic M, Schnabelrauch M, Grujovic N, Choy KL, editors. Biomaterials in Clinical Practice. Cham: Springer International Publishing; 2018. pp. 407-28. [DOI: 10.1007/978-3-319-68025-5_14] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
467 Bednarz-Knoll N, Alix-Panabières C, Pantel K. Clinical relevance and biology of circulating tumor cells. Breast Cancer Res. 2011;13:228. [PMID: 22114869 DOI: 10.1186/bcr2940] [Cited by in Crossref: 110] [Cited by in F6Publishing: 95] [Article Influence: 11.0] [Reference Citation Analysis]
468 Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK, Vonderheide RH. EMT and dissemination precede pancreatic tumor formation. Cell. 2012;148:349-361. [PMID: 22265420 DOI: 10.1016/j.cell.2011.11.025.emt] [Reference Citation Analysis]
469 Olivier T, Fernandez E, Labidi-Galy I, Dietrich PY, Rodriguez-Bravo V, Baciarello G, Fizazi K, Patrikidou A. Redefining cancer of unknown primary: Is precision medicine really shifting the paradigm? Cancer Treat Rev 2021;97:102204. [PMID: 33866225 DOI: 10.1016/j.ctrv.2021.102204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
470 Robinson NJ, Taylor DJ, Schiemann WP. Stem cells, immortality, and the evolution of metastatic properties in breast cancer: telomere maintenance mechanisms and metastatic evolution. J Cancer Metastasis Treat 2019;5:39. [PMID: 31440584 DOI: 10.20517/2394-4722.2019.15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
471 Knutsen T, Padilla-Nash HM, Wangsa D, Barenboim-Stapleton L, Camps J, McNeil N, Difilippantonio MJ, Ried T. Definitive molecular cytogenetic characterization of 15 colorectal cancer cell lines. Genes Chromosomes Cancer 2010;49:204-23. [PMID: 19927377 DOI: 10.1002/gcc.20730] [Cited by in Crossref: 14] [Cited by in F6Publishing: 28] [Article Influence: 1.3] [Reference Citation Analysis]
472 Spano D, Heck C, De Antonellis P, Christofori G, Zollo M. Molecular networks that regulate cancer metastasis. Semin Cancer Biol 2012;22:234-49. [PMID: 22484561 DOI: 10.1016/j.semcancer.2012.03.006] [Cited by in Crossref: 225] [Cited by in F6Publishing: 208] [Article Influence: 25.0] [Reference Citation Analysis]
473 Mekenkamp LJ, Haan JC, Israeli D, van Essen HF, Dijkstra JR, van Cleef P, Punt CJ, Meijer GA, Nagtegaal ID, Ylstra B. Chromosomal copy number aberrations in colorectal metastases resemble their primary counterparts and differences are typically non-recurrent. PLoS One 2014;9:e86833. [PMID: 24505270 DOI: 10.1371/journal.pone.0086833] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
474 Barriere G, Rigaud M. After clouds sun again shines on circulating tumor cells research. Ann Transl Med 2013;1:19. [PMID: 25332963 DOI: 10.3978/j.issn.2305-5839.2013.06.03] [Reference Citation Analysis]
475 Xia M, Li H, Ma Q, Yu D, Li J, Zhang Y, Sheng Y, Guo Y. Identifying the clonal relationship model of multifocal papillary thyroid carcinoma by whole genome sequencing. Cancer Lett 2017;396:110-6. [PMID: 28315434 DOI: 10.1016/j.canlet.2017.03.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
476 Ghasemi R, Grassadonia A, Tinari N, Piccolo E, Natoli C, Tomao F, Iacobelli S. Tumor-derived microvesicles: the metastasomes. Med Hypotheses. 2013;80:75-82. [PMID: 23177570 DOI: 10.1016/j.mehy.2012.10.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
477 Charpentier M, Martin S. Interplay of Stem Cell Characteristics, EMT, and Microtentacles in Circulating Breast Tumor Cells. Cancers (Basel). 2013;5:1545-1565. [PMID: 24240660 DOI: 10.3390/cancers5041545] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
478 Olivier T, Pop D, Chouiter Djebaili A, Falk AT, Iannessi A, Saada E, Nettekoven W, Blay J, Baque P, Cupissol D, Thyss A, Thariat J. Treating metastatic sarcomas locally: A paradoxe, a rationale, an evidence? Critical Reviews in Oncology/Hematology 2015;95:62-77. [DOI: 10.1016/j.critrevonc.2015.01.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
479 Ye X, Weinberg RA. Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression. Trends Cell Biol. 2015;25:675-686. [PMID: 26437589 DOI: 10.1016/j.tcb.2015.07.012] [Cited by in Crossref: 559] [Cited by in F6Publishing: 524] [Article Influence: 93.2] [Reference Citation Analysis]
480 Walens A, DiMarco AV, Lupo R, Kroger BR, Damrauer JS, Alvarez JV. CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors. Elife 2019;8:e43653. [PMID: 30990165 DOI: 10.7554/eLife.43653] [Cited by in Crossref: 49] [Cited by in F6Publishing: 32] [Article Influence: 24.5] [Reference Citation Analysis]
481 Allen JG, Galloway DB, Ehsanullah RS, Ruane RJ, Bird HA. The effect of bromazepam (Lexotan) administration on antipyrine pharmacokinetics in humans. Xenobiotica. 1984;14:321-326. [PMID: 6147049 DOI: 10.1016/j.gendis.2018.05.001] [Cited by in Crossref: 166] [Cited by in F6Publishing: 125] [Article Influence: 4.5] [Reference Citation Analysis]
482 Romero-Moreno R, Curtis KJ, Coughlin TR, Miranda-Vergara MC, Dutta S, Natarajan A, Facchine BA, Jackson KM, Nystrom L, Li J, Kaliney W, Niebur GL, Littlepage LE. The CXCL5/CXCR2 axis is sufficient to promote breast cancer colonization during bone metastasis. Nat Commun 2019;10:4404. [PMID: 31562303 DOI: 10.1038/s41467-019-12108-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 19.0] [Reference Citation Analysis]
483 Singh M, Venugopal C, Tokar T, Brown KR, McFarlane N, Bakhshinyan D, Vijayakumar T, Manoranjan B, Mahendram S, Vora P, Qazi M, Dhillon M, Tong A, Durrer K, Murty N, Hallet R, Hassell JA, Kaplan DR, Cutz JC, Jurisica I, Moffat J, Singh SK. RNAi screen identifies essential regulators of human brain metastasis-initiating cells. Acta Neuropathol 2017;134:923-40. [PMID: 28766011 DOI: 10.1007/s00401-017-1757-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
484 Ang JE, Kaye S, Banerji U. Tissue-based approaches to study pharmacodynamic endpoints in early phase oncology clinical trials. Curr Drug Targets 2012;13:1525-34. [PMID: 22974395 DOI: 10.2174/138945012803530062] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
485 Bushnell GG, Orbach SM, Ma JA, Crawford HC, Wicha MS, Jeruss JS, Shea LD. Disease-induced immunomodulation at biomaterial scaffolds detects early pancreatic cancer in a spontaneous model. Biomaterials 2021;269:120632. [PMID: 33418200 DOI: 10.1016/j.biomaterials.2020.120632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
486 Li X, Seebacher NA, Hornicek FJ, Xiao T, Duan Z. Application of liquid biopsy in bone and soft tissue sarcomas: Present and future. Cancer Lett. 2018;439:66-77. [PMID: 30223067 DOI: 10.1016/j.canlet.2018.09.012] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
487 Tulchinsky E, Pringle JH, Caramel J, Ansieau S. Plasticity of melanoma and EMT-TF reprogramming. Oncotarget 2014;5:1-2. [PMID: 24369126 DOI: 10.18632/oncotarget.1662] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
488 Wang N, Wang Q, Tang H, Zhang F, Zheng Y, Wang S, Zhang J, Wang Z, Xie X. Direct inhibition of ACTN4 by ellagic acid limits breast cancer metastasis via regulation of β-catenin stabilization in cancer stem cells. J Exp Clin Cancer Res 2017;36:172. [PMID: 29197410 DOI: 10.1186/s13046-017-0635-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
489 Nath A, Chan C. Genetic alterations in fatty acid transport and metabolism genes are associated with metastatic progression and poor prognosis of human cancers. Sci Rep 2016;6:18669. [PMID: 26725848 DOI: 10.1038/srep18669] [Cited by in Crossref: 87] [Cited by in F6Publishing: 82] [Article Influence: 17.4] [Reference Citation Analysis]
490 Umer M, Vaidyanathan R, Nguyen N, Shiddiky MJ. Circulating tumor microemboli: Progress in molecular understanding and enrichment technologies. Biotechnology Advances 2018;36:1367-89. [DOI: 10.1016/j.biotechadv.2018.05.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 10.3] [Reference Citation Analysis]
491 Sciamanna I, De Luca C, Spadafora C. The Reverse Transcriptase Encoded by LINE-1 Retrotransposons in the Genesis, Progression, and Therapy of Cancer. Front Chem 2016;4:6. [PMID: 26904537 DOI: 10.3389/fchem.2016.00006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
492 Dupuy AJ. Transposon-based screens for cancer gene discovery in mouse models. Semin Cancer Biol 2010;20:261-8. [PMID: 20478384 DOI: 10.1016/j.semcancer.2010.05.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
493 Aldecoa I, Atares B, Tarragona J, Bernet L, Sardon JD, Pereda T, Villar C, Mendez MC, Gonzalez-Obeso E, Elorriaga K, Alonso GL, Zamora J, Planell N, Palacios J, Castells A, Matias-Guiu X, Cuatrecasas M. Molecularly determined total tumour load in lymph nodes of stage I-II colon cancer patients correlates with high-risk factors. A multicentre prospective study. Virchows Arch 2016;469:385-94. [PMID: 27447172 DOI: 10.1007/s00428-016-1990-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
494 Smith SC, Baras AS, Lee JK, Theodorescu D. The COXEN principle: translating signatures of in vitro chemosensitivity into tools for clinical outcome prediction and drug discovery in cancer. Cancer Res 2010;70:1753-8. [PMID: 20160033 DOI: 10.1158/0008-5472.CAN-09-3562] [Cited by in Crossref: 79] [Cited by in F6Publishing: 35] [Article Influence: 7.2] [Reference Citation Analysis]
495 Hartkopf AD, Banys M, Krawczyk N, Staebler A, Becker S, Hoffmann J, Hahn M, Wallwiener M, Fehm T. Bone marrow versus sentinel lymph node involvement in breast cancer: a comparison of early hematogenous and early lymphatic tumor spread. Breast Cancer Res Treat 2012;131:501-8. [DOI: 10.1007/s10549-011-1802-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
496 Wu T, Cheng B, Fu L. Clinical Applications of Circulating Tumor Cells in Pharmacotherapy: Challenges and Perspectives. Mol Pharmacol 2017;92:232-9. [PMID: 28356334 DOI: 10.1124/mol.116.108142] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
497 Chockley PJ, Keshamouni VG. Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression. J Immunol. 2016;197:691-698. [PMID: 27431984 DOI: 10.4049/jimmunol.1600458] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
498 Lambert AW, Pattabiraman DR, Weinberg RA. Emerging Biological Principles of Metastasis. Cell. 2017;168:670-691. [PMID: 28187288 DOI: 10.1016/j.cell.2016.11.037] [Cited by in Crossref: 1131] [Cited by in F6Publishing: 962] [Article Influence: 282.8] [Reference Citation Analysis]
499 Msaki A, Pastò A, Curtarello M, Arigoni M, Barutello G, Calogero RA, Macagno M, Cavallo F, Amadori A, Indraccolo S. A hypoxic signature marks tumors formed by disseminated tumor cells in the BALB-neuT mammary cancer model. Oncotarget 2016;7:33081-95. [PMID: 27105499 DOI: 10.18632/oncotarget.8859] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
500 Chernysheva O, Markina I, Demidov L, Kupryshina N, Chulkova S, Palladina A, Antipova A, Tupitsyn N. Bone Marrow Involvement in Melanoma. Potentials for Detection of Disseminated Tumor Cells and Characterization of Their Subsets by Flow Cytometry. Cells 2019;8:E627. [PMID: 31234438 DOI: 10.3390/cells8060627] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
501 Matthew EM, Zhou L, Yang Z, Dicker DT, Holder SL, Lim B, Harouaka R, Zheng SY, Drabick JJ, Lamparella NE, Truica CI, El-Deiry WS. A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cells. Oncotarget 2016;7:3662-76. [PMID: 26695546 DOI: 10.18632/oncotarget.6657] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
502 Konczalla L, Ghadban T, Effenberger KE, Wöstemeier A, Riethdorf S, Uzunoglu FG, Izbicki JR, Pantel K, Bockhorn M, Reeh M. Prospective Comparison of the Prognostic Relevance of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow of a Single Patient's Cohort With Esophageal Cancer. Ann Surg 2021;273:299-305. [PMID: 31188197 DOI: 10.1097/SLA.0000000000003406] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
503 Wu XL, Tu Q, Faure G, Gallet P, Kohler C, Bittencourt Mde C. Diagnostic and Prognostic Value of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: a systematic review and meta-analysis. Sci Rep 2016;6:20210. [PMID: 26831813 DOI: 10.1038/srep20210] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
504 Chimonidou M, Kallergi G, Georgoulias V, Welch DR, Lianidou ES. Breast cancer metastasis suppressor-1 promoter methylation in primary breast tumors and corresponding circulating tumor cells. Mol Cancer Res 2013;11:1248-57. [PMID: 23744981 DOI: 10.1158/1541-7786.MCR-13-0096] [Cited by in Crossref: 41] [Cited by in F6Publishing: 21] [Article Influence: 5.1] [Reference Citation Analysis]
505 Ghajar CM, Bissell MJ. Metastasis: Pathways of parallel progression. Nature 2016;540:528-9. [PMID: 27974802 DOI: 10.1038/nature21104] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 4.4] [Reference Citation Analysis]
506 Gkountela S, Szczerba B, Donato C, Aceto N. Recent advances in the biology of human circulating tumour cells and metastasis. ESMO Open 2016;1:e000078. [PMID: 27843628 DOI: 10.1136/esmoopen-2016-000078] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 5.2] [Reference Citation Analysis]
507 Sleeman J, Steeg PS. Cancer metastasis as a therapeutic target. Eur J Cancer 2010;46:1177-80. [PMID: 20307970 DOI: 10.1016/j.ejca.2010.02.039] [Cited by in Crossref: 125] [Cited by in F6Publishing: 111] [Article Influence: 11.4] [Reference Citation Analysis]
508 Diepenbruck M, Christofori G. Epithelial-mesenchymal transition (EMT) and metastasis: yes, no, maybe? Curr Opin Cell Biol. 2016;43:7-13. [PMID: 27371787 DOI: 10.1016/j.ceb.2016.06.002] [Cited by in Crossref: 246] [Cited by in F6Publishing: 229] [Article Influence: 49.2] [Reference Citation Analysis]
509 Ryser MD, Min BH, Siegmund KD, Shibata D. Spatial mutation patterns as markers of early colorectal tumor cell mobility. Proc Natl Acad Sci U S A 2018;115:5774-9. [PMID: 29760052 DOI: 10.1073/pnas.1716552115] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 7.3] [Reference Citation Analysis]
510 Caswell DR, Swanton C. The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome. BMC Med 2017;15:133. [PMID: 28716075 DOI: 10.1186/s12916-017-0900-y] [Cited by in Crossref: 89] [Cited by in F6Publishing: 75] [Article Influence: 22.3] [Reference Citation Analysis]
511 Knopeke MT, Ritschdorff ET, Clark R, Vander Griend DJ, Khan S, Thobe M, Shear JB, Rinker-Schaeffer CW. Building on the foundation of daring hypotheses: using the MKK4 metastasis suppressor to develop models of dormancy and metastatic colonization. FEBS Lett 2011;585:3159-65. [PMID: 21925502 DOI: 10.1016/j.febslet.2011.09.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
512 Losa F, Soler G, Casado A, Estival A, Fernández I, Giménez S, Longo F, Pazo-Cid R, Salgado J, Seguí MÁ. SEOM clinical guideline on unknown primary cancer (2017). Clin Transl Oncol 2018;20:89-96. [PMID: 29230692 DOI: 10.1007/s12094-017-1807-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
513 Hubert S, Abastado J. Les étapes précoces du processus métastatique. Med Sci (Paris) 2014;30:378-84. [DOI: 10.1051/medsci/20143004010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
514 Woestemeier A, Harms-Effenberger K, Karstens KF, Konczalla L, Ghadban T, Uzunoglu FG, Izbicki JR, Bockhorn M, Pantel K, Reeh M. Clinical Relevance of Circulating Tumor Cells in Esophageal Cancer Detected by a Combined MACS Enrichment Method. Cancers (Basel) 2020;12:E718. [PMID: 32197486 DOI: 10.3390/cancers12030718] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
515 Nair R, Teo WS, Mittal V, Swarbrick A. ID proteins regulate diverse aspects of cancer progression and provide novel therapeutic opportunities. Mol Ther 2014;22:1407-15. [PMID: 24827908 DOI: 10.1038/mt.2014.83] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
516 Tachtsidis A, McInnes LM, Jacobsen N, Thompson EW, Saunders CM. Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells. Clin Exp Metastasis 2016;33:521-50. [PMID: 27189371 DOI: 10.1007/s10585-016-9796-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
517 Sleeman JP, Nazarenko I, Thiele W. Do all roads lead to Rome? Routes to metastasis development. Int J Cancer 2011;128:2511-26. [PMID: 21365648 DOI: 10.1002/ijc.26027] [Cited by in Crossref: 83] [Cited by in F6Publishing: 74] [Article Influence: 8.3] [Reference Citation Analysis]
518 Tang J, Zuo Z, Kong X, Steiner M, Yin Z, Perry JK, Zhu T, Liu D, Lobie PE. Signal Transducer and Activator of Transcription (STAT)-5A and STAT5B Differentially Regulate Human Mammary Carcinoma Cell Behavior. Endocrinology 2010;151:43-55. [DOI: 10.1210/en.2009-0651] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
519 Eccles SA. Models for Evaluation of Targeted Therapies of Invasive and Metastatic Disease. In: Teicher BA, editor. Tumor Models in Cancer Research. Totowa: Humana Press; 2011. pp. 447-95. [DOI: 10.1007/978-1-60761-968-0_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
520 Joosse SA, Pantel K. Genetic traits for hematogeneous tumor cell dissemination in cancer patients. Cancer Metastasis Rev 2016;35:41-8. [PMID: 26931653 DOI: 10.1007/s10555-016-9611-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
521 Li J, Ma X, Chakravarti D, Shalapour S, DePinho RA. Genetic and biological hallmarks of colorectal cancer. Genes Dev 2021;35:787-820. [PMID: 34074695 DOI: 10.1101/gad.348226.120] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
522 Garg AD, Galluzzi L, Apetoh L, Baert T, Birge RB, Bravo-San Pedro JM, Breckpot K, Brough D, Chaurio R, Cirone M, Coosemans A, Coulie PG, De Ruysscher D, Dini L, de Witte P, Dudek-Peric AM, Faggioni A, Fucikova J, Gaipl US, Golab J, Gougeon ML, Hamblin MR, Hemminki A, Herrmann M, Hodge JW, Kepp O, Kroemer G, Krysko DV, Land WG, Madeo F, Manfredi AA, Mattarollo SR, Maueroder C, Merendino N, Multhoff G, Pabst T, Ricci JE, Riganti C, Romano E, Rufo N, Smyth MJ, Sonnemann J, Spisek R, Stagg J, Vacchelli E, Vandenabeele P, Vandenberk L, Van den Eynde BJ, Van Gool S, Velotti F, Zitvogel L, Agostinis P. Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death. Front Immunol 2015;6:588. [PMID: 26635802 DOI: 10.3389/fimmu.2015.00588] [Cited by in Crossref: 187] [Cited by in F6Publishing: 181] [Article Influence: 31.2] [Reference Citation Analysis]
523 Nguyen N, Couts KL, Luo Y, Fujita M. Understanding melanoma stem cells. Melanoma Manag 2015;2:179-88. [PMID: 26594315 DOI: 10.2217/mmt.15.4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
524 Bartkowiak K, Effenberger KE, Harder S, Andreas A, Buck F, Peter-katalinic J, Pantel K, Brandt BH. Discovery of a Novel Unfolded Protein Response Phenotype of Cancer Stem/Progenitor Cells from the Bone Marrow of Breast Cancer Patients. J Proteome Res 2010;9:3158-68. [DOI: 10.1021/pr100039d] [Cited by in Crossref: 69] [Cited by in F6Publishing: 55] [Article Influence: 6.3] [Reference Citation Analysis]
525 Buim ME, Fanelli MF, Souza VS, Romero J, Abdallah EA, Mello CA, Alves V, Ocea LM, Mingues NB, Barbosa PN, Tyng CJ, Chojniak R, Chinen LT. Detection of KRAS mutations in circulating tumor cells from patients with metastatic colorectal cancer. Cancer Biol Ther 2015;16:1289-95. [PMID: 26252055 DOI: 10.1080/15384047.2015.1070991] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
526 Sleeman JP, Christofori G, Fodde R, Collard JG, Berx G, Decraene C, Rüegg C. Concepts of metastasis in flux: the stromal progression model. Semin Cancer Biol 2012;22:174-86. [PMID: 22374376 DOI: 10.1016/j.semcancer.2012.02.007] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 6.7] [Reference Citation Analysis]
527 Zhao Y, Tan Y, Meng T, Liu X, Zhu Y, Hong Y, Yang X, Yuan H, Huang X, Hu F. Simultaneous targeting therapy for lung metastasis and breast tumor by blocking the NF-κB signaling pathway using Celastrol-loaded micelles. Drug Deliv 2018;25:341-52. [PMID: 29355035 DOI: 10.1080/10717544.2018.1425778] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 7.3] [Reference Citation Analysis]
528 El Rassy E, Kattan J, Pavlidis N. A new entity of abdominal squamous cell carcinoma of unknown primary. Eur J Clin Invest 2019;49:e13111. [PMID: 30908618 DOI: 10.1111/eci.13111] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
529 Gonzalez-Rivera M, Picornell AC, Alvarez EL, Martin M. A Cross-Sectional Comparison of Druggable Mutations in Primary Tumors, Metastatic Tissue, Circulating Tumor Cells, and Cell-Free Circulating DNA in Patients with Metastatic Breast Cancer: The MIRROR Study Protocol. JMIR Res Protoc 2016;5:e167. [PMID: 27531554 DOI: 10.2196/resprot.6024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
530 Lee KH, Kim JS, Cheon KS, Song IS, Kang DY, Kim JY. TisN0M1 Sigmoid Colon Cancer: A Case Report. Ann Coloproctol 2014;30:141-6. [PMID: 24999466 DOI: 10.3393/ac.2014.30.3.141] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
531 Vlaeminck-Guillem V. When Prostate Cancer Circulates in the Bloodstream. Diagnostics (Basel) 2015;5:428-74. [PMID: 26854164 DOI: 10.3390/diagnostics5040428] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
532 Chen YC, Gowda R, Newswanger RK, Leibich P, Fell B, Rosenberg G, Robertson GP. Targeting cholesterol transport in circulating melanoma cells to inhibit metastasis. Pigment Cell Melanoma Res 2017;30:541-52. [PMID: 28685959 DOI: 10.1111/pcmr.12614] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
533 Fabbri F, Carloni S, Zoli W, Ulivi P, Gallerani G, Fici P, Chiadini E, Passardi A, Frassineti GL, Ragazzini A, Amadori D. Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs. Cancer Lett 2013;335:225-31. [PMID: 23419522 DOI: 10.1016/j.canlet.2013.02.015] [Cited by in Crossref: 171] [Cited by in F6Publishing: 142] [Article Influence: 21.4] [Reference Citation Analysis]
534 Boral D, Liu HN, Kenney SR, Marchetti D. Molecular Interplay between Dormant Bone Marrow-Resident Cells (BMRCs) and CTCs in Breast Cancer. Cancers (Basel) 2020;12:E1626. [PMID: 32575420 DOI: 10.3390/cancers12061626] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
535 Yates LR, Knappskog S, Wedge D, Farmery JHR, Gonzalez S, Martincorena I, Alexandrov LB, Van Loo P, Haugland HK, Lilleng PK, Gundem G, Gerstung M, Pappaemmanuil E, Gazinska P, Bhosle SG, Jones D, Raine K, Mudie L, Latimer C, Sawyer E, Desmedt C, Sotiriou C, Stratton MR, Sieuwerts AM, Lynch AG, Martens JW, Richardson AL, Tutt A, Lønning PE, Campbell PJ. Genomic Evolution of Breast Cancer Metastasis and Relapse. Cancer Cell 2017;32:169-184.e7. [PMID: 28810143 DOI: 10.1016/j.ccell.2017.07.005] [Cited by in Crossref: 294] [Cited by in F6Publishing: 231] [Article Influence: 73.5] [Reference Citation Analysis]
536 Wiles ET, Bell R, Thomas D, Beckerle M, Lessnick SL. ZEB2 Represses the Epithelial Phenotype and Facilitates Metastasis in Ewing Sarcoma. Genes Cancer 2013;4:486-500. [PMID: 24386509 DOI: 10.1177/1947601913506115] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
537 Cleris L, Daidone MG, Fina E, Cappelletti V. The Detection and Morphological Analysis of Circulating Tumor and Host Cells in Breast Cancer Xenograft Models. Cells 2019;8:E683. [PMID: 31284534 DOI: 10.3390/cells8070683] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
538 Strino F, Parisi F, Micsinai M, Kluger Y. TrAp: a tree approach for fingerprinting subclonal tumor composition. Nucleic Acids Res 2013;41:e165. [PMID: 23892400 DOI: 10.1093/nar/gkt641] [Cited by in Crossref: 89] [Cited by in F6Publishing: 58] [Article Influence: 11.1] [Reference Citation Analysis]
539 Wang HM, Wu MH, Chang PH, Lin HC, Liao CD, Wu SM, Hung TM, Lin CY, Chang TC, Tzu-Tsen Y, Hsieh JC. The change in circulating tumor cells before and during concurrent chemoradiotherapy is associated with survival in patients with locally advanced head and neck cancer. Head Neck 2019;41:2676-87. [PMID: 30903634 DOI: 10.1002/hed.25744] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
540 Giancotti FG. Mechanisms governing metastatic dormancy and reactivation. Cell 2013;155:750-64. [PMID: 24209616 DOI: 10.1016/j.cell.2013.10.029] [Cited by in Crossref: 315] [Cited by in F6Publishing: 270] [Article Influence: 45.0] [Reference Citation Analysis]
541 Huang S. Genetic and non-genetic instability in tumor progression: link between the fitness landscape and the epigenetic landscape of cancer cells. Cancer Metastasis Rev 2013;32:423-48. [PMID: 23640024 DOI: 10.1007/s10555-013-9435-7] [Cited by in Crossref: 101] [Cited by in F6Publishing: 66] [Article Influence: 14.4] [Reference Citation Analysis]
542 Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011;147:275-292. [PMID: 22000009 DOI: 10.1016/j.cell.2011.09.024] [Cited by in Crossref: 2075] [Cited by in F6Publishing: 1839] [Article Influence: 207.5] [Reference Citation Analysis]
543 Nathanson SD, Detmar M, Padera TP, Yates LR, Welch DR, Beadnell TC, Scheid AD, Wrenn ED, Cheung K. Mechanisms of breast cancer metastasis. Clin Exp Metastasis 2021. [PMID: 33950409 DOI: 10.1007/s10585-021-10090-2] [Reference Citation Analysis]
544 Bae HW, Yoon KH, Kim JH, Lim SM, Kim JY, Park HS, Park S, Kim SI, Cho YU, Park BW. Impact of Micrometastatic Axillary Nodes on Survival of Breast Cancer Patients with Tumors ≤2 cm. World J Surg 2018;42:3969-78. [PMID: 29959491 DOI: 10.1007/s00268-018-4725-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
545 Baccelli I, Trumpp A. The evolving concept of cancer and metastasis stem cells. J Cell Biol. 2012;198:281-293. [PMID: 22869594 DOI: 10.1083/jcb.201202014] [Cited by in Crossref: 261] [Cited by in F6Publishing: 207] [Article Influence: 29.0] [Reference Citation Analysis]
546 Demeulemeester J, Kumar P, Møller EK, Nord S, Wedge DC, Peterson A, Mathiesen RR, Fjelldal R, Zamani Esteki M, Theunis K, Fernandez Gallardo E, Grundstad AJ, Borgen E, Baumbusch LO, Børresen-Dale AL, White KP, Kristensen VN, Van Loo P, Voet T, Naume B. Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing. Genome Biol 2016;17:250. [PMID: 27931250 DOI: 10.1186/s13059-016-1109-7] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 9.2] [Reference Citation Analysis]
547 Nedosekin DA, Verkhusha VV, Melerzanov AV, Zharov VP, Galanzha EI. In vivo photoswitchable flow cytometry for direct tracking of single circulating tumor cells. Chem Biol 2014;21:792-801. [PMID: 24816228 DOI: 10.1016/j.chembiol.2014.03.012] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
548 Makhoul I, Montgomery CO, Gaddy D, Suva LJ. The best of both worlds - managing the cancer, saving the bone. Nat Rev Endocrinol 2016;12:29-42. [PMID: 26503674 DOI: 10.1038/nrendo.2015.185] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
549 Willaert W, Mareel M, Van De Putte D, Van Nieuwenhove Y, Pattyn P, Ceelen W. Lymphatic spread, nodal count and the extent of lymphadenectomy in cancer of the colon. Cancer Treatment Reviews 2014;40:405-13. [DOI: 10.1016/j.ctrv.2013.09.013] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 5.9] [Reference Citation Analysis]
550 Ashworth A, Lord CJ, Reis-Filho JS. Genetic interactions in cancer progression and treatment. Cell 2011;145:30-8. [PMID: 21458666 DOI: 10.1016/j.cell.2011.03.020] [Cited by in Crossref: 290] [Cited by in F6Publishing: 229] [Article Influence: 29.0] [Reference Citation Analysis]
551 Burinaru TA, Avram M, Avram A, Mărculescu C, Ţîncu B, Ţucureanu V, Matei A, Militaru M. Detection of Circulating Tumor Cells Using Microfluidics. ACS Comb Sci 2018;20:107-26. [PMID: 29363937 DOI: 10.1021/acscombsci.7b00146] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
552 Angelucci A, Alesse E. Molecular Pathology of Cancer Metastasis: Suggestions for Future Therapy. In: Bologna M, editor. Biotargets of Cancer in Current Clinical Practice. Totowa: Humana Press; 2012. pp. 469-515. [DOI: 10.1007/978-1-61779-615-9_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
553 Masoodi T, Siraj S, Siraj AK, Azam S, Qadri Z, Parvathareddy SK, Tulbah A, Al-Dayel F, AlHusaini H, AlOmar O, Al-Badawi IA, Alkuraya FS, Al-Kuraya KS. Genetic heterogeneity and evolutionary history of high-grade ovarian carcinoma and matched distant metastases. Br J Cancer 2020;122:1219-30. [PMID: 32099096 DOI: 10.1038/s41416-020-0763-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
554 Das R, Gregory PA, Hollier BG, Tilley WD, Selth LA. Epithelial plasticity in prostate cancer: principles and clinical perspectives. Trends Mol Med 2014;20:643-51. [PMID: 25262538 DOI: 10.1016/j.molmed.2014.09.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
555 Brix N, Tiefenthaller A, Anders H, Belka C, Lauber K. Abscopal, immunological effects of radiotherapy: Narrowing the gap between clinical and preclinical experiences. Immunol Rev. 2017;280:249-279. [PMID: 29027221 DOI: 10.1111/imr.12573] [Cited by in Crossref: 84] [Cited by in F6Publishing: 82] [Article Influence: 28.0] [Reference Citation Analysis]
556 Aguirre-Ghiso JA. On the theory of tumor self-seeding: implications for metastasis progression in humans. Breast Cancer Res 2010;12:304. [PMID: 20459594 DOI: 10.1186/bcr2561] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
557 Deryugina EI, Quigley JP. The Role of Matrix Metalloproteinases in Cellular Invasion and Metastasis. In: Parks WC, Mecham RP, editors. Extracellular Matrix Degradation. Berlin: Springer Berlin Heidelberg; 2011. pp. 145-91. [DOI: 10.1007/978-3-642-16861-1_7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
558 Zhou F, Gao J, Xu Z, Li T, Gao A, Sun F, Wang F, Wang W, Geng Y, Zhang F, Xu ZP, Yu H. Overcoming immune resistance by sequential prodrug nanovesicles for promoting chemoimmunotherapy of cancer. Nano Today 2021;36:101025. [DOI: 10.1016/j.nantod.2020.101025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
559 Yuan W, Liu Z, Wang Y, Liu M, Pan Y, Lei W, Yang H, Xu R, Zhang L, Cai H, Li J, Ke Y. Clonal evolution of esophageal squamous cell carcinoma from normal mucosa to primary tumor and metastases. Carcinogenesis 2019;40:1445-51. [PMID: 31570939 DOI: 10.1093/carcin/bgz162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
560 Wang S, Zheng G, Cheng B, Chen F, Wang Z, Chen Y, Wang Y, Xiong B. Circulating tumor cells (CTCs) detected by RT-PCR and its prognostic role in gastric cancer: a meta-analysis of published literature. PLoS One. 2014;9:e99259. [PMID: 24901848 DOI: 10.1371/journal.pone.0099259] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
561 Pradhan S, Sperduto JL, Farino CJ, Slater JH. Engineered In Vitro Models of Tumor Dormancy and Reactivation. J Biol Eng 2018;12:37. [PMID: 30603045 DOI: 10.1186/s13036-018-0120-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
562 Li D, Zhang Y, Li R, Guo J, Wang C, Tang C. Selective Capture and Quick Detection of Targeting Cells with SERS-Coding Microsphere Suspension Chip. Small 2015;11:2200-8. [DOI: 10.1002/smll.201402531] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
563 Tam KW, Ho CT, Tu SH, Lee WJ, Huang CS, Chen CS, Wu CH, Lee CH, Ho YS. α-Tocopherol succinate enhances pterostilbene anti-tumor activity in human breast cancer cells in vivo and in vitro. Oncotarget 2018;9:4593-606. [PMID: 29435127 DOI: 10.18632/oncotarget.23390] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
564 Meseure D, Drak Alsibai K, Nicolas A. Pivotal role of pervasive neoplastic and stromal cells reprogramming in circulating tumor cells dissemination and metastatic colonization. Cancer Microenviron 2014;7:95-115. [PMID: 25523234 DOI: 10.1007/s12307-014-0158-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
565 Comen E, Morris PG, Norton L. Translating mathematical modeling of tumor growth patterns into novel therapeutic approaches for breast cancer. J Mammary Gland Biol Neoplasia 2012;17:241-9. [PMID: 23011603 DOI: 10.1007/s10911-012-9267-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
566 Jour G, Al-rohil RN. Cutaneous metastases. Diagnostic Histopathology 2019;25:87-95. [DOI: 10.1016/j.mpdhp.2018.12.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
567 Rzhevskiy A, Kapitannikova A, Malinina P, Volovetsky A, Aboulkheyr Es H, Kulasinghe A, Thiery JP, Maslennikova A, Zvyagin AV, Ebrahimi Warkiani M. Emerging role of circulating tumor cells in immunotherapy. Theranostics 2021;11:8057-75. [PMID: 34335980 DOI: 10.7150/thno.59677] [Reference Citation Analysis]
568 Dhillon AS, Tulchinsky E. FRA-1 as a driver of tumour heterogeneity: a nexus between oncogenes and embryonic signalling pathways in cancer. Oncogene 2015;34:4421-8. [PMID: 25381818 DOI: 10.1038/onc.2014.374] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
569 Yang C, Chen F, Wang S, Xiong B. Circulating Tumor Cells in Gastrointestinal Cancers: Current Status and Future Perspectives. Front Oncol 2019;9:1427. [PMID: 31921680 DOI: 10.3389/fonc.2019.01427] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
570 Nguyen DX. Tracing the origins of metastasis. J Pathol 2011;223:195-204. [PMID: 21125675 DOI: 10.1002/path.2801] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
571 Jin X, Mu P. Targeting Breast Cancer Metastasis. Breast Cancer (Auckl) 2015;9:23-34. [PMID: 26380552 DOI: 10.4137/BCBCR.S25460] [Cited by in Crossref: 35] [Cited by in F6Publishing: 45] [Article Influence: 5.8] [Reference Citation Analysis]
572 Gaiani F, Marchesi F, Negri F, Greco L, Malesci A, de'Angelis GL, Laghi L. Heterogeneity of Colorectal Cancer Progression: Molecular Gas and Brakes. Int J Mol Sci 2021;22:5246. [PMID: 34063506 DOI: 10.3390/ijms22105246] [Reference Citation Analysis]
573 Yamaguchi J, Kokuryo T, Yokoyama Y, Ebata T, Ochiai Y, Nagino M. Premalignant pancreatic cells seed stealth metastasis in distant organs in mice. Oncogene 2021;40:2273-84. [PMID: 33649537 DOI: 10.1038/s41388-021-01706-8] [Reference Citation Analysis]
574 Sharma D, Koshy G, Grover S, Sharma B. Sentinel Lymph Node Biopsy: A new approach in the management of head and neck cancers. Sultan Qaboos Univ Med J 2017;17:e3-e10. [PMID: 28417021 DOI: 10.18295/squmj.2016.17.01.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
575 Wang Z, Xia H, Chen B, Wang Y, Yin Q, Yan Y, Yang Y, Tang M, Liu J, Zhao R, Li W, Zhang Q, Wang Y. pH‐Amplified CRET Nanoparticles for In Vivo Imaging of Tumor Metastatic Lymph Nodes. Angew Chem Int Ed 2021;60:14512-20. [DOI: 10.1002/anie.202102044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
576 Han M, Watts JA, Jamshidi-Parsian A, Nadeem U, Siegel ER, Zharov VP, Galanzha EI. Lymph Liquid Biopsy for Detection of Cancer Stem Cells. Cytometry A 2021;99:496-502. [PMID: 32869909 DOI: 10.1002/cyto.a.24221] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
577 Gires O, Stoecklein NH. Dynamic EpCAM expression on circulating and disseminating tumor cells: causes and consequences. Cell Mol Life Sci. 2014;71:4393-4402. [PMID: 25103341 DOI: 10.1007/s00018-014-1693-1] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 9.0] [Reference Citation Analysis]
578 Rossi F, Noren H, Jove R, Beljanski V, Grinnemo KH. Differences and similarities between cancer and somatic stem cells: therapeutic implications. Stem Cell Res Ther 2020;11:489. [PMID: 33208173 DOI: 10.1186/s13287-020-02018-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
579 Das S, Batra SK. Pancreatic cancer metastasis: are we being pre-EMTed. Curr Pharm Des. 2015;21:1249-1255. [PMID: 25506899 DOI: 10.2174/1381612821666141211115234] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
580 Ishaque N, Abba ML, Hauser C, Patil N, Paramasivam N, Huebschmann D, Leupold JH, Balasubramanian GP, Kleinheinz K, Toprak UH, Hutter B, Benner A, Shavinskaya A, Zhou C, Gu Z, Kerssemakers J, Marx A, Moniuszko M, Kozlowski M, Reszec J, Niklinski J, Eils J, Schlesner M, Eils R, Brors B, Allgayer H. Whole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancer. Nat Commun 2018;9:4782. [PMID: 30429477 DOI: 10.1038/s41467-018-07041-z] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 15.7] [Reference Citation Analysis]
581 Schadendorf D, Fisher DE, Garbe C, Gershenwald JE, Grob JJ, Halpern A, Herlyn M, Marchetti MA, McArthur G, Ribas A, Roesch A, Hauschild A. Melanoma. Nat Rev Dis Primers 2015;1:15003. [PMID: 27188223 DOI: 10.1038/nrdp.2015.3] [Cited by in Crossref: 212] [Cited by in F6Publishing: 179] [Article Influence: 35.3] [Reference Citation Analysis]
582 Fernandez SV, Bingham C, Fittipaldi P, Austin L, Palazzo J, Palmer G, Alpaugh K, Cristofanilli M. TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients. Breast Cancer Res 2014;16:445. [PMID: 25307991 DOI: 10.1186/s13058-014-0445-3] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 11.0] [Reference Citation Analysis]
583 Jose CC, Jagannathan L, Tanwar VS, Zhang X, Zang C, Cuddapah S. Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1. Mol Carcinog 2018;57:794-806. [PMID: 29528143 DOI: 10.1002/mc.22802] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
584 Long Y, Lu Z, Xu S, Li M, Wang X, Zhang Z, He Q. Self-Delivery Micellar Nanoparticles Prevent Premetastatic Niche Formation by Interfering with the Early Recruitment and Vascular Destruction of Granulocytic Myeloid-Derived Suppressor Cells. Nano Lett 2020;20:2219-29. [DOI: 10.1021/acs.nanolett.9b03883] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 13.0] [Reference Citation Analysis]
585 Zacksenhaus E, Liu J, Jiang Z, Yao Y, Xia L, Shrestha M, Ben-david Y. Transcription Factors in Breast Cancer—Lessons From Recent Genomic Analyses and Therapeutic Implications. Chromatin Proteins and Transcription Factors as Therapeutic Targets. Elsevier; 2017. pp. 223-73. [DOI: 10.1016/bs.apcsb.2016.10.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
586 Unger C, Kramer N, Unterleuthner D, Scherzer M, Burian A, Rudisch A, Stadler M, Schlederer M, Lenhardt D, Riedl A, Walter S, Wernitznig A, Kenner L, Hengstschläger M, Schüler J, Sommergruber W, Dolznig H. Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms. Oncogene 2017;36:5341-55. [PMID: 28534511 DOI: 10.1038/onc.2017.116] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 9.5] [Reference Citation Analysis]
587 Lee SY, Haq F, Kim D, Jun C, Jo HJ, Ahn SM, Lee WS. Comparative genomic analysis of primary and synchronous metastatic colorectal cancers. PLoS One. 2014;9:e90459. [PMID: 24599305 DOI: 10.1371/journal.pone.0090459] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 10.0] [Reference Citation Analysis]
588 Marino N, Woditschka S, Reed LT, Nakayama J, Mayer M, Wetzel M, Steeg PS. Breast cancer metastasis: issues for the personalization of its prevention and treatment. Am J Pathol 2013;183:1084-95. [PMID: 23895915 DOI: 10.1016/j.ajpath.2013.06.012] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
589 Falck AK, Bendahl PO, Ingvar C, Isola J, Jönsson PE, Lindblom P, Lövgren K, Rennstam K, Fernö M, Rydén L. Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study. BMC Cancer 2012;12:403. [PMID: 22963449 DOI: 10.1186/1471-2407-12-403] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
590 Liang H, Yang C, Zhang B, Wang H, Liu H, Zhao Z, Zhang Z, Wen X, Lai X. Hydroxyethyl starch 200/0.5 decreases circulating tumor cells of colorectal cancer patients and reduces metastatic potential of colon cancer cell line through inhibiting platelets activation. Med Oncol 2015;32:151. [PMID: 25832864 DOI: 10.1007/s12032-015-0601-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
591 Nadal R, Lorente JA, Rosell R, Serrano MJ. Relevance of molecular characterization of circulating tumor cells in breast cancer in the era of targeted therapies. Expert Rev Mol Diagn. 2013;13:295-307. [PMID: 23570407 DOI: 10.1586/erm.13.7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
592 Barrière G, Riouallon A, Renaudie J, Tartary M, Rigaud M. Mesenchymal and stemness circulating tumor cells in early breast cancer diagnosis. BMC Cancer. 2012;12:114. [PMID: 22443102 DOI: 10.1186/1471-2407-12-114] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 7.0] [Reference Citation Analysis]
593 Tahergorabi Z, Khazaei M, Moodi M, Chamani E. From obesity to cancer: a review on proposed mechanisms. Cell Biochem Funct. 2016;34:533-545. [PMID: 27859423 DOI: 10.1002/cbf.3229] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 9.6] [Reference Citation Analysis]
594 Lazăr AD, Dinescu S, Costache M. The Non-Coding Landscape of Cutaneous Malignant Melanoma: A Possible Route to Efficient Targeted Therapy. Cancers (Basel) 2020;12:E3378. [PMID: 33203119 DOI: 10.3390/cancers12113378] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
595 Zhou Q, Li W, Zhang X, Chen Y, Chen X, Guan Y, Ding Y, Wen X, Xia Q, Zhou Q, Peng R, Hou J, Zhu X, Zeng Y, Zhang X. The Mutation Profiles of Common Oncogenes Involved in Melanoma in Southern China. Journal of Investigative Dermatology 2012;132:1935-7. [DOI: 10.1038/jid.2012.64] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
596 Oskarsson T, Batlle E, Massagué J. Metastatic stem cells: sources, niches, and vital pathways. Cell Stem Cell. 2014;14:306-321. [PMID: 24607405 DOI: 10.1016/j.stem.2014.02.002] [Cited by in Crossref: 408] [Cited by in F6Publishing: 346] [Article Influence: 58.3] [Reference Citation Analysis]
597 Arouri A, Mouritsen OG. Anticancer double lipid prodrugs: liposomal preparation and characterization. Journal of Liposome Research 2011;21:296-305. [DOI: 10.3109/08982104.2011.563365] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
598 Birkbak NJ, McGranahan N. Cancer Genome Evolutionary Trajectories in Metastasis. Cancer Cell 2020;37:8-19. [PMID: 31935374 DOI: 10.1016/j.ccell.2019.12.004] [Cited by in Crossref: 46] [Cited by in F6Publishing: 31] [Article Influence: 46.0] [Reference Citation Analysis]
599 Stodden GR, Lindberg ME, King ML, Paquet M, MacLean JA, Mann JL, DeMayo FJ, Lydon JP, Hayashi K. Loss of Cdh1 and Trp53 in the uterus induces chronic inflammation with modification of tumor microenvironment. Oncogene 2015;34:2471-82. [PMID: 24998851 DOI: 10.1038/onc.2014.193] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
600 Bera A, Lewis SM. Regulation of Epithelial-to-Mesenchymal Transition by Alternative Translation Initiation Mechanisms and Its Implications for Cancer Metastasis. Int J Mol Sci 2020;21:E4075. [PMID: 32517298 DOI: 10.3390/ijms21114075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
601 Armacki M, Polaschek S, Waldenmaier M, Morawe M, Ruhland C, Schmid R, Lechel A, Tharehalli U, Steup C, Bektas Y, Li H, Kraus JM, Kestler HA, Kruger S, Ormanns S, Walther P, Eiseler T, Seufferlein T. Protein Kinase D1, Reduced in Human Pancreatic Tumors, Increases Secretion of Small Extracellular Vesicles From Cancer Cells That Promote Metastasis to Lung in Mice. Gastroenterology 2020;159:1019-1035.e22. [PMID: 32446697 DOI: 10.1053/j.gastro.2020.05.052] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
602 Felsenstein M, Hruban RH, Wood LD. New Developments in the Molecular Mechanisms of Pancreatic Tumorigenesis. Adv Anat Pathol. 2018;25:131-142. [PMID: 28914620 DOI: 10.1097/pap.0000000000000172] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 8.3] [Reference Citation Analysis]
603 Chan KK, Matchett KB, McEnhill PM, Dakir el H, McMullin MF, El-Tanani Y, Patterson L, Faheem A, Rudland PS, McCarron PA, El-Tanani M. Protein deregulation associated with breast cancer metastasis. Cytokine Growth Factor Rev 2015;26:415-23. [PMID: 26088937 DOI: 10.1016/j.cytogfr.2015.05.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
604 Tsai FC, Wang MC, Lo JF, Chou CM, Lin YL. Spatiotemporal dynamics of the biological interface between cancer and the microenvironment: a fractal anomalous diffusion model with microenvironment plasticity. Theor Biol Med Model 2012;9:36. [PMID: 22889191 DOI: 10.1186/1742-4682-9-36] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
605 Brouwer A, De Laere B, Peeters D, Peeters M, Salgado R, Dirix L, Van Laere S. Evaluation and consequences of heterogeneity in the circulating tumor cell compartment. Oncotarget. 2016;7:48625-48643. [PMID: 26980749 DOI: 10.18632/oncotarget.8015] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 11.7] [Reference Citation Analysis]
606 Palange AL, Di Mascolo D, Singh J, De Franceschi MS, Carallo C, Gnasso A, Decuzzi P. Modulating the vascular behavior of metastatic breast cancer cells by curcumin treatment. Front Oncol 2012;2:161. [PMID: 23162792 DOI: 10.3389/fonc.2012.00161] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
607 Hartkopf AD, Wallwiener M, Kommoss S, Taran F, Brucker SY. Detection of disseminated tumor cells from the bone marrow of patients with early breast cancer is associated with high 21-gene recurrence score. Breast Cancer Res Treat 2016;156:91-5. [DOI: 10.1007/s10549-016-3728-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]